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A B S T R A C T .
The livers of rats dosed acutely with As III developed a 
lipid vacuolation of the periportal area, a general loss of 
glycogen, dilation of the bile canaliculi, and various degrees of 
mitochondrial condensation. These morphological changes were more 
evident in phenobarbitone pretreated rats.
As III induced hepatic haem oxygenase activity, regardless 
of the pretreatment. This induction was reflected by an increase 
in the excretion of bilirubin 6 hr after treatment. The source of 
haem being degraded was investigated by injecting rats with 5- 
amino-[ 4 - ] - lae vu 1 inic acid. The radioactive label was excreted
before the bulk of the bilirubin, suggesting that hepatic haem 
was the first to be degraded. The excretion of haem is presumably 
due to haemoglobin breakdown, since immunoelectrophoresis show 
haptoglobin to be increased in the bile of As III rats.
Cytochrome P-450 levels and ethoxycoumarin-O-deethylase 
a c t i v i t y  g r a d u a l l y  d e c r e a s e d  w i t h  t i m e  a f t e r  As III 
administration. The effect appears to be isoenzyme non-specific 
because As III administration to phenobarbitone pretreated rats 
s i g n i f i c a n t l y  d e c r e a s e d  p e n t o x y r e s o r u f i n - 0 - d e e t h y l  ase, 
benzphetamine-N-demethylase, and ethoxyresorufin-O-deethylase 
activities, but did not significantly affect ethoxycoumarin-O- 
deethy lase .
_In v itro, and at high concentrations. As III produced no 
change in the rat liver microsomal cytochrome P-450 content, but 
produced a fall in cytochrome concentration when NADPH was 
added. No effect was found at concentrations likely to be present
- 11 -
in v_ivo. Hence, it appears that As III may bind apo-cytochrome P- 
45 0, rather than holo-cytochrome P-450, and as a consequence of 
this, the "free" haem pool increases, triggering the induction of 
HO .
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Benzphetamine-N-demethylase.
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Sodium arsenite.
Sodium arsenate.
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INTRODUCTION.
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1. INTRODUCTION.
1 . 1 ARSENIC.
1.1.1 111 or i c a 1 Aspec t s_^  . ■
Arsenic is an ubiquitous and abundant element in the. earth's 
crust and the biosphere. This element enjoys a dual reputation. 
It is widely known as a toxin, although popular myth has greatly 
exaggerated its power to kill, it has also been regarded by many 
as a tonic and medicine.
The toxicity of several arsenical compounds to man has been 
well known for many centuries. Although it is much less toxic 
than many other c h e m i c a l s  it has long p r o v i d e d  a simple, 
inexpensive and safe vehicle in the art of homicide, indeed 
because intoxicated people do not present pathognomonic signs. As 
a consequence it was undetectable until the last century, when 
the Marshall test was developed which provided an accurate and 
sensitive method for its detection in minute amounts (Emsley, 
1985).
Arsenic compounds have also been used, since ancient times, 
as medicines. Hippocrates used arsenic as a remedy for sores, and 
more recently it has been used for the treatment of rheumatism, 
arthritis, asthma, malaria, diabetes and venereal diseases. In 
the eighteenth century, several solutions containing arsenic were 
used as tonics. Among examples of this are: Dr. Fowler's solution 
or l_iquor arsenical is (1% arsenic trioxide) developed as a tonic 
for the curing of fevers and headaches. This tonic remained in 
use for 150 years. Other arsenic medicaments were Donovan's
-  3
solution (arsenic iodide) and de Valagin's solution (arsenic 
trichloride), (Emsley, 1985). Some traditional medicines still 
use inorganic salts of arsenic in their formulations, such is the 
case of a Burmese preparation containing a. mixture of arsenic 
trisulphide, mercuric sulphide and sulphur which is used for the 
treatment of headaches.
At the beginning of this century, Ehrlich synthesized 
Salvarsan, an organo-arsenica1 compound which became extensively 
used in the treatment of syphilis; this compound remained in use 
until the advent of penicillin. Other arsenicals, such as atox i l , 
carbarsone, g l y c o b i a r s o l , melarsoprol and tryparsamide, all 
organ0 -arsenica 1 s , are still in use as antiparasitic drugs, 
(Martindale, 1977). In addition, organo-arsenicals, such as 
raroxone ( 3-ni t r o -A -h ydroxypheny1 a rso ni c acid) are currently 
used in farms to stimulate growth of pigs and hens (Ishinishi, et 
a_l., 1986). However, the majority of arsenic compounds in recent
years have been substituted for more effective and less toxic 
medicaments.
1.1.2. Physical and chemical properties.
Elemental arsenic.
Arsenic, a metalloid, constitutes about 5 X 10"^ percent of 
the earth's crust, thus ranking as the 20th most abundant 
element. It exists principally in the form of sulphide minerals.
Arsenic has an atomic number of 33 and an atomic weight of 
74.9. It has at least two allotropie forms: ' 1) C r y s t alline 
hexagonal rhombic grey arsenic or metallic arsenic with typical
- 4 -
metallic conductivity and a density of 5.78 g cm~^. If grey 
arsenic is heated, it sublimes without melting at 800°C forming a 
lemon-yellow gas.
2) Yel low arsenic is a metastable form, obtained when 
arsenic gas is condensed at very low temperature, which as far as 
properties and structure are concerned, is completely analogous 
to cubic white phosphorus. If the condensation takes place on a 
surface that has a temperature of TOO - 200°C, a lustrous black 
coating is obtained (black arsenic). The coating layers are 
similar to those of metallic arsenic, but the individual layers 
have not yet attained complete order with respect to each other, 
(Hagg, 1 969).
The electronic distribution of arsenic is: 1s^, 2s^, 2p^, 
3s^, 3p^, 4s^, 3d^^ and 4p^, which confers to arsenic the
following valences: -3, +3 and, +5. Valences of -1 and +1 have 
also been considered when arsenic is part of an organic molecule 
(Knowles and Benson, 1983).
Trivalent arsenic (A s III).
Arsenic trioxide (AspO^) has been prepared since ancient 
times by roasting arsenic sulphides. It is commercially prepared 
by recovery from copper or lead smelter flue dusts. A product of 
higher purity, "white arsenic" (99% arsenic trioxide) is obtained 
when the p r e v i o u s  c o m m e r c i a l  p r e p a r a t i o n  is r e s u b l i m e d .  
Arsenopyrite (FeAsS) is the main source of arsenic trioxide. The 
most important producers in the world are France, Mexico and 
Sweden. The world's production of arsenic during the year of 1979 
was 34.5 million kg, ( I ARC, 1 980).
Arsenic trioxide is a rather stable compound, which at
- 5  -
ordinary temperatures forms colourless cubical crystals. It has a 
melting point of 3 12.3°C, and a boiling point of 465°C. Arsenic 
trioxide has a low water solubility. When arsenic trioxide is in 
solution, it forms arsenious acid, whose structure has not been 
firmly established but it is believed to be HgAsOg. Arsenious 
acid is a weak triba s i c  acid, when it reacts with basic 
solutions, arsenite salts are formed (Jolly, 1966).
Sodium arsenite, which is also called sodium meta-arsenite,' 
is produced commercially by the reaction of arsenic trioxide with 
sodium hydroxide. It is very soluble in water.
Pent avalent arsenic (A s V ) .
The oxidation of arsenic with concentrated nitric acid 
produces arsenic acid H^AsO^. Diarsenic pentoxide (AspO^) is 
obtained by careful dehydration of arsenic acid. Diarsenic pewTOx/de 
easily redissolves in water to give arsenic acid. The reaction 
between arsenic acid and metallic hydroxides produces arsenates, 
from which sodium, calcium and lead arsenates are the most 
important commercial products.
Arsenic is used in many different industries: as an element
it is used to produce a l l o y s  with copper and iron g i v i n g  
increased hardness and heat resistance to the product (Carapella, 
1978). Arsenic is used in the manufacture of synthetic crystals 
for the microelectronic industries, (La Due, 1984). Arsenic 
derivatives are also used in the agrochemical industry as a 
insecticide; in the glass industry as decolourants;
i'essei; e x i e - n t i i r )  -the chemi 'ca.L industry as intermediary products.
During the First World War, arsenic was used for warfare through
-  6
the synthesis of L e w i s i t e  (t r i e h o r o v i n y l  arsine), a very 
effective toxic gas. (lARC, 1980).
1.1.3 Distribution of arsenic in the environment.
The occurrence of elemental arsenic in the environment is 
believed to be very small in comparison with the amount of 
arsenic o c c u r r i n g  in other c h e m i c a l  forms. A r s e n i c  exist 
principally in sulphide minerals such as arsenical pyrites 
(FeAsS), orpiment (A s pS ^ ), and realgar (As^S^). Some arsenic 
exists as the oxide claudetite ('AspO^), and as arsenides FeAs, 
CoAsp, and NiAs. Generally, the element is not mined as such but 
it is recovered as a by-product from the smelting of copper, 
lead, zinc and other ores.
The average content of arsenic in the soil varies between 3 
and 5 mg/kg. Crystalline rocks of the Earth crust contain a mean 
of 2 mg/kg of arsenic, but in some places their concentrations 
are considerably higher (Schroeder and Balassa, 1966). For 
example, in the Region Lagunera, Mexico, values between 3 and 9 
mg/kg have been found (Gonzalez, 1977).
Organic and inorganic arsenic is also widely present in 
natural water. The World Health Organization's standard for 
inorganic arsenic in drinking water is 0.05 mg/1, (WHO, 1971). 
The arsenic content varies from 0.82 ug/1 in rainwater to 1000 
ug/1 or more in certain springs and hot springs. However, when 
abnormally high concentrations are present in surface water, 
these are usually due to man-made contamination. Groundwater 
normally contains low levels of arsenic, averaging 1 ug/1,
dep e n d i n g  on its c o n c e n t r a t i o n s  in the bedrock, but high
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carbonate springwaters in the USSR and New Zealand have been 
reported to contain as much as 0.4 to 1.3 mg As/I (Schroeder and 
Balassa, 1966). In Taiwan, artesian well water has been shown to 
contain up to 1.8 mg As/1 (Kuo, 1968). In the Region Lagunera, in 
Mexico, arsenic concentration in well waters varies from 0.4 to 
1.0 mg As/1. In one case, which was followed over a period of 
three years (1975-1978), the concentration was 0.411 + 0.11 mg 
As/1, and these levels remained fairly constant over that period 
of time (Cebrian and Albores, 1983).
The chemical form of arsenic in different groundwaters is 
largely unknown. Clement and Fouts (1973) found that 25 to 50% of 
the arsenic contained in a few samples was in the form of 
tri valent arsenic. Harrington, (l 978), reported that 39% of the 
arsenic present in some samples was As III. In the Region 
Lagunera, Mexico, pentavalent arsenic comprised 70% of the total 
(Cebrian,1986).
Arsenic is also present in the air and humans can be exposed 
to arsenic concentrations which can range from a few nanograms to 
a few tenths of a micrograms per cubic metre close to an emission 
source. The statutory recommended for arsenic exposure in the 
work place vary according to the compound. There are no generally 
accepted international regulations in this matter (lARC, 1980), 
but the U.S. A. Occupational Safety and Health Administration 
(1979) have considered a tolerance in a working environment of 10 
ug/m-^, averaged over a 8 hr period for inorganic arsenic (all 
inorganic compounds containing arsenic except arsine, lead 
arsenate and calcium arsenate). There are no standards for
airborne arsenic in a non-occupational environment.
Most food contains low levels of arsenic, norma l l y  below 
0.25 mg/kg (Jellineck and Corne 1 iussen, 1977). However, arsenic
concentrations in marine seaweed in general are considerably 
higher. Many species of bony fish contain 1 to 10 mg/kg, while 
certain bottomfeeding fish, crustaceans and seaweed may contain 
over 100 m g / k g (Lunde, 1 973). Tolerance for arsenic content in 
kidney and liver of cattle and horses is 2.7 mg/kg, and that for 
meat and fat, and meat product of cattle and horses is 0.7 mg/kg, 
(Interagency Regulatory Liaison Group, 1978). The World Health 
Organization (1981) has calculated that the total dietary intake 
of arsenic is less than 0.2 mg/day, but this figure depends, to a 
great extent, on the amount of seafood in the diet (WHO, 1973).
There are also regulations for the concentration of arsenic 
in pesticides, industrial exposure to arsenicals , etc. These 
regulations are described in lARC (1980).
1.1.4 Metabolism of arsenic.
1.1.4.1 Absorption of arsenic.
Inhalation.
Airborne arsenic dust is mainly present as arsenic trioxide, 
absorption depends on the size and the chemical composition of 
the particles. Particles over 5.5 um will be deposited on the 
mucus of the upper respiratory tract, and will be transported by 
mucocilliary secretions and swallowed. Arsenic is finally 
a b s o r b e d  i n the g a s t r o i n t e s t i n a l  tract a c c o r d i n g  to the 
solubility of these particles. Particles below 7 um may be
-  9 -
deposited in the lower respiratory tract (Vahter, 1983a). 
Clearance of arsenicals from the lung depends on the chemical 
properties of the compound, the lower the solubility, the longer 
the retention in the lungs ( Per shagen, 198 1).
Gastrointestinal absorption.
Absorption of inorganic compounds depends on their water 
solubility. Nearly 100% of any dose of trivalent or pentavalent 
inorganic arsenic given to mice, is absorbed from the g a s t r o ­
intestinal tract when it is given in aqueous solution (Vahter and 
Norin, 1980). However, there are some species differences, since 
Char bonn e a u , £jt al^.,(1 980). have reported that Syrian golden 
hamsters absorbed only 30% of the dose.
When particles of arsenic trioxide are given orally to rats 
and rabbits, the absorption is very low, and as much as 70% of a 
single dose is readily excreted and recovered in faeces (Ariyoshi 
and Ikeda, 19 74).
The g a s t r o i n t e s t i n a l  a b s o r p t i o n  of arsenic is a l s o  
influenced by other factors such as : different portions of the 
gastrointestinal tract have different absorption rates, the small 
intestine being the most efficient (Otani, 1957); the composition 
of the diet, since casein, or trypsin-hydrolyzed casein or 
phosphates, decrease the absorption of arsenic (Nosaki, e_t a_lj_, 
1975). The nutritional status also affects absorption,since food 
deprived animals retain more arsenic over a period of 48 hr than 
animals fed ^  libitum, (Vahter and Norin, 1980).
absorption.
Inorganic trivalent compounds are irritants to skin and 
mucous membranes. The skin lesions arise either due to a direct
— 10 —
irritant action, or to an allergie response (Fielder, 1986). 
Systemic toxic effects have resulted from occupational accidents 
where arsenicals have been splashed on workers, indicating that 
the skin is a possible route for absorption of arsenic (Garb and 
Hine 1977).
1.1.4.2 Transport of arsenic.
Once arsenic has been absorbed, it is transported through 
out the organism via blood (WHO, 1981). Arsenic clearance from 
the blood is fairly quick in most species (Vahter, 1983), for 
example, the rabbit’s blood concentration of arsenic decreases in 
a biphasic manner, exhibiting a fast plasma clearance with a 
h a l f - l i f e  of 2 hr, f o l l o w e d  by a second phase of s l o w  
disappearance with a half-life of 42 hr (Bertolero a_3^ 1981),
plasma proteins have shown low affinity for arsenic (Marafante, 
e_t a .,1 982).
The clearance of arsenic from rat blood is exceptionally 
long, with a half-life of 60 days (Ariyoshi and Ikeda, 1 97 4), 
resulting apparently from binding to haemoglobin in intact 
erythrocytes. Herman and Clarkson (1983) have speculated that it 
is dimethy1 arsinic acid (DMA), an arsenic metabolite, that is 
actually bound to haemoglobin. In this regard it is notable that 
in v itro assays have shown that both rat and mice red blood cells 
have low affinity for arsenic. (Vahter, 1981).
1.1.4.3 Tissue distribution of arsenic.
The observed pattern of distribution of arsenic in tissues
- I l ­
ls affected by the time interval after exposure, the valence 
state of the arsenic compound and species variation (Vahter, 
1 9 8 3 ) .
After dosing mice and rabbits intravenously with  ^^  A s III 
and ^ ^ A s V, Lindgren, e jt a _1 (1982), found that arsenic,
r e g a r d l e s s  of the v a l e n c e  state, reaches its highest 
concentrations in liver, kidney, lungs and bile 30 mi n after 
dosing. These concentrations decreased with time, and 2 4 hr 
later, the liver arsenic concentration was only 2% of that found 
previously It would appear that arsenic clearance from most of 
the tissues is fairly rapid. The skin is an exception, since 
arsenic levels in this tissue tend to decrease more slowly.
In human patients, terminally ill with malignant diseases, 
the pattern of d i s t r i b u t i o n  of r a d i o l a b e l  led a rsenic, 
administered intravenously, was similar to that found in other 
species. The highest concentrations of arsenic were found in the 
liver and the kidney (Ducoff, 1948).
As far as the valence state is concerned, it seems that As 
III is more efficiently retained in tissues than As V, probably 
because As III binds more efficiently to cell components than As 
V.
In general, the patterns of distribution of As III and As V 
are similar. However, As III tends to concentrate mainly in 
liver, followed by kidney, bile and skin (Lindgren, e_t a_l. 1982), 
w h i l e  As V is m a i n l y  l o c a l i z e d  in the kidney, s k e l e t o n ,  
intestinal mucosa and hair (Deak, e_t a_l. 1 976).
There are some species differences in the arsenic retention 
pattern. Marmoset monkeys retain higher concentration of arsenic
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for longer periods than other species (Vahter, ejb a^^, 1 982).
Rats are also exceptional since they tend to accumulate arsenic 
in the red blood cells (Ducoff, 1948). These observations may be 
a consequence of species differences in the biotransformation of 
arsenic.
^i^2_t i^_b_u_t 2^25 £ £  ^^ s u b c e llular
distribution and retention of arsenic in hepatocytes has been 
estimated in rabbits intravenously injected with [?^As]-As V. The 
cytosolic fraction was shown to retain the highest amount of 
arsenic, followed by nuclei, lysosomal + microsomes, and 
mitochondrial fractions. The relative proportion, but not the 
concentration, of arsenic in the different organelles remained 
stable 24 hr after dosing (Marafante je^  a 1., 1985).
The hepatic m i c r o s o m a l  f r a c t i o n  of m a r m o s e t s  dosed 
intraperitonea lly with ["^^AsJ-arsenite and killed 4 days later, 
was found to retain the highest amount of radiolabel, followed by 
nuclei, cytosol, mitochondrial and lysosomal fractions. In this 
experiment, arsenic was demonstrated to be tightly bound to the 
microsomal fraction (Vahter e_t a 1., 1982).
The species differences described above may be due to 
differences in the metabolism of arsenic.
1 . 1.4.3 Excretion of arsenic.
The major route of elimination of arsenic in all the species 
studied so far is via the kidneys (Vahter, 1983). However, there 
are marked differences in the rate of excretion of arsenic. Mice 
and rabbits excreted about 70% of intravenously injected ^  A s  -
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A s III via the kidneys in the first 2 4 hr f o l l o w i n g  
administration (Ducoff, 1948). In dogs, the renal clearance of a 
single dose of ^ A s as arsenic acid was identified as a two 
compartment system. The fastest component accounted for the 85.5% 
of the dose with a h a l f - l i f e  of 5.0 + 0.9 hr, the second
compartment accounted for a further 14 + 5% of the dose with a 
half-life of 2.4 + 0.6 days (Hollins, ejt a_lj_ 1979). DMA was the 
major excreted metabolite and accounted for 80% of the arsenic 
present in the urine, MMA was also excreted but in very low 
concentrations (Charbonneau e^ a j^_, 1979). Gins burg (1 96 5) has
reported that arsenite is excreted in the urine of dogs injected 
intravenously with arsenate, and suggested that the chemical 
reduction of arsenate is a prerequisite for its excretion into 
the urine. Cynomo1ogus monkeys also excreted arsenic readily into 
the urine, when 1 mg/kg body weig h t  of As 111 oxide was 
administered by gavage, 57% of the dose being excreted in the 
urine during the following 24 hr; the amount of arsenic excreted 
in faces was negligible (Charbonneau, e_t a 1., 1978).
Hamsters dosed orally with arsenic trioxide excreted 60% of 
the administered dose, 49% in the urine and 11% in faeces during 
the first 120 hr. Inorganic arsenic accounted for about one half 
of the total arsenic excretion in the urine. DMA was found to 
be the major component of the methylarsenic compounds excreted 
(Yamauchi and Yamamura, 1985).
When normal human subjects took oral doses of ^\As as 
arsenic acid, its excretion was represented by a three-phase 
process as follows: In the first, 65.9% was excreted with a half- 
life of 2.09 days; in the second, 30.4% with a h alf-life of 9.5
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days; and In the third 3.7% with a half-life of 38.4 days. Over a 
period of 7 days, 62.3% of the dose was excreted in the urine and 
6.1% in the faeces, (Pomroy, et a 1^, 1 980). In humans orally
dosed with '^^As, the arsenic in the urine consisted of 51% DMA, 
21% MMA, and 27% inorganic arsenic (Tam, _ejt a 1., 1 979).
Excretion of arsenic in the rat is slow in comparison with 
most other species. Rats intravenously dosed with sodium arsenite 
showed a cumulative urinary excretion of only 6%. + 0.39% of the 
administered dose during the following 24 hr (Cikrt and Bencko, 
1974).
Ariyoshi and Ikeda (1974) administered arsenic trioxide to 
rats and found that 68.6% of the dose was excreted in the feces 
in a period of 4 days, and 1.8% of the dose was excreted into the 
urine after 30 days. This suggests that the arsenic compound may 
not have been totally absorbed.
Arsenic is also excreted into the bile at different rates 
depending on its valency state. As III being more quickly removed 
than As V. The excretion of arsenic via bile was studied in rats 
dosed intravenously with 100 ug of sodium arsenite or sodium 
arsenate (containing per rat. The cumulative excretion via
bile after 24 hr for As 111 and As V were 10.82 + 8.9% and 7.42 +
0.75% of the total dose respectively (Cikrt and Bencko, 1974).
Klaassen (197 4) found that when rats were intravenously 
dosed with arsenic chloride, arsenic rapidly reached the liver 
and was excreted in the bile. The maximum rate excretion for 
arsenic in the bile was during the first 15 min, the peak being 
r e a c h e d  4-6 min a f t e r  a d m i n i s t r a t i o n .  A f t e r  2 hr of
_ —
administration, 25% of the dose was excreted, but less than 10% 
of the dose was excreted into the faeces of intact rats over a 7 
days interval, suggesting the possibility of the presence of an 
enterohepatic circulation mechanism for arsenic. The excretion of 
arsenic into the bile can occur against a concentration gradient, 
this is suggestive of the presence of an active transport system.
Although the chemical form in which arsenic is excreted into
the bile is unknown, Vahter (1983) has suggested that it could be
a glutathione-arsenic complex.
There is a significant difference in biliary excretion of 
arsenic among various animal species. The administration of 
labelled arsenic chloride to rats has revealed that this species 
excretes arsenic into the bile 40 times faster than rabbits and 
800 times faster than dogs (Klaasen, 1974).
1. ^ ,  k Biotransformation of arsenic .
Arsenic is a very reactive element which can be oxidised, 
reduced or substituted with different organic moieties, among 
which methyl groups are the most common (Challenger, 1 945; 
Ginsburg, 1965; Edmonds and Francesconi, 1977a).
The biotransformation of arsenic was demonstrated as early
as 193 3, when Challenger _e^  a d e s c r i b e d  the production of
trimethylarsine and dimethylarsine by Scopulariopsis brev icou lis. 
The mould was grown up on fresh bread crumbs containing an 
aqueous solution of arsenic oxide. Me Bride and Wolfe (1971) have 
shown that M e_t han o ba£^e r_i um is able to produce dimethylarsine 
from arsenate, methyIcobalamin (methyl-B^g) as methyl-donor. The 
possible metabolic pathway is shown in figure 1.1.
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Marine species are also able to biotransform arsenic, eg. 
mussels ( M edulis £l:anu_la_tu_s ) , western rock lobster
( f £ i s n u _ s )  and stingray (Da_syajt_i^ 
w a ). All of them produce dimethy lated and t rimethy la ted
arsenic derivatives together with some inorganic arsenic (Edmonds 
and Francesconi, 1977a). Lunde (1977) has found that arsenic is 
present in the oil of marine organisms of which 10 to 30% are 
lipid-soluble organic derivatives. He suggested that in the 
remaining aqueous fraction obtained after boiling fish there may 
be an o r g a n o - a r s e n i c a l  in the form of base. E d m o n d s  and 
Francesconi (1977b) have identified arsenobetaine from the tail 
muscle of the western rock lobster.
CH
CH - As - CH - COO 
3 I 2
CH
3
Arsenobetaine.
In mammals. As V can be reduced to As 111 (Ginsburg, 1 965, 
Bencko e^ a 1_^ , 1 976); while As 111 can be oxidized to produce As 
V (Vahter and En vail, 1983), or methylated to form MM A or DMA. As 
we have seen, the latter is the most abundant of the excretory 
forms of arsenic (Vahter, 1981). Both, MMA and DMA have been 
isolated by ion-exchange chromatography from dog plasma and urine 
(Tam, e_t a_l_^ , 1 978).
The méthylation of arsenic modifies its distribution and 
retention in organism. Méthylation is less effective when the 
arsenic dose is increased (Vahter, 1981). Methylated arsenic is 
less reactive than As 111 and binds more weakly to proteins.
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Thus, the arsenic méthylation process has been regarded as a 
detoxification mechanism (Vahter, 1981).
Arsenic méthylation occurs in the majority of mammals, but 
there are some species differences. The marmoset monkey, for 
example, is able to reduce As V, but it cannot methylate As III. 
Therefore, the As III retention-time in tissues is longer and 
binds more extensively to microsomal membranes, as a consequence 
of these, arsenic is a very potent toxicant to marmosets (Vahter,
1 982, and Vahter e_t a ]^, 1 984). Man excretes a small but
significant amount of MMA (Crecelius, 1977).
In rats, arsenic is retained in the red blood cells bound to 
cell components; for this reason, rats have been considered as an 
inadequate model for arsenic metabolism studies (Marafante, 
1982). On the other hand, Rowland and Davies, 1982, have found 
that sodium arsenate is rapidly reduced and methylated in this 
species. Thus, in this regard rat does not seem to be markedly 
different from other species. It should be noted that the major­
ity of the arsenic appearing in red blood cells was DMA, with 
less than 15% of the total dose remaining as inorganic arsenic, 
after 1 hr of administration (Lerman and Clarkson, 1983).
DMA is very resistant to degradation and is consequently 
excreted unchanged in the urine of treated animals (Vahter and 
Marafante, 1985).
The tissue sites at which the méthylation process takes 
place is unknown, but liver and kidney slices incubated with 
arsenite solutions produce DMA (Lerman and Clarkson, 1983). The 
general pathway of the méthylation of arsenic is not we l l
- 1 9  -
understood. Uthe and Reinke, (1975) have stated that the 
reduction of. As V into As III is partially due to a purely 
chemical reaction, which can be favoured by the presence of 
cysteine. When As V enters the blood it is actively reduced into 
As 1 1 1 ,  this reduction might be mediated by intra c e l l u l a r  
glutathione. The resultant As 111 can be taken up by the liver 
and the kidney where active méthylation can take place (Lerman 
and Clarkson, 1983).
Challanger (1945) proposed that the méthylation of As 111 
involved an "activated" methionine derivative. This m e t h y 1- 
transfer compound was later identified as S-adenosyImethionine 
(SAM). SAM is the methyl-donor compound in the synthesis of . 
methylarsine by moulds which occurs in a reductive environment 
(Woods, 1 978). In micro-organisms, m e t h y l - B ^2 has proven
to be a methyl-donor (McBride and Wolfe, 1971).
In mammals, SAM is also the methyl-donor compound for the 
m é t h y l a t i o n  of As 1 1 1 .  When r a bbits were r e t r e a t e d  with 
p e r i o d a t e - o x i d i z e d  a d e nosine, an in h i b i t o r  of c e l l u l a r  
methylases, the As 111 méthylation decreased and the tissue 
retention increased with time (Marafante and Vahter, 1984). When 
As V was used, it was p a r t i a l l y  reduced and s u b s e q u e n t l y  
methylated. When this process was inhibited using periodate- 
oxidized a de nos in e , arsenic tissue retention was increased and 
its excretion is delayed in a similar fashion to that of animals 
treated with As 111 and periodate-oxidized adenosine (Marafante 
and Vahter, 1985).
Woods, ejt ( 1978) have suggested that biomet hylation of
y
metalloids by either SAM or methyl-B^2 occurs by a nucleophilie
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or free radical attack by metalloid salts of lower oxidation 
state. If correct it implies that for arsenic to be methylated, 
it must first be reduced to As III.
1.1.5 Arsenic effects on biomolecules.
The physico-chemical properties of As III and As V are 
reflected in their interactions with biological materials. As III 
reacts with nucleophiles, while As V usually substitutes for 
phosphate in m e t a b o l i c  reactions. The r e l e v a n c e  of these 
interactions are discussed below.
1. 1. 5. 1 ^  111 interactions with biological systems.
As 111 is an enzyme inhibitor, the mechanisms of inhibition 
being: 1) reaction with sulfhydryl groups, persulphide residues,
or metal ions, 2) r e a c t i o n  with s u b s t r a t e s  or enzyme 
intermediates, 3) inhibition of substrate binding, or 4) n o n ­
specific effects altering enzymical1 y important acidic or basic 
dissociation constants.
The most important mechanism by which As 111 inhibit.s 
enzymes is through its reaction with thiol residues (Leonard and 
Lawerys, 1980). The significance varies in different enzyme 
systems, for example, the activity of monothiol dependent 
enzymes, such as d-monoamine oxidases and transaminases, could 
be restored if an excess of glutathione is present (Barron and 
Singer,1943).
A second group of target enzymes is the dithiol-cofactor 
dependent enzymes, such as lipoate dehydrogenase and alpha
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oxidases, these are potentially more sensitive because of the 
arsenic avidity for dithiols. The stability of the arsenic 
complex in these cases is due to the formation of 5- or 6- 
membered rings (Peters, 1955), eg, the reaction between lipoic 
acid and lewisite, as illustrated, forms a 6- members ring;
(CH ) -COOH + 01 As-CH = CH-Cl------ V(CH ) -COOH
2 4 2 I I 2 4
SH SH S S
/  + 2  HCl
As-CH=CH-Cl
The great sensitivity of these systems to arsenite i^ n v_ivo 
.is due to the high s t a b i l i t y  of the A S - S 2 c o m p l e x e s .  
Substituted As 111 compounds are very useful tools to investigate 
-SH groups. Disubstituted arsenicals will react only with single 
thiol groups while monosubtituted arsenicals react with two thiol 
groups. Thus, using arsenic as a reagent is p o s s i b l e  to 
distinguish between single and vicinal pairs of thiol groups in 
enzymes (Weeb, 1966).
Phenylarsine oxide, an As 111 derivative, interferes with 
coenzyme (NAD/NADH) binding in beta-hydroxybutyrate dehydrogen­
ase, but it does not interfere in the substrate/product binding 
(Squibb and Fowler, 1981). An example of As 111 reacting with a 
metal ions is xanthine oxidase, in which arsenic reacts with 
molybdenum, inhibiting the electron transfer and substrate h y ­
droxylation by the enzyme, withôut. impairment of the substrate 
binding (Johnson and Rajagopalan, 1978).
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1.1.5.2 ^  V interaction wi^h biological systems.
As V i n t e r a c t s  with b i o l o g i c a l  systems m a i n l y  by 
substituting for phosphate, since these two ions are both 
isosteric and isoelectronic (Jolly, 1966). PhosphoglyceraIdehyde 
dehydrogenase is an example where arsenate can substitute for 
phosphate as an acceptor ion (Needham and Pillai, 1937).
As V can substitute for phosphate in the synthesis of ATP 
and form ADP-As V, which is rather unstable and more reactive 
than the last phosphoester bound in the ATP. This process is 
called "ar s en o 1y si s" and has been demonstrated in a number of 
biological systems (Doudoroff, e;t a 1^, 1 947). ADP-As V can be
synthesized from ADP and As V using s u c c i n a t e - e n e r g i z e d  
submitochondria 1 particles (Gresser, 1981); the product rapidly 
hydrolyses or reacts with glucose forming glucose-6-arsenate 
(Squibb and Fowler, 1983).
1. 1.5 . 3 Some specific effects of arsenic on metabolic pathways.
Due to the capacity of arsenic to bind proteins, arsenic is 
able to affect several metabolic pathways, either directly or 
indirectly.
Rats dosed subacutely with As V show a decrease in the 
activity of the pyruvate dehydrogenase complex (Schiller _e_t a 1.,
1977). This enzyme complex is inhibited both in the liver and in 
the intestine (Schiller ^  a 1., 1978), this effect may occur also
in other tissues. Arsenic can bind to any of the enzymes which 
constitute the pyruvate dehydrogenase complex. Because of the 
central role of this enzyme in mitochondrial metabolism, a
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decrease in its activity may affect the supply of acetyl-CoA; 
thus the tricarboxylic acid cycle, energy generation and fatty 
acid synthesis may be affected (Schiller ejt a 1., 1 978).
Arsenic administration to animals increases the NAD/NADH 
ratio (Fowler £_t a_l_^ , 1979), this increases the activity of the 
endogenous-NAD dependent mitochondrial aldehyde dehydrogenase, 
causing a stimulation in the oxidative metabolism of microsomal - 
generated formaldehyde (Fowler, 1982).
As far as respiratory-chain phosphorylation is concerned. As 
V is an uncoupler which induces a slight increase of ATPase 
activity in mitochondria. The biochemical mechanism involved is 
not f u l l y  understood, but it has been s u g g e s t e d  that the 
formation of an unstable As-ester may be invo l v e d  (Crane and 
Lipman, 1953). However, this hypothesis has been challenged by 
Mitchell e^ a 1. (1971), who have postulated a possible interac­
tion between arsenic (or inorganic phosphate) and ADP with a 
respiratory control site. Recently Gresser (1981) has d e m o n ­
strated the synthesis of ADP-arsenate by succinate-energized 
submitochondrial particles.
The synthesis and degradation of the haem group is also 
affected by arsenic; these effects will be discussed later.
1.1.6 Toxicology of arsenic.
As described above the valence state and water solubility of 
arsenic compounds, the route of administration and species 
studied are factors which influence the toxicity of arsenic. 
Nonetheless, the general symptoms of both but not the actual
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potency i nor gan ic A s 111 and As V toxicity are similar, this is 
presumably due to the ready interconversion between the two 
valency states (Ginsburg, 1965).
Arsenite is generally considered more toxic than arsenate. 
Rats orally exposed to As III or As V have a 96 hr L D ^ q of 1 1.2 
and 112 mg/kg body weight respectively ( Schroeder and Balassa, 
1966). Solubility also affects arsenic toxicity, for example, 
sodium arsenite, which is more soluble in water, is 10 times more 
toxic than As III oxide (Done and Peart, 1971).
The route of administration is also a factor in the toxicity 
of arsenic trioxide. In rabbit, the oral and subcutaneous minimal 
lethal dose (MLD) are 15 and 8 mg/kg body weight respectively 
(Venugopal and Luckey, 1978). As far as species differences are 
concerned, the oral arsenic trioxide MLD’s in guinea pig, rabbit 
and man are 30, 8 and 1 mg/Kg body weight (Venugopal and Luckey,
1978). The arsenic toxicity is determined particularly by the 
ability of the species to metabolize and detoxicate this element 
(Vahter, 1983a).
1. 1 . 6. 1 Acute toxicity.
The acute effects in man have been very well documented in 
the literature (WHO, 1981). In humans, the major lesion is 
profound gastrointestinal damage, resulting in severe vomiting 
and diarrhoea, often with blood tinged stools. Other symptoms and 
signs are: oedema, a severe drop in blood pressure and often
shock. There is also a loss of voluntary and i nvoluntary 
movement. Arsenic eventually produces a paralysis of respiratory 
muscles, which often leads to death (Squibb and Fowler, 1983).
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The effects observed in acutely intoxicated animals resemble 
those found in human subjects (WHO, 1981).
1 . 1 . 6 . 2 Subacute toxicity.
Arsenic produces systemic pathological changes in exposed 
individuals, mainly involving the respiratory, gastrointestinal, 
cardiovascular, nervous, and haematopoietic systems (WHO, 1981). 
Peripheral nervous disturbances have been found in surviving 
individuals exposed to high doses 1 to 2 weeks after ingestion 
(Le Quesne and McLeod, 1977).
1.1.6.3 Chronic toxicity.
The chronic symptoms of arsenic intoxication in humans have 
been well documented (WHO, 198 1). Chronic arsenic poisoning 
affects many of the same organ systems that are affected by acute 
arsenic exposure. The main signs and symptoms are hyperkeratosis 
of palms and soles, hyperpigmentation, desquamation and loss of 
hair. There are also circulatory disorders, first leading to 
severe artheriosclerosis followed by artheriosclerotic gangrene 
(Tseng, 1977). There is also h a e m a t o p o i e t i c  d e p r e s s i o n ;  
anhydremia due to loss of fluids from blood into tissue and the 
gastrointestinal tract; liver damage characterized by jaundice, 
portal cirrhosis and ascites; peripheral neuritis, anorexia and 
loss of weight (Webb, 1966). Diarrhoea, nausea, and epigastric 
pain are also exacerbated (Albores e_t a 1^,1 979, Cebrian and 
Albores, 1 983).
Arsenic has also been shown to be a teratogen. A dose of 20
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mg/kg body weight g iven to preg n a n t  hamsters induced 
malformations and resorption ( H o 1 m be r g e_t a 1 969). In humans, 
occupational exposure of women to arsenic dust in a Swedish 
smelter has resulted a significant increase in the frequency of 
congenital malformations (Nordstrom ^  a 1., 197^). Furthermore,
Sweins (1 983) has shown that As III increases the frequency of 
c h r o m o s o m a l  a b e r r a t i o n s ,  e s p e c i a l l y  gap breaks in the 
chromosomes.
Arsenic has also been categorized as a carcinogen by the 
lARC (1980). There is epidemiological evidence of the capacity of 
inorganic arsenic to produce both skin and lung cancer in humans, 
and there is also suggestive evidence that this element plays an 
aetiological role in the evolution of angiosarcoma of the liver 
(Pershagen, 1981). Intratracheal instillations of arsenic 
trioxide, charcoal, and sulphuric acid dissolved in distilled 
water and given to rats have produced pulmonary carcinomas 
(3/47). A l t h o u g h  these r e s u l t s  were not s t a t i s t i c a l l y  
significant, they were re 1 evant when considered in conjunction 
with other non-malignant lesions (Pershagen £t a 1., 1 984).
Nonetheless, arsenic may be an essential element, Nielsen e_t 
a 1 . (1 975) have claimed the existence of an As-deficiency
syndrome in rats, characterized by lower growth rate, rough hair 
coat, increase in spleen size, and a decrease in the haematocrit 
and in erythrocyte osmotic fragility. Frost (1983) reported that 
arsenic is essential in at least three further species.
1.1.7 Morphological effects of inorganic arsenic.
The liver is a target organ for inorganic arsenic. Arsenic
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is concentrated and retained in this organ (Vahter and Norin, 
1980). The liver is also the main site for arsenic detoxication 
by methyl a t i on (Vahter, 1981). Some morphological aspects of 
arsenic effect will be considered in this section.
1 . 1. 7 . 1 Histological effects of arsenic.
Gr o ss p a t h o 1.0 g y .
Arsenic e x p o s u r e  p roduces fatty liver, c e n t r i l o b u l a r  
necrosis, cirrhosis and cholestasis (Rouiller, 1964). Calmus et 
a 1. (1982) have associated liver diseases in human patients with 
high hepatic concentrations of arsenic and copper.
In animals, dogs and rats dosed with As III or As V showed 
enlargement and thickening of the wall of the common bile duct, 
which contained, in some cases, a green to grey fluid with a 
s e m i s o l i d  consistency. There was a p r o l i f e  r a tion of the 
i n t r a h e p a t i c  bile ducts and v a r i a t i o n  in the size of the 
hepatocytes (Byron e_t a 1., 1 967). These findings were confirmed 
by I s h i n i s h i  £_t a j. (1980) who r e p o r t e d  a dose d e p e n d e n t  
proliferation of the bile duct and chronic angitis. 
observ ations.
Arsenic may cause degenerative changes in hepatocytes such 
as cloudy swelling, trabeculae or irregularity of the hepatocyte 
tracts, necrosis and proliferation of intralobular bile ducts; 
all these changes were shown to be irreversible after cessation 
of arsenic administration (Ishinishi et al., 1980).
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1 . 1.7 . 2 Cytological arsenic effects.
Electron microscopic observations of hepatocytes from rats 
treated with As III showed vescicularisation of the endoplasmic 
reticulum with an increase in lysosomes. Large bundles of 
collagen also appeared near ducts (Ishinishi _e_t a 1., 1980). Rats
treated with sodium arsenate in drinking water for 6 weeks 
showed mitochondrial swelling, large bundles of connective fibres 
and large lipidic vacuoles (Fowler e^ a 1.,1977). In another long­
term study performed in mice treated with sodium arsenite in 
drinking water, it was found that the nuclear membranes and 
mitochondrial surfaces of hepatocytes were enlarged. Glycogen was 
less abundant in the treated animals and peroxisomes increased in 
number. These features were less apparent in mice exposed for 
longer, probably due to a developed tolerance to arsenic 
(Mohelska et al., 1980).
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1.2 SELENIUM
1.2.1 Introduction
Selenium is a metalloid located in the group VI of the 
periodic table, it is. member of the "chalcogens" family. Selenium 
has an atomic number of 34 and an atomic mass of 78.9; its 
valency states are -2, +4, and +6 (Hagg, 1969). The average
content of selenium on the earth's crust has been estimated at 
between 0.03 to 0.8 mg/kg, but there are some rocks near 
volcanoes which contain as much as 350 mg/kg. Most selenium 
produced is used in the electricity industry (Glover, 1983).
1.2.2 Biology of selenium.
Selenium has been shown to be an essential nutritional 
factor. Selenium forms part of enzymes such as glutathione 
peroxidase, glycine reductase, bacterial thiolase, and nicotinic 
acid hydrolase. In these enzymes selenium is found as seleno- 
cysteine, selenomethionine, or in a labile form. Selenium also 
forms part of a t-RNA (Stadtman, 1983). The role of selenium and 
vitamin E in protection against i^ n y;i^vo lipid peroxidation has 
been described by Tapp el (1 980), in which selenium is at active 
site of glutathione peroxidase and vitamin E accepts the lipid 
free radicals.
As a nutritional factor, selenium deficiency has been 
associated with Keshan disease, a cardiomyopathy of children and 
young women prevalent in China (Burk, 1 98 3). It also has been 
shown that under most dietary conditions, selenium reduces the 
spontaneous mammary tumour incidence in an inbred strain of mice.
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This a n t i c a r c in o g e n i c effect is i m p r o v e d  by s y n t h e t i c  
antioxidants, vitamin A and E, and ascorbic acid (Whanger, 1983).
1.. 2 . 3 Toxicology of selenium.
Acute toxicity.
The limits of selenium compatible with health are very 
narrow; 0.03 to 0.4 mg/kg body weight. Deficiency symptoms often 
appear under these limits, and above these limits, pathological 
manifestations are very likely to appear (Luckey and Venugopal, 
1978).
The MLD of 5 0 ^ cum selenite in several species is around
1.5 and 3 mg/kg body weight, r e g a r d l e s s  of the route of 
administration. Selenium is more toxic than arsenic, and 
selenites are more toxic than selenates, but elemental selenium 
is not toxic to animals (Luckey and Venugopal, 1978).
Acute toxic signs of selenium include nervousness, fever, 
vomiting, and somnolence. The blood pressure falls, and laboured 
breathing-taking is accompanied by tetanic and clonic spasms; 
death is caused by the toxic action on the nervous system 
(Hogberg and Alexander, 1986). Selenium was found to accumulate 
in pancreas, liver, spleen, and adipose tissue following the 
ingestion of selenium oxide in a human suicide attempt (Koppel et 
al^, 1986).
Chronic toxicity.
C h r o n i c  t o x i c i t y  in h u m a n s  is c h a r a c t e r i z e d  by 
gastrointestinal disturbances, icteroid discolouration of the 
skin and decayed teeth, inflammation of the perivascular lymph
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channels, haemolytic anaemia, serum bilirubin, and damage to 
spleen, pancreas and liver (Luckey and Venugopal, 1978).
A chronic syndrome, called "alkali disease" has been 
described in livestock grazing on rich selenium soils. The 
characteristics of this condition are lack of vitality, loss of 
appetite, emaciation, deformation and shedding of hoofs, loss of 
hair, and erosion of the joints of the long bones. I n m o r e  
advanced cases, liver cirrhosis may develop (Hogberg and 
Alexander, 1986).
Selenium is able to replace sulphur in enzymic reactions 
(Stadtman, 1983) since sulphate exists as SO^^", and selenate as
p
SeO^ . Furthermore, both ions are able to cross the c e l l u l a r  
membrane both by passive transport and mediated permeation. The 
capacity of Se IV to react with thiol groups present in many 
enzymes could be involved in its toxicity (Jennette, 1981)>
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1 . 3 THE LIVER
The liver is the largest gland in the body. It functions 
both as an exocrine gland secreting bile through the bile duct 
into the duodenum and as an endocrine gland synthesizing a 
variety of substances that are released directly into the blood 
stream. Because the liver is interposed between the intestine
and the systemic circulation, it receives in the portal blood the 
majority of nutrients and xenobiotics absorbed in the intestine 
these must be taken up, metabolized and stored in the hepatocytes 
or distributed elsewhere. The liver also receives both 
e n d o g e n o u s  and exo g e n o u s  toxic substances. They are 
biotransformed in the liver into more polar forms, often by 
conjugation and in many cases excreted into the bile.
1.3.1 Histological organization of the liver
The lobule has been considered the anatomical unit of the 
liver. It consist of interconnected plates or laminae of
epithelial cells radially disposed toward a branch of the hepatic 
vein (central vein). The lobule has a hexagonal shape; in each 
corner a portal canal is located. This portal space is formed by 
a branch of the portal vein, a small branch of the hepatic artery 
and a bile duct surrounded by common connective tissue. (Fawcet, 
1986).
Although the concept of the lobule has been convenient, it 
is in many ways inadequate because there is considerable evidence 
that h e p a t o c y t e s  are f u n c t i o n a l l y  a r r a n g e d  a l o n g  a 
micro circulatory pathway. Rappaport et al. (1954) proposed a
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different model based on the concept of the liver acinus which is 
defined as the tissue supplied by a terminal branch of portal 
vein and of the hepatic artery and drained by a terminal branch 
of the bile duct.
The acinus consists of 3 zones (figure 1.2) in which the 
parenchyma is centred around the terminal branches of the hepatic 
artery and portal vein. The nearest hepatocytes to the branches 
of the portal vein and the hepatic artery are considered as zone 
1, they receive the higher supply of oxygen and nutrients. The 
zone 2 cells are less favoured, and the zone 3, near to the 
central vein, are the least favoured; being the most liable to 
damage from anoxia, i s c h a e m i a  or n u t r i t i o n a l  d e f i c i e n c y  
(Rappaport ,1963). There are no physically recognizable limits 
of the acinus, the parenchyma being continuous from one acinus to 
the other. Consequently, if the supply and drainage of one unit 
fails, it would still be supplied and drained by others.
From the p h y s i o l o g i c a l  point of view, it seems that 
hepatocytes activity depends on their location into the liver; 
thus, 3 zones similar to those of Rappaport et. a l.(1 963) have 
been described as follows: 1) Zone of permanent function, which 
is periportal, 2) Zone of varying activity which is intermediate 
and 3) Zone of permanent repose which is centrilobular. This 
zonation has been defined by the differential deposit of glycogen 
and by the distribution and appearance of mitochondria in the 
hepatocytes.
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F I G U R E  1 . 2  D i a g r a m  i l l u s t r a t i n g  t h e  f u n c t i o n a l  u n i t  o f  t h e  
h e p a t i c  p a r e n c h y m a  ( t h e  a c i n u s ) .  R e d r a w n  f r o m  
F a w c e  t t  ( 1 9 8 6  ).
C e n t r o 1 o b u 1 a r  s p a c e . 
C e n t r a l  v e i n .
H e p a t i c  S i n u s o i d s
Zone I
P e r i p o r t a l  s p a c e .  
P o r t a l  v e i n ,  
h e p a t i c  a r t e r y ,  a n d  
bile duct.
H e p a t o c y t e s
D i r e c t i o n  o f  t h e  o x y g e n  a n d  n u t r i e n t s  s u p p l y  ( )
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1.3.2 T cytology of the hepatic parenchymal cell
The hepatocytes are polyhedral and present several surfaces; 
1) the perisinusoida1 space, 2) the bile canaliculus and 3) those 
in contact with adjacent liver cells. A diagram of a liver cell 
is presented in figure 1.3, and in plates 1.1, 1.2, and 1.3,
which illustrate the microstructure of the hepatocyte, either 
from unfasted and fasted rats. The nucleus is vesicular with 
scattered chromatin clumps and one or two nucleoli. . Cytosolic 
space is an extensive rough endoplasmic reticulum (RER) and 
smooth e n d o p l a s m i c  r e t i c u l u m  (SER). The RER forms many 
cisternae, and its membranes are full of ribosomes. There are 
some free ribosomes too. The smooth endoplasmic reticulum forms 
a closed meshed plexus of branching and anastomosing tubules. 
Glycogen can be adequately preserved and seems to be in close 
association with the SER.
Lipids occur in the form of osmiophylic droplets of varying 
size and can be distributed randomly in the cytosol.
Mitochondria are usually numerous and filamentous, but they 
may vary in size and shape in different parts of the lobule. 
Their lamellar or tubular cristae are projected into a matrix of 
relatively low density containing some granules.
The Golgi complex of the cell consists of several parts, 
each situated near a bile canaliculus. It consists of 3 to 4 flat 
sacculus or cisternae which contain at their ends moderately 
dense granules.
Peroxisomes are scattered in the cytoplasm, these are 
spherical in shape and measure 0.2 to 0.8 um. In rodents, they
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F I G U R E  1 . 3  D i a g r a m  i l l u s t r a t i n g  a h e p a t o c y t e ,  i t s  r e l a ­
t i o n s h i p s  w i t h  o t h e r s ,  a n d  w i t h  t h e  s i n u s o i d s  
T h e  s c h e m e  a l s o  s h o w s  t h e  p r i n c i p a l  c e l l u l a r  
e l e m e n t s  a s  o b s e r v e d  in e l e c t r o m i c r o g r a p h s ,  
( T a k e n  f r o m  F a w c e t t ,  1 9 8 6 ) .
^ s p o c e  of Disse
^Lipoprotein  
- 9 ^ % ^  Agronulor reticulum
Kupffer cell
Hepatic sinusoid
^% G olg i complex
m m  . ..Granular y.X. 
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Q
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contain a core of urlease. The peroxisomes usually contain 
catalase .
The bile canaliculi are situated between two hepatic cells. 
They form an i n t ercellular mesh connecting all the parenchyma. 
This mesh is maintained by the presence of tight junctions which 
seal the cell-cell junctions of the canaliculus and prevent its 
contents from escaping into the intercellular cleft on either 
side.
Abbreviations: Nucleus (N), mitochondria (M), smooth endoplasmic
reticulum (S ), rough endoplasmic reticulum (R } , peroxisomes 
(P), bile canaliculus (B ), Golgi complex (G), glycogen (GY).
w
iiT'
PLATE 1.1 Electron micrograph of a liver from a rat fed control 
diet.
B#
g. .. %
PLATE 1.2 Electron micrograph of liver from a rat fed a control 
diet and then fasted for 24 hr.
w
PLATE 1.3 Electron micrograph of a liver from a rat pretreated 
with phenobarbitone (0.3 mmol/kg body weight daily for 3 days), 
and then dosed with sodium arsenite (75 umol/kg body weight). 
This photomicrograph shows a bile duct (BD) within a periportal 
area with a space of Bering (H).
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1.4. CYTOCHROME P-450.
All the living organisms are exposed to xenobiotics which 
are defined as foreign compounds entering an organism but which 
do not serve as nutrients or as other essential factors to the 
living entity; Xenobiotics may affect a living organism through 
their pharmacological or toxicological properties. Such 
xenobiotics cannot be separated during ingestion from nutritional 
factors; once ingested they cannot be allowed to concentrate into 
the body beyond certain limits and must be eliminated. Since 
many compounds enter the organism their excretion cannot be 
efficiently achieved without conversion to water-soluble or less 
reactive compounds. Thus, a logical evolutionary step for the 
organism has been to develop a metabolizing system to achieve 
such conversion to more readily excretable compounds. This 
process is called detoxication. As a result of this, the 
monooxygenase systems were developed and in particular cytochrome 
P-450 which is widely distributed in all living systems. (Jenner 
e_t a ,1 983). Some aspects of cytochrome P-450 (P-450) will be
reviewed in this section.
1.4.1 G eneral aspects.
The presence of a drug metabolizing system in mammals has 
been known for more than 100 years , when hippuric acid was 
identified as a metabolite of benzoic acid (see H o r n i n g , 1983). 
More recently, it was shown that liver homogenates and liver 
sub c e l l u l a r  suspensions were able to perform an oxidative 
deamination of benzphetamine producing phenylacetone and ammonia.
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The microsomal location of the enzyme system responsible for the 
reaction and the dependence of this enzyme on the presence of 
NADPH and oxygen was described by Axelrod (1956). The first 
indication that the microsomal oxidation enzymes might be
cytochromes was the demonstration that the microsomal oxidation 
of estrogen was inhibited by CO (Ryan and Engel, 1957).
The presence of an unusual CO-binding pigment in liver
microsomes reduced with sodium dithionite was subsequently
described by Klingenberg (1958) and Garfinkel (1958); this 
pigment had an intense a b s o r p t i o n  band at 4 5 0 nm. The 
s p e c t r o p h o t o m e t r i c  p r o p e r t i e s  of this pigment and its
haemoprotein nature were described by Omura and Sato (1964a). 
The conversion of P-450 into P-420 following a treatment with 
heated snake venom (a phospholipase A) was also reported. The 
haem content of the converted pigment P-420 was estimated, and 
evidence was given that the pigment P-450 spectra was compatible 
with that of a cytochrome b (Omura and Sato,1964b).
The hepatic microsomal hydroxylating system consists of 
three components, cytochrome P-450 itself, NADPH-cytochrome c 
reductase, and phospholipids, mainly phosphatidyl choline. The 
reconstituted system was able to form an active complex which 
catalyzes the oxidation of lauric acid (Lu and Coon, 1968). An 
excellent review has been published by Lu and Levin (1974).
1.4.2 Location of the cytochrome P-450
C y t o c h r o m e  P-450 is w i d e l y  d i s t r i b u t e d  among l i v i n g  
organisms (Gustafsson, 1980). In mammals, cytochrome P-450 is 
found ubiquitously distributed in organs and tissues and is
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located in mitochondria, endoplasmic reticulum and nuclear 
membrane (Sato and Omura, 1978). In all vertebrates studied so 
far, it is bound to membrane (Schenkman and Gibson, 1983).
1.4.3 aspects of cytochrome P-450.
C y t o c h r o m e  P - 4 5 0  is a h a e m o p r o t e i n .  The f u l l  
characterization of this molecule was disclosed after overcoming 
the difficult purification of this protein. (Lu and Levin, 1974).
The unsaturated fatty acids involved in the phospholipids as 
a constituent of microsomal membranes are oxidizable in the 
presence of air producing lipid peroxidation and haem destruction
leading to the disappearance of the cytochrome P-450 without
formation of P-420.
Mu 11 er-Eberhard _et a 1., (1 969) identified Fe-protoporphyrin
IX as the prosthetic group of cytochrome P-4 50 cam, which 
catalyzes the 5-exo-hydroxylation of camphor in pseudomonas 
£U^^da, a strain of bacteria that degrades camphor to obtain 
carbon atoms and energy. In addition, Yu and Gunsalus (1974) 
isolated Fe-protoporphyrin IX from cytochrome P-450 cam. The 
prosthetic group was identified by the haemochromogen spectrum 
and by CO- Furthermore, the spectra and catalytic
activity of cytochrome P-450 could be satisfactorily restored on
addition of equimolar protohaem to the apo-cytochrome followed by
cysteine-glycer'ol treatment (Yu and Gunsalus, 1 974).
The molecular weight of the major cytochrome P-450 isoforms, 
using SDS-urea-polyacrylamide gel electrophoresis, vary from 
50000 to 55000. When the isolated microsomal cytochrome P-450 is
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resuspended in aqueous solution, it tends to polymerize, this 
fact being possibly due to its non-polar nature (Sato and Omura,
1978). Capaldi and Vanderkooi (1972) have shown that membrane 
proteins (such as cytochrome b ^  ) have polarities that are 
significantly lower than those of the majority of soluble 
proteins. Thus, low polarity proteins are likely to be totally 
or partially buried in the hydrophobic interior of the membrane; 
therefore, it is to be expected that microsomal P-450 contains 
numerous non-polar residues.
The' presence o f t h i o l  groups is a general feature in the 
structure of the cytochromes P-450. Based on the conversion of 
P-450 to P-420 by p-chloromercuribenzoate (PCMB), Mans on e_t a 1. 
(1965) proposed a coordination bond between a thiol group and the 
haem of this cytochrome. The binding between the haem and a 
thiol group has been confirmed spectrophotometrica1 ly by Co 11 man 
and Sorre1(1975).
Hydrophobic interactions may play an important role in 
maintaining the integrity of P-450 (Imai and Sato, 1967). These 
interactions may stabilize the cytochrome P-450 structure, 
thereby exposing a specific thiol group to the iron of the haem, 
(see Sato and Omura, 1 9 7 8). However, the substrate is usually 
bound on the side opposite to the thiol bond to the Fe-haem. 
(Groves, 1985).
Dus e t  a (1 982) reported that several thiol groups play 
crucial roles in the structure and function of P - 4 5 0 s . One of 
these thiol groups binds haemin to the catalytic centre, another 
may be involved in the formation of the substrate-enzyme complex.
The sequences of two cytochromes P-450 have been determined
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so far, the major phenobarbitone inducible cytochrome P-450 (P- 
450 PB) from rat liver microsomes (Fujii-Kuriyama e£ a_l, 1982) and 
camphor -inducible cytochrome P-450 (Haniu e_t a 1., 1982).
There is a statistically significant homology in the 
ami noacid sequence of two regions, called HR1 and HR2 of the 
major rat liver microsomal P-450 PB, and cytochrome P-450 cam. In 
accordance with the hydrophobic characteristics of the HR1 region 
and its p o s i t i o n  in the s e c o n d a r y  s t r u c t u r e  of these two 
proteins, it is suggested that the cysteinyl residue which binds 
the haem is located in this region ( Go t oh je£ a_l,1983).
1.4.4 Biochemical activation of oxygen by the cytochrome P-450.
The activity of monoxygenase or mixed function oxygenases is 
characterized by the incorporation of one atom of m o l e c u l a r  
oxygen into the substrate (SH); the other atom is used to form 
water. The reaction requires NADPH.
SH + NADPH + H+ + Og—  ►S-OH + NADP + HgO
The monoxygenase is an enzymic system which generates free 
radicals in a controlled manner (Dolphin, 1985). The production 
of free radicals is probably formed through the capacity to 
generate an iron-oxene, that is an oxygen atom coordinated to an 
iron porphyrin (Castro, 1982). However, the iron-protoporphyrin- 
oxene complex has not been synthetically produced.
Es tab rook e_t a 1., (1973) has proposed a 7 step cycle for the
activity of the cytochrome P-450. Although there is a great deal 
of aspects that need future research, the current knowledge 
allows the scheme shown in fig. 1-4.
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The main steps are; 1) Interaction between cytochrome P-450
and substrate (S). The iron in the P-450 is found as a mix of
"high spin" (the five valence electrons are paired) and "low
spin" M 2 g (four of the v a l e n c e  e l e c t r o n s  are paired) in
e q u i l i b r i u m .  In the m i c r o s o m a l  m e m b r a n e  the "low spin"
conformation seems to be predominant, but substrates produce a
shift in the equilibrium towards the "high spin" conformation.
The "high spin" cytochromes (M ° ^ ) are ready to be reduced. 2)
Reduction. NADPH reduces to at a faster velocity than
hs hs
that of the M ° ^  formation. 3) Oxygen activation. M o l e c u l a r
oxygen binds M^^ producing oxocytochrome which can exist in
hs
two e q u i l i b r a t i n g  forms: S u p e r o x i d e  anion bound ferric
h a e m o p r o t e i n s  M ° ^ Q 2 -(Fe"’Ü 2 ~) and oxygen bound f e r r o u s  
cytochrome P-450, M ^ ^02 (Fe"02). The exact nature of the one 
electron reduced oxygen is not clear but in some micro-organisms 
has been shown to auto-oxidize releasing super oxide anion. 4) 
Addition of a second electron. It has been postulated that a 
second NADPH m o l e c u l e  d o n ates a second electron, to the 
oxycy tochrome P- 450 p r o d u c i n g  a f e r r o u s - c y t o c h r o m e  P- 4 50 - 
superoxide. Cytochrome b^ has been suggested as an alternative 
(NADPH dependant) electron mediator. 5) Oxidation. The ferrous - 
cytochrome P-450 superoxide produces a molecule of water and an 
oxene. The oxene reacts with the s u b s t r a t e  y i e l d i n g  a 
hydroxylated product. 6) Products. Once products have been 
generated the cycle is completed and the cytochrome P-450 is 
released as a low spin complex. 7) The f errous-cy tochrome P -
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F I G U R E  1 . 4  T h e  c y t o c h r o m e  P - 4 5 0  m o n o - o x y g e n a s e  c y c l e  
( F r o m :  S c h e n k m a n  a n d  G i b s o n ,  1 9 8 3 ) .
SOH
HgO
NADPH-►Fp.j.
-CO
+00
m rsCO
I
1 - -
m “ 0 2
m°'+0o P
-> o; ?
K e y s :  M o n o - o x y g e n a s e  ( m ) ,  o x i d i z e d  i r o n  ( o ) ,  r e d u c e d  
i r o n  ( r ) ,  s t a t e  ( s ) ,  s u b s t r a t e  ( S ) ,  h i g h  s p i n  
( h ) ,  l o w  s p i n  ( 1 ) ,  s u p e r o x i d e  ( O ^ ) .
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450-superoxide complex is in equilibrium with ferric cytochrome- 
P-450-peroxide complex and peroxide ions could be released. 
(Shenkman and Gibson, 1983; Castro, 1982; Dolphin, 1985).
1.4.5 Induction of multiple forms of cytochrome P-450
The use of different inducers to manipulate the biochemical 
and biophysical properties of the microsomal monooxygenase system 
has been a very useful tool in establishing the identity of the 
different isoproteins which constitute this system.
More than 200 drugs, insecticides, carcinogens, and other 
c h e m i c a l s  are known to s t i m u l a t e  the a c t i v i t y  of drug- 
metabolizing enzymes in liver microsomes. These compounds show 
different pharmacological actions and there is no apparent 
relationship between either their actions or structure and their 
ability to induce enzymes. However, most of such inducers are 
soluble in lipids at physiological pH. 4 comprehensive list of 
i nducers and their e f fects on the m e t a b o l i s m  of s p e c i f i c  
substrates has been published by Conney (1967).
The inducers may be classified into two main categories:
a) Those which increase the metabolism of a wide variety of 
drugs, eg. phenobarbitone (PB) and b) Those which increase the 
m e t a b o l i s m  of a s m a l l  r a n g e  of s u b s t r a t e s ,  eg. 3- 
methylcholanthrene (3-MC) (Sladek and Mannering, 1969a).
The two best studied inducers have been PB and 3-MC, but 
many other compounds with inductive properties have also been 
described. Sladek and Mannering (1969a) found that rats treated 
with PB and/or 3-MC show different patterns of microsomal protein 
and different substrate specificities. Thus, PB produced a
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parallel Increase in the microsomal protein content and in the N- 
demethylation activity of ethylmorphine; moreover, when PB 
administration was discontinued, the previous effects decreased 
in a similar manner. On the other hand, 3-MC increased the 
microsomal protein and the N-demet hy.la t ion activity of 3-methyl -
4-methylaminoazobenzene; but these effects did not parallel one 
another and the microsomal protein content and metabolic activity 
endured for longer. (Mannering, e_t a_l 1969). Furthermore, when 
PB and 3-MC were administered simultaneously to rats, the levels 
of liver microsomal cytochrome P-450, binding of hexobarbital and 
aniline, and the 3-methyl-4-methylaminoazobenzene demethyl at ion 
were found elevated and additive (Bid 1eman and Mannering, 1 970).
The concept of different isocytochromes P-450 came from the 
observations of a differential inhibitory effect of SKF 525-A on 
the metabolism of 3-methyl-4-methylaminoazobenzene by entreated 
and PB treated, but not of 3-MC treated rat microsomes. The 3-MC 
microsomal preparation specifically shifted the absorption maxima 
(448 nm) of the reduced-CO complex spectra, as a consequence of 
this the presence of a cytochrome P-450^ (Sladek and Mannering 
1969b), now known as cytochrome P-448 (Alvares _ejb a 1., 1967) was
proposed.
A great deal of evidence about the possibility of multiple 
mammalian microsomal cytochromes P-450 has been collected. For 
e x ample, find i n g s  from i^ n y_i_tro i n h i b i t i o n  s t u d i e s  u s i n g  
substances like 7,8 benzoflavone (Wiebel a 1^, 1971), Chlortion
(Conney _e^ a ^ , 1 9 6 9) and CO were shown to m o d i f y  the
hydroxylation of benzo( a) py rene and the inhibition of the 16-
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hydroxylation of testosterone.
Purification methods using column chromatography (Levin et 
a l ., 1977) and sodium dodecyl sulphate (SDS)-polyacrylamide gel
electrophoresis have led to the separation of several bands of 
proteins (in the region of 47000 to 52000 mw) in a partially 
purified preparation of microsomes from PB treated rats. Welton 
and Aust (1974) found an increase in the 49000 band in PB-treated 
rat liver microsomes and an increase in the 53000 band in 3-MC- 
treated rat liver microsomes.
Ten pure cytochrome P-450 isoproteins have now been isolated 
and characterized using criterias such as subunit m o l e c u l a r  
weight, absorption maxima of the reduced-CO complex, substrate 
specificity, immunological characteristics and the N-terminal 
aminoacid of the polypeptidic chain sequence; (Ryan _ejt aj.,'1985. 
Haniu ^  a_l, 198 2), they have been classified alphabetically as 
cytochrome P-450 a to j (Conney 1986).
Each one of these isocytochromes P-450 show a different 
substrate specificity. They may be induced by different compounds 
the whole profile of cytochromes P-450, and also may show a 
different degree of induction for each inducer. Benzphetamine, 
hexobarbital, and 7-ethoxycoumarin are substrates readily 
m e t a b o l i z e d  by c y t o c h r o m e  P - 4 5 0 b (P- 4 5 0 PB), w h i l e  7- 
e t h o x y c o u m a r i n ,  z o x a z o l a m i n e , b e n z o - ( a ) - p y r e n e ,  and p- 
nitroanisole are substrates for cytochrome P-450c (P-450 3-MC).
(Conney, 1986).
Burke and Mayer (1974 and 1983) have studied the liver 
m i c r o s o m a l  7 - 0 - d e a l k y l a t i o n  m e t a b o l i s m  of r e s o r u f i n  and 
aIkoxyresorufins (hydrocarbon chain 1 to 8). They found that the
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rate of resorufin formation (7 hydrox y -phenox a z o n e ) was highly 
dependent on the length of the alkoxy side chain. This reaction 
rate was different when control, PB-induced or 3-MC-induced 
microsomes were assayed. Therefore, phenoxazone, methoxy, and 
ethoxy ethers were good substrates for control microsomes; 3-MC 
microsomes were jps.v’o u < 3 l  for ethoxy ethers and to a
lesser extent methoxy, and propoxy, while PB-induced microsomes 
preferentially metabolized butoxy, pentoxy, and resorufin,. 
Although these reactions may well be catalyzed by more than one 
isocytochrome P-450, the use of those substrates could help to 
gain a better estimation of the pattern of induction by PB and 3- 
MC than other previously used cytochrome P-450 substrates.
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1.5 HAEM METABOLISM.
1.5.1 General aspects.
Haem (Protoporphyrin IX) is a cofactor for many proteins, 
which are collectively called haemoproteins; the haem group for 
example, is a part of all the cytochromes in the electron- 
transport chain. Because of this, it is believed that all the 
cells in the human organism are capable of actively synthesize 
haem. The erythropoietic tissue and the liver produce about 80% 
and 20% respectively, of the haem which turns over everyday 
(Tait, 1978). The two major h a e m o p r o t e i n s  in the body are 
haemoglobin and myoglobin, the former remains 120 days in the 
erythrocytes of humans, sheeps, and dogs (London, 1961), and 
about 60 days in the rat (Akeson _e^  a ]^, 1960). Myoglobin has a
slower turnover (Daly e_t a 1., 1967). In rat liver, the total haem
content is about 70 nmol/g wet weight, which is distributed as 
follows: 4 3% is contained in mitochondrial cytochromes, 32% in 
cytochrome P-450, 17% in cytochrome b^, and 7% in catalase (Meyer 
and Marver, 1971a).
A l t h o u g h  the l i v e r  haem content is less than in the 
erythrocytes, the hepatic haem proteins have a quicker turnover. 
For example, liver cytochrome P-450 shows a diphasic turn over, a 
larger fraction with a half life of 7 to 20 hr, and a smaller 
fraction of 24 to 48 hr (Levin and Kuntzman, 1969; Meyer and 
Marver, 1971b).
1.5.2 The haem metabolic pathway.
The synthesis of haem requires the participation of the
- 5 1  -
mitochondrial and cytoplasmic compartments, and consists of 5 
steps, of which the first and the last three are situated in the 
mitochondria and the intermediate enzymes are located in the 
cytosol.
The general pathway of haem synthesis is shown in figure 
1.5. The formation of a protoporphyrin molecule requires the 
participation of 8 molecules of glycine. The first step is the 
c o n d e n s a t i o n  of g l y c i n e  and s uccinic acid to produce 5- 
amino 1 a e V u 1 inate (5-ALA), this step is catalyzed by 5 - amino- 
laevulina.te synthetase in the mitochondria. The 5-ALA then passes 
into the cytosol where 2 molecules are condensed by 5-amino- 
l a e v u l i n a t e  dehydr a t a s e ,  (second step) to form a pyr r o l  
porphobilinogen (PEG). The third step is catalyzed by two 
enzymes PEG deaminase and uroporphyrinogen 3-cosynthetase which 
produce the condensation of four molecules of PEG to form 
uroporphyrin III. This is an octa-carboxylic porphyrin. The 
fourth step, catalyzed by uroporphyrinogen decarboxylase, reduces 
to 4 the number of carboxylates because four acetate groups are 
converted into methyl residues, producing coproporphyrinogen III. 
This compound is transported into the mitochondria where two 
propionic acid residues are oxidatively decarboxylated to produce 
two vinyl groups present in protoporphyrin IX. The fifth step is 
catalyzed by coproporphyrinogen oxidase. The sixth and last 
biosynthetic step is catalyzed by ferrochelatase. This enzyme 
inserts a ferrous iron into the protoporphyrin IX producing haem 
itself.
The catabolism of the haem group is catalyzed by two
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enzymes. The haem ring is first cleaved using NADPH or NADH by 
haem oxygenase producing biliverdin IX-alpha, a linear tetra- 
pyrrole which is then reduced to bilirubin IX-alpha by biliverdin 
reductase. Bilirubin is then transported to the liver where it 
is conjugated through the propionic acid residues to different 
carbohydrates, of which glucuronic acid is the most frequent. 
These conjugated compounds are then excreted into the bile. 
(Rayner e_t a 1., 1978; Ibraham, 1 983 and Maines 1984).
The cellular content of haem is carefully regulated through 
its synthetic and degradative pathways. Thus, the effect of many 
chemical groups or inherited abnormalities which alter the 
homeostasis of this metabolic routes may produce alterations such 
as anemias or porphyrias. Some excellent reviews on different 
aspects of haem metabolism have been published by Tephly e_t al^  
(197^), Kappas £jb aJ^ (1 982), Granick and Beale (1 978), Maines 
(1984) and Marks, (1985).
1. 5.2.1 5 - A m i n o l a e v u l inic a£ i^ d synthetase ( E. C . 2.3.1.37).
5-Aminolaevulinic acid synthetase (5-ALAS) is the rate 
limiting enzyme in hepatic haem synthesis (see Kappas £_t a 1., 
1982), it is located loosely bound to the inner mitochondrial 
membrane (McKay, 1969) and in the cytosol. The mol e c u l a r  weight 
of the mitochondrial 5-ALAS is 77000 (Whiting and Elliot, 19 72), 
and for the cytosolic 5-ALAS is 1 78000 (Kikuchi and H a yas h i ,
1981). However, the molecular weight varies depending on the 
sources of tissues, species studied, and the conditions of 
purification. Oh ash i and Kikuchi (1979) found that cytosolic 5- 
ALAS from rat liver had a molecular weight of 250000, but when
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this p r o t e i n  was a n a l y z e d  by S D S - p o l y a c r y l a m i d e  g e l  
electrophoresis, they found three bands with the following 
molecular weights: 120500, 79000 and 55000. Consequently, they
proposed that 5-ALAS was synthesized in the cytosol and consisted 
of two subunits having molecular weights of 79000 and 120000. 
After the synthesis, the two low molecular weight subunits were 
transported into the mitochondria (Nakakuki e£ a]^, 1 980) where
they were assembled in the inner membrane of this organelle. When 
5-ALAS activity is induced, a significant proportion of the total 
activity is present in the cytoplasm (Hayashi ejb a 1_^ , 1969).
The 5-ALAS half-life depends on the animal species and 
developmental stage (Sardesai ££ a ]^, 1 97 2), and also on the
cellular location of the enzyme. For example, in foetal rat liver 
the 5-ALAS 3 4 min (Woods, 1 97 4), while in adult rat liver is 
about 70 min, the latter half - life is similar to that of the m - 
RNA for this enzyme (Tschudy, 1 965). As far as i n tracellular 
location is concerned, the half-life of the cytosolic enzyme in 
adult rat liver is 20 min in the absence of haemin, and 120 min 
in its presence (Hayashi e£ a 1., 1 972). Therefore the turnover of
this enzyme is very fast. This observation is in agreement with 
its role as a regulatory enzyme (Schimke, 1973).
5-ALAS activity in rat liver has been measured by many 
research workers and values between 10 and 100 nmol 5-ALA 
formed/hr/g liver have been reported (Tait, 1978).
Catalytic mechanism. The formation of 5-ALA from succinyl-CoA and 
glycine needs pyridoxal phosphate as cofactor. Tait (1978) has 
described the mechanism of this reaction. Briefly, glycine reacts
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with the pyridoxal phosphate bound to the enzyme forming a stable 
carbanion. This carbanion, then, reacts with the electrophilic 
carbo n y l  group of s u c c i n y l - C o A  to form the i n t e r m e d i a t e  
metabolite alpha-amine be ta -keto adipic acid, losing CoA and 
carbon dioxide. Then the alpha-amine beta-keto adipic acid is 
decarboxylated, forming 5-ALA which is released afterwards.
2 .L There are a number of i n d u c e r s  and
physiological situations which increase the activity of 5-ALAS. 
Examples of exogenous inducers are 3,4 diethoxycarbony 1 - 1,4-di- 
hy dr oxyco 11 id ine (DDC) (De Matteis ejt a 1., 1973), a 11 y 1 isopropy 1
acetamide (A I A ) ( Granick, 1 966), ethanol (Rubin e t  aj^, 1 970) 
and m e t a l s  (Maines and Kappas, 19 7 7 ) , w h i l e  e x a m p l e s  of 
physiological factors are: metabolic (Tschudy et al., 1964), and
hormonal status (Granick and Kappas, 19 67) and age (Ibrahim _e£ 
al^, 1 9 83).
The activity of 5-ALAS is finely regulated by a feed-back 
effect exerted by haem. A decrease in the haem pool will pro d uc e 
an induction in the activity of 5-ALAS. This effect can be 
achieve in four different ways:
a). Blocking one or more enzymes in the haem biosynthetic 
pathway. An example of this is DDC, which causes a gross decrease 
in the ferrochelatase, activity leading t o a  decrease in haem 
level, as a consequence the 5-ALAS activity is stimulated (De 
Matteis _e_t a 1., 1 973).
b). Increased haem breakdown. A 11 y 1 groups which are metabolized 
by cytochrome P-450 cause an alkylation of the haem fraction of 
the cytochrome P-450 itself producing "green pigments" (Ortiz de 
Mon te 11 ano and Correia,1983). AIA is an example of a "suicide"
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substrate, which alkylates specifically cytochrome P-450-haem, 
but does not affect the apoprotein (De Matteis, 1978).
c). Induction of apoproteins. Drugs such as phenobarbitone may 
stimulate the synthesis of cytochrome P-450, producing a protein 
with a high affinity for haem, a depletion in the levels of the 
cofactor, and indirectly inducing 5-ALAS activity. (Meier and 
Meyer, 1976).
d). Induction of haem oxygenase. Haem oxygenase is the rate 
limiting enzyme of the haem degradative pathway. The induction of 
this enzyme produces an increase in haem catabolism and an 
induction of 5-ALAS (Granick and Beale, 1978).
1.5.2.2 5-aminolaevulinic acid dehydratase E. C. 4.2.1.24.
5-aminolaevulinic acid dehydratase (5-ALAD) is a cytosolic 
enzyme which catalyzes the condensation of two molecules of 5-ALA 
to form the pyrrole- porphobilinogen (PBG). Enzymes purified to 
homogeneity have been obtained from different sources, all of 
them have many similar properties. They require Zn^+ as a 
cofactor (Chemin, 1972, Granick and Beale, .1 978, Cheh and 
Nieland, 1973), the pH optimum for this enzyme is 6.2.
5-ALAD is a polymeric enzyme which consists of 8 subunits of 
35000 mw (Wu e_t a_1,1974). Each octomer has 8 active sites, but 
only 4 seem to be bound to 5-ALA at any given time (Tsukamoto e_t 
a]-, 1979, Shemin, 1976). 5-ALAD is usually present in vast excess 
in comparison with 5-ALAS, therefore does not seem to have any 
haem regulatory role (Doyle and Schimke, 1969). The enzyme 
contains thiol groups which are i n v o l v e d  in the maintenance of
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the molecular structure rather than in the catalytic role (Tait, 
19 7 8). This enzyme is strongly inhibited by EDTA, copper, 
mercury, silver, zinc and lead (Gibson e t  a , 1955). All of
these metals could react against thiol groups. It has yet to be 
established whether arsenic, as a thio1-reagent, binds to the SH 
groups of the 5-ALAD.
M echani sm of c a t a l y s is. The formation of PBG takes place 
when the keto group of one 5-ALA molecule, which contributes with 
the acetate side chain of PBG, binds the epsilon-ami ne of a 
lysine residue in the active site of the enzyme forming a 
Schiff's base. Then the carbon 3 (a carbanion) of this 5-ALA 
molecule attacks the keto group of a second 5-ALA molecule. The 
cyclization is completed when the amine group of the second 5-ALA 
molecule reacts with the carbon of the first 5-ALA m o l e c u l e  
i n v o l v e d  in the Schiff's base; and after an e l e c t r o n i c  
rearrangement PBG is released (Nandi and Shemin, 1968).
1.5.2.3 Ferrochelatase (E.G.4.99.1.1)
Ferrochelatase (FC) is also known as protohaem ferrolyase 
(Rimington, 1958), haem synthetase (Reithmuller and Tuppi, 1964) 
and haem synthase (Porra and Ross, 1965). FC catalyses the 
terminal step of the haem biosynthetic pathway by incorporating a 
Fe^+ ion into the protoporphyrin IX ring.
Protoporphyrin IX Ferrochelatase^ Haem + 2H
This enzyme has been identified in a wide variety of animal 
and human tissues (Lochhead and Goldberg, 1961) in bacteria
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(Porra and Jones, 1963) and chloroplasts (Porra and L a s c elles 
1968). In all eukaryotic cells examined so far, FC has been 
found to be bound to the internal membrane of the mitochondria. 
(Jones and Jones, 1968).
The rat liver ferrochelatase has been reported to be a 
multimer with a molecular weight of 24 00 0 0 and constituted of 
40000 molecular weight subunits (Take tani and Tokunaga, 19 81). 
The enzyme has a pH optimum at 8.2 (Jones and Jone s , 1 969). 
However, ferrochelatase obtained from different sources shows 
different characteristics (Tait, 1978).
FC shows an specific incorporation of Fe^"^ but not Fe^"^ into 
the protoporphyrin IX, but it does not show such specificity with 
respect to other divalent cations such as C o^ "*", Z n^"^, and C u^"^, 
(Jo n e s  and J o n e s ,  1969), a l s o  t e t r a p y r r o l S  l i k e
deuteroporphyrin and mesoporphyrin (Porra and Jones, 1963, Jones 
and Jones, 1969) can be used instead of its natural substrates.
Regulation of the ferrochelatase activity. The activity of 
FC is inhibited by a feed-back mechanism involving haem (Jones 
and Jones, 1970), it is also inhibited £n v££ro by some metals 
such as Mn^"*", Cd , Hg^"*", As^ '*', and Pb^ '"' which is a weaker
inhibitor than the former elements (Dailey, 1986).
On the other hand, this enzyme and 5-ALAS are induced by 
phenobarbitone (Tephly e£ al., 1971). There is also a correlation 
between the decrease of cytochrome P-450 concentration and the 
degree of inhibition of FC (Wagner ££ a ]., 1976). These facts 
suggest that FC may i n f l u e n c e  the c o n t r o l  of the haem 
biosynthetic pathway (Wagner e t  a l ,  1976). Jones and Jones 
(1969) calculated the haem synthesizing activity of FC in
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approximately 0.4 nmol/min./mg protein. This would suggest that 
haem production potential outstrips the needs of the cell. This 
fact, and the presence of an earlier regulatory step (5-ALAS) in 
the haem metabolism (Granick and Ura t a , 1963), suggest that in 
the healthy cell, FC does not play any major regulatory role.
1 .5.2.4 Haem oxygenase (B.C. 1.5.2.4)
Haem oxygenase (HO) is the first and rate limiting enzyme of 
the catabolic pathway of the haem group. This enzyme is located 
in the microsomal membrane of various tissues (Tenhunen _e_t a_1, 
1970) and forms part of the complex HO-NADPH cytochrome c (P-450) 
reductase. This enzyme has been purified from rat liver 
(Yoshida and Kikuchi, 1979) and from pig spleen microsomes 
(Yoshida and Kikuchi, 1978).
The purified rat liver HO has a mo l e c u l a r  weight of about 
32000 to 35000 da 1 tons which is similar to that obtained from pig 
spleen (Yoshida and Kikuchi, 1978, and 1979, Kutty and Maines, 
1982). HO is NADPH dependent, however NADH can also be used as a 
cofactor, but is less effective (Maines, _ejb a_l, 1 977). The
purified HO c o n t a i n s  s m a l l  a m o u n t s  of haem and shows an 
absorbance peak at 405 nm which increases when the amount of 
haem increases. (Yoshida and Kikuchi, 1979).
Protohaemin IX is the best substrate but mesohaemin IX, 
deuterohaemin IX, and coprohaemin I are also converted to their 
corresponding biliverdins.
Those haemproteins to which haem is loosely bound (eg. 
me thaemaIbumin) are also substrates, but those haemoproteins to
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which haem is firmly bound (eg. myoglobin) are not (Tenhunen £t_ 
a_l , 1 969). Porphyrins and complexes of porphyrins with metals 
other than iron are not substrates for HO (Schacter and Waterman, 
1974).
De Matteis and Gibbs (1977) found that cobalt-treated rats 
produced an abnormal protoporphyrin. Subsequently Yoshida and 
Kikuchi (1979) found that this-compound had a spectrum similar to 
that of c o b a 1 t-protoporphyrin IX, and they suggested that the 
cobaIt-protoporphyrin could remain attached to HO. Furthermore, 
it has been shown that cobalt-porphyrins can easily bind HO 
(Yoshida and Kikuchi, 1978).
M_e_chan_i_sm of haem degra_da_t£on by haem oxygen a se. HO, which 
pH optima is 7.4 (Tenhunen _e£ a_l_^ , 1969), c a t a l y s e s  the
stoichiometric oxidation of proto-haem b at the a 1pha-methene C 
bridge to form biliverdin at the expense of three m o l e c u l e s  of 
oxygen and about 3 molecules of NADPH. A molecule of CO is 
produced during this reaction. (Yoshida and Kikuchi, 1978b).
Although specific areas of the reaction sequence remain to 
be clarified, there is agreement about the overall scheme which 
is shown in figure 1.6.
HO is not a haemoprotein by nature, but it easily binds haem 
to form a haem-protein complex in which haem may have a stereo- 
specific orientation. NADP is used either to reduce Fe^ "*" or to 
maintain Fe ^ , since only the latter is able to bind m o l e c u l a r
oxygen covalently. This oxygen is activated presumably through 
intracellular NADPH, then the alpha-methene C group is attacked, 
forming a hydroxyhaem-HO complex. Two intermediates have been 
proposed; verdohaem, which is an ether where the oxygen atom
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binds the rings I and II; and formy1 -biIiverdin iron complex in 
which the alpha-methene bridge has already been- broken down 
(Maines, 1984). A carbon monoxide molecule is produced when the 
previous intermediate is converted into an iron-biIiverdin-HO 
complex. In the last step biliverdin and iron are detached from 
HO (Yoshida and Kikuchi, 1978).
Inductive mechanisms of hepatic haem oxygenase. The activity 
of HO, as a regulatory enzyme, can be induced by a number of 
different treatments such as: 1) splenectomy, 2) administration
of haematin, haemoglobin, or steroids (Tenhumen e^ al., 1970) and 
3) dosification with metals such as Co (De Matteis and Gibbs, 
1976), Cd, Sn, Pt, Hg, Cu, Pb, Fe, Ni, Zn (Maines and Kappas, 
1 97 7) Se, A g , Mn, Or (Eaton e^ al^, 1 980), Sb (Drummond and 
Kappas, 1981), and As (Sardana _e^  a ^ ,  1981). Arsenic capacity 
to induce HO is only exceeded by Co and Cd.
The induction of hepatic HO is apparently mediated by two 
different mechanisms; a) haem mediated, and b) independent of 
haem mediation.
In r e l a t i o n  to the haem m e d i a t e d  m e c h a n i s m  s e v e r a l  
hypotheses have been elaborated:
a). Intermediate action of endogenous haem. Tenhunen e t  
aJL, (1970) showed that exogenous haem has an inductive effect on 
HO. Starvation also induced HO, which might be mediated via 
microsomal lesions produced by lipid peroxides (De Matteis,
1982). This hypothesis is supported by Penning and Scopa (1977), 
who found that in hepatic microsomes from lead poisoned rats, 
both NADPH-dependent peroxidation of endogenous lipids and the
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breakdown of cytochrome P-450 were increased.
b). Maines (1977) has proposed that the haem which increases 
the "free" haem pool and triggers the induction of HO comes from 
cytochrome P-450, since this haemoprotein is the most abundant in 
the hepatocyte. This author has specifically proposed that cobalt 
administration may increase the conversion of cytochrome P-450 
into cytochrome P-420 which has a lower haem affinity than the 
former.
c). De Matteis and Gibbs (1976), have found that in rats 
dosed with cobal tous chloride and 5 - amino - [ 4 -  ^C ] - l.a e vu 1 ini c 
acid, which is a hepatic specific haem precursor (Daly e^;t a 1., 
1967; D r u y a n  _e^ a ].j_, 1 9 6 9) , and is not i n c o r p o r a t e d  into
haemoglobin (Tait, 1978), the label was incorporated into a
compound with s i m i l a r  c h a r a c t e r i s t i c s  to those of C o ­
protoporphyrin IX. It was found later that Co-protoporphyrin IX 
readily binds HO, but is not metabolized by this enzyme (Yoshida 
and Kikuchi,1979).
d). It also has been suggested by Maines and Kappas (19 76b) 
that metal effects could be a result of direct interactions with 
enzyme sulfhydryl groups leading to the HO induction. They also 
showed that cysteine pretreatment blocked such induction and that 
depletion of thiol groups magnified the effect of the metal. 
However, cysteine pretreatment did not prevent haem induction in 
rats dosed with Sb (Drummond and Kappas, 1981). The mechanism 
remains to be completely clarified, elucidation of the arsenic’s 
effects on HO induction may help in this respect.
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1 . 5 . 2.5 Billverdin reductase (E.G.1.3.1.24)
Biliverdin reductase (BR) catalyses the reductive conversion 
of biliverdin into bilirubin at the expense of one equivalent of 
reduced nicotinamide dinucleotide (Noguchi _e_t 1 979). The
enzyme is located in the cytosolic fraction. In guinea pigs, the 
highest activity is located in liver, spleen, and kidney but it 
was not found in pancreas, heart and skeletal muscle (Singleton 
and Laster, 1965). In rat, the brain and spleen possess the 
highest enzymic activity, followed by liver (Tenhunen _e^  a 1.,
1 970). However, there is a wide animal species variation in the 
content, and tissue distribution of BR (Colleran and O ’carra, 
1978). BR has been obtained at a 90% purity from rat and guinea 
pig liver by Noguchi e;t a ]., (1 979). They found that the enzyme 
is a monomer with a mo l e cular weight of 34000 daltons. BR was 
specific to biliverdin and no other oxido-reductase activity was 
found. The enzyme does not seem to require metal ion cofactors 
(Colleran and O ’carra, 1 970).
The rat liver enzyme was further purified by Kutty and 
Maines (1981) who that the enzyme continued 3 cysteine residues 
per molecule, and could use either N4DH or NADPH as electron 
donors. The enzyme showed a differential pH optima when reacted 
using NADPH (pH 8.7) or NADH (pH 7.0); the former was the best 
electron-donor.
The NADPH-dependent enzyme was extremely sensitive to thiol 
reagents and it was inhibited irreversibly by mercuric chloride. 
The enzyme was also inhibited by haemin, biliverdin (substrate) 
at concentrations up to 4 or 5 u M , bilirubin in a competitive
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fashion, and zinc-protoporphyrin (Kutty and Maines, 1981). Rats 
dosed with sodium arsenite, arsenate or cadmium chloride, showed 
no-significant effect on the hepatic, renal and testicular BR 
activity (Cebrian, 1986).
1.5.2.6 The ea_dy _^t ajt_e of ha^m synthesi s and degradat ion.
Regu1 at ion of the "free" haem pool.
The size of the "free" haem pool is carefully controlled 
through its rate of synthesis by 5-ALAS and degradation by HO. 
(Ibrahim e^ a_l> 1 983).
The amount of 5-ALAS activity under basal conditions is very 
low but. sufficient to maintain an adequate supply of microsomal 
haem. This basal activity can be induced by the following 
mechanisms:
1) A direct inhibition of 5-ALAS. The regulatory "free" haem pool 
is low in concentration (0.1 to 0.2 uM) of both free and loosely- 
bound haem. It measures about 0.1% of the total haemoprotein haem 
of the liver parenchymal cells, into which newly synthesized haem 
is fed, and out of which haem is withdrawn for haemoprotein 
synthesis or degradation ( De Matteis, 1975). When the haem 
concentration is increased up to 10"^ M by means of exogenous 
haemin, the induction of the 5-ALAS is inhibited. When the "free" 
haem pool d e c r e a s e s  to 50 n M the s y n t h e s i s  of 5 - A L A S  is 
derepressed (Druyan and Kelly, 19.72).
2) Inhibition of mRNA synthesis for 5-ALAS. Haem may function as 
a repressor or co-repressor, inhibiting the translation of the 
mRNA coding for 5-ALAS. (Whiting, 1976).
3) Inhibition at a post-transcriptional step. Haem may repress
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the synthesis of mRNA for 5-ALAS at the genome level (Granick ejb 
a _1 , 1 9 6 6 ) .
4 ) Inhibition of the enzyme transferred from the cytosol to the 
mitochondrial inner membrane. Hayashi e_t al., ( 1 972 ) have found 
t h a t h a e m i n  a l s o  i n h i b i t s  the m i t o c h o n d r i a l  uptake of the 
cytoplasmic 5-ALAS or its conversion into mitochondrial form.
HO also play a key role in the control of the "free" haem 
pool. Haem concentrations over 5 X 10"^ ^ induce HO in isolated 
chick embryo cell suspensions (Srivastava £_t al._^ , 1 980) and 8 X 
10“®M when the same cells are grown as monolayer culture (Maines 
and Sinclair, 1 977 ). HO is induced, i^ n vi^vo, by many compounds 
and is affected by physiological status. This increase in 
activity is usually accompanied by a decrease in the cytochrome 
P-450 content and a loss of cellular haem. Therefore, compounds 
that stimulate the _d_e nov£ synthesis of HO may be able to deplete 
the regulatory "free" haem pool (Kappas e_t al., 1982).
Tryptophan £y£££ j:a_s_e ( E . C . 1.13.11.11) a good indicator of 
the "free" haem pool.
Tryptophan pyrrolase (TP), also called tryptophan oxygenase 
is a cytosolic haem-dependent enzyme which catalyzes the first 
and rate limiting step of the kynurenine-nicotinic acid cycle of 
tryptophan catabolism. —TP cleaves the indole ring of the 
tryptophan to produce N-formyl kynurenine (Badawy, 1979).
TP seems to be located specifically in the liver of some 
species (Knox and Mehler, 1950). The enzyme comprises four 
subunits (43000 d a l t o n s  each) of two e l e c t r o p h o r e t i c a l l y  
different protein species, which contain 2 moles of haem and 2
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moles of copper (Schütz and Feigelson, 1972; Brady al., 1 972).
Both, in humans and rats, hepatic TP is found as an 
equilibrium between the apo-enzyme and holo-enzyme; the latter is 
the one catalitically active. The activation of the apo-enzyme 
involves a two steps mechanism; firstly the formation of a haem 
conjugate, and secondly a reduction of the oxidized holo-enzyme.
Kd = 10"°
Haemin +Apo-TP ---------------------►Holo-TP
The degree of haem-saturation of the apo-enzyme depends on 
the availability of haem (Badawy and Evans, 1975).
When TP is assayed iri v itro, the already reduced holo-enzyme 
does not require haemin, whereas the free-haem predominant form 
does (Badawy, 1977). Therefore, a good estimation of the "free" 
haem pool can be obtained from the difference between the basal 
activity of TP, measured _in v itro, and its total activity by 
adding exogenous haemin, saturating all the apo-enzyme present.
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1.6 AIMS OF THIS STUDY.
This study was undertaken to investigate some effects of 
sodium arsenite on the morphology and metabolism of the liver 
with reference to: 1) the effects of acute doses of As III on the
histology and cytology of the liver, and 2) the combined effect 
of As III, and inducers of the microsomal monooxygenase system on 
liver morphology and metabolism. As a result of these experiments 
it is hoped to gain some insight into the effects of As III on 
morphology, haem metabolism and cytochrome P-450 dependent 
metabolism, which may in turn help to explain aspects of the 
toxicity of this element.
CHAPTER TWO
MATERIAL AND METHODS
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2. MATERIAL AND METHODS.
2. 1 CHEMICALS.
Sodium arsenate, sodium selenite, isosafrole and coumarin 
were supplied by Merck GmbH (Darmstadt, West Germany).
NADH,NADPH, glycine, ATP, sucrose, EDTA, biliverdin, sodium 
cacodi late, 3-methyl oholanthrene, benzphetamine, osmic acid. Tris 
(Trizma), cytochrome c, 5-aminolae vu 1 inic acid, mesoporphyrin IX, 
protoporphyrin IX, glutathione, glucose 6-phosphate dehydrogen­
ase, polyoxyethyLene sorbitan mono-oleate (Tween 80), lactic 
dehydrogenase, gamma-glutamy1-p-nitroanilide, were all purchased 
from the Sigma London Chemical Co. Ltd. (Poole, Dorset).
[2,3-^^C] succinic acid, 5-amino-[4-^ ]-1aevulinic acid and 
ferric chloride were supplied by Amersham International 
Pic. (Amersham, Buckinghamshire).
Sodium dithionite, and Fo1in-Cioca1taeu phenol reagent were 
obtained from Fisons Scientific Equipment Ltd. (Loughborough, 
Leicestershire).
Phenobarbitone, d i m e t h y l s u l p h o x i d e , haemin, L-tryptophan, 
barbitone, sodium barbitone, methanol, Coomasie brilliant blue, 
dimethylsulphoxide, picric acid, DPX and fibrowax were purchased 
from British Drug House Ltd. (Poole, Dorset). Haematoxy1 in, eosin 
and oil red "0" were obtained from Gurr/British Drug House.
The Dowex AG 50W-X8 resin in the sodium form 200-400 mesh, 
was obtained from Bio-Rad, Co. (Richmond, California).
Ready-Solv MP scintillant liquid was purchased from Beckman- 
RIIC Ltd. (High Wycombe, Buckinghamshire).
Resorufin and 7-e-thoxyresorufin we re purchased from Pierce
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and Warrimer (UK) Ltd. (Chester, Cheshire).
7 -Ethoxycoumarin was kindly provided by Dr. J.C. Conn e l l y  
and Dr. S. Maloney.
Carbon monoxide, nitrogen and oxygen were purchased from 
British Oxygen Co. (London).
Glutarald ehyd e , Epon 812, methyl nadic anhydride (MNA), 
2,4,6-Tri(dimethylaminomethyl) phenol (DMP 30), dodecenyl 
succinic anhydride and electromicroscopy containers were provided 
by TAAB Laboratories Equiment Limited (Reading, Berkshire).
Agarose A 37 (Indubiose) was purchased from Pharmindustrie 
(Clichy, France).
7 - P e n t o x y r e s o r u f i n  was p r o v i d e d  by M o l e c u l a r  Probes 
(Junction City, U.S.A.).
All the photographic material was purchased from Eastman 
Kodak Co. (Rochester, U.S.A.).
All the remaining reagents were Analytical Grade or similar.
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2 . 2  ANIMALS.
M a l e  wistar rats (200-300g) were o b tained from the 
University of Surrey Animal Unit. The rats were housed in cages 
with sawdust bedding (Lee and Co., Chertsey, Surrey) and were 
allowed food (LAD 1, LABSURE, Croydon) and water ad 1ibitum. The 
rabbits were obtained from Ranch Rabbit (Crowley Down, Sussex) 
and were allowed food ( Lab su r e Diet R 14 B, Christopher Hill 
Group, Ltd., Poole, Dorset) and water ad _l_i_b£_t u m. A 12-hr 
light/dark cycle was operated (0700-1900 light) at a temperature 
of 22°C and 5 0% humidity.
2.2.1 Pretreatment of animals.
Controls.
Control animals received saline (0.9% sodium chloride w/v) 
or corn oil (2.5 ml/kg body weight) by intraperitonea 1 (i.p.)
injection daily for 1, 2 or 3 days as appropriate. Animals were 
killed at different times after the last injection.
Food deprivation.
Animals were deprived of food 8 hr before the administration 
of sodium arsenite and killed 16 hr later, unless as otherwise 
indicated in the appropriate experiment.
Phenobarbitone.
Phenobarbitone sodium salt was administered in saline. 
Animals received 0.3 mmol/kg body weight (80 mg/kg) by i.p. 
injection for 1, 2 or 3 days. Rats were subcutaneously (s.c.)
injected with sodium arsenite either together with the last 
a d m i n i s t r a t i o n  of p h e n o b a r b i t o n e  or 24 hr after the last
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phenobarbitone injection.
3-Methylcholanthrene.
3-Methylcholanthrene was administered to rats as a solution 
in corn oil at a dose level of 0.075 mmol/kg body weight (20 
mg/kg) by i.p. injection for 3 days. Arsenic was s.c. injected 
together with the last administration of 3-MC.
Isosafrole.
Isosafrole was administered to rats as a solution in corn 
oil at a dose of 5 mmol/kg body weight (675 mg/kg), by i.p. 
injection, for 3 days. Sodium arsenite was injected s.c. 24 hr 
after the last administratrion of isosafrole.
2.2.2 Surgical procedures for bile and blood collection.
Acute bile collection procedure.
For collection of bile samples, rats (200-250 g) were
anaesthetized with Sagatal^ (May and Baker Ltd., Dagenham,
Essex), using 1.0 ml/kg body weight, the abdomen was opened and a
plastic cannula tube inserted into an opening in the common bile 
duct. After tying the cannula in the place the incision was 
closed using Mitchel clips and animals were maintained under 
a n a e s t h e s i a  for periods up to 2 hr. Body t e m p e r a t u r e  was
regulated by using an insulated heat pad. Bile samples were 
c o l l e c t e d  ov e r  timed periods. At the t e r m i n a t i o n  of the 
experiment and before recovery from anaesthesia the rats were 
killed by cervical dislocation.
Chronic bile collection.
Chronic bile collection was carried out according to, the 
procedure of Johnson and Reising (1978). Rats (200 g ) were
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anaesthetized with Sagatal^, using 1.0 ml/kg body weight. The 
ventral surface was swabbed with alcohol 70% (v/v). A mild
incision 4-6 cm length was made in the abdominal wall. The 
intestinal tract was then gently removed. The duodenal loop was 
exposed and the bile duct ligated at approximately 2.5 cm from 
the liver. The duct became filled with bile a few seconds after 
ligation. A second ligature was placed around the duct between 
the first ligature and the liver. Using Castrovejo scissors and 
pulling the- loose ends of the first ligature to preserve tension, 
the duct was punctured approximately 2 cm from the liver. 
Immediately a plastic cannula tubing, having a slightly tapered 
end, was introduced into the duct and secured by tightening a 
second ligature. To provide e x t r a a n c h o r a g e , the loose ends of 
the first ligature was also tied around the cannula.
Using a hollow-spike constructed from stainless steel, aT\ 
l'nser'tîoY) was made in the dorsal body wall, and the wide side of a 
glass container was placed and anchored by using a rubber collar. 
The glass vessel was then inserted into the peritoneal cavity. 
The free end of the cannula was adjusted to a length sufficient 
to allow it to be passed into the bottom of the glass bulb 
through the narrow side-arm whilst maintaining a free loop of 
approximately 3 cm between the reservoir and the bile duct. The 
narrow glass side-arm of the reservoir had a length (0.5 cm) of 
silicone tubing attached to it, so that the cannula could be 
firmly tied into the glass vessel, thereby preventing leakage of 
bile into the peritoneal cavity. The intestinal tract was then 
replaced into the peritoneal cavity and gently shaken. The inner
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body wall was closed using chromât e sterilized surgical catgut 
4/0 ( Et hi c o n , Edinburgh). The outer body wall was closed using 
Mitchel clips. Anaesthesia was discontinued and the animal 
allowed to recover.
Blood collection procedure.
Rats (200-250 g) were dosed with Sagatal^, using 1.0 m 1 /kg 
body weight. The ventral surface was swabbed with 70% alcohol and 
the abdomen was opened. Blood was gently withdrawn from the 
inferior vena cava using a 5 ml plastic syringe fitted
with a 20 swg needle. Blood was taken into a glass tube and 
allowed to coagulate.
2.2.3 Pre- and post-mortem procedures
Animals were allowed to acclimatize for at least -3 days in 
the U n i v e r s i t y  of Surr e y  A n i m a l  Unit before s t a r t i n g  any 
experimental protocol. Rats were weighed and dosed as previously 
described. Rats and rabbits were killed by cervical dislocation 
and liver, kidneys and testis were excised and weighed. When 
necessary, livers were perfused £n s itu with ice cold saline 
until bleached of haemoglobin. A portion of the medial, left, 
right and caudate lobes were removed and fixed as appropriate for 
histological and electron microscopic examination. The remaining 
liver and kidney and testis were treated as described below.
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2.3 PREPARATION OF SUBCELLULAR FRACTIONS FROM LIVER, KIDNEY AND 
TESTIS.
Homogenat e .
These methods are based on those of De Duve ££ a_l ( 1 959) and 
Woods (1976).
The remaining liver, kidney and testis were individual ly 
treated as follows. Organs were washed, blotted dry and weighed, 
then placed into three volumes of ice cold 0.25M sucrose, 2 OmM 
Tris-HCl buffer pH 7.4. Subsequent operations were carried out at 
0-4^0. After scissor mincing of the organs, they were homogenized 
using a motor-driven Potter-Elvehjem glass-teflon homogenizer 
until the tissue suspension appeared uniform (usually 3-4 strokes 
were enough). A sample of the homogenate was retained for further 
analysis.
Mitochondrial preparations.
The remaining homogenate was placed in polycarbonate tubes 
and centrifuged at 800 g X 10 min using a Beckman refrigerated 
tabletop centrifuge (model TJ-6) and plastic buckets (Beckman 
Instruments, Inc., Palo Alto, U.S.A.).
The supernatant was transferred into a clean polycarbonate 
tube and centrifuged at 10000 g X 15 min using a 8 X 50 ml 
aluminium head rotor in an MSE "High Speed 18" refrigerated 
centrifuge at 4 °C (MSE Scientific Instruments, Crawley, Sussex).
The supernatant was used to prepare microsomal and cytosolic 
suspensions.
The pellet was resuspended in 0.25M sucrose, 20mM Tris-HCl 
buffer pH 7.4 using a Potter-Elvehjem homogenizer and centrifuged
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again under similar conditions. The operation was repeated 3 
times. The supernatants resulting from these washings were 
discarded. The pellet was finally resuspended in 0.25M sucrose 
and used for the measurement of mitochondrial enzymes.
Microsomal preparation.
The 1 0 0 0 0 g s u p e r n a t a n t  was then p l a c e d  in a c l e a n  
polycarbonate tube and centrifuged at 105000 g X 1 hr using 
either a 8 X 35 ml angle titanium rotor in a MSE Prespin 50 
refrigerated centrifuge (MSE Scientific Instruments, Crawley, 
Sussex) or a 12 X 38 ml titanium fixed angle rotor in a Centr ikon 
T-225 refrigerated centrifuge (Kontron, Ltd. Zurich, Switzerland) 
both centrifuges were set at 4°C.
The supernatant obtained was retained in order to analyse 
cytosolic enzymes. The pellet was resuspended in ice-cold 0.25M 
sucrose, 2 OmM Tris-HCl buffer, pH 7.4 using a P o t t e r - E l v e h j e m  
homogenizer, then centrifuged again at 1 05000 g X 1 hr and 4°C. 
The washed microsomal pellet was finally resuspended in ice-cold 
0.25M sucrose, 5.4mM EDTA, 20 mM Tris-HCl buffer, pH 7.4 to a 
concentration equivalent to 1.0 g wet weight of tissue per ml. 
This suspension was either assayed immediately or stored in 1 ml 
aliquots in polycarbonate sample cups at -20°C.
2.3.1 Protein assay in tissue subfractions.
Based on; Lowry_e£ ajU (1 956).
Principle.
The development of a coloured compound is due to a two steps 
reaction, a) reaction with copper in alkali, and b) a reduction 
of the phosphomolybdic-phosphotungstic reagent to molybdenum blue
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and tungsten blue both by copper-treated proteins and by tyrosine 
and tryptophan of the proteins. The latter two give colour in the 
absence of Cu^+ but the rest of the protein gives no colour 
without Cu^+. About 75% of the colour is dependent on the Cu^+. 
Reagents.
0.5M NaOH.
1% (w/v) Copper sulphate pentahydrate.
2% (w/v) Sodium potassium tartrate.
0.05M NaOH containing 2%(w/v) sodium carbonate.
Bovine serum albumin in water (250 ug/ml).
F o 1 in-Ci00 a 1 1eau phenol reagent, diluted with water (1:2,
v/v).
Method.
Samples were predigested with 0.5M NaOH for at least 5 hr, 
and diluted to an appropriate protein concentration with 0.5M 
NaOH. Protein standard was diluted with 0.5M NaOH to give a 
range of concentration of 50, 100 , 150, 200 and 250 ug/ml. 1 %
copper sulphate, 2% sodium potassium tartrate and 2% sodium 
carbonate in 0.05M NaOH were mixed at a ratio of 1:1:100 (v/v) 
immediately before use. Sodium carbonate reagent (5 ml) was added 
to the samples, standards and blanks (0.5 ml), mixed and allowed 
to stand at room temperature for 10 min. Diluted Folin-CiocaIteau 
reagent (0.5 ml) was added, and the solution mixed immediately. 
After standing for a minimum of 30 min at room temperature, the 
a b s o r b a n c e  at 750 nm was r e c o r d e d  u s i n g  a L a m b d a  5 
spectrophotometer (Perkin Elmer Corp., Norwalk, USA).
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2.4 SPECTROPHOTOMETRY.
Routine a b s o r b a n c e  m e a s u r e m e n t s  were made using an 
Ultrascope spectrophotometer (LKB Biochrom, Ltd., Milton Road, 
Cambridge). Spectral determinations were carried out using a 
Lambda 5 UV/VIS double beam spectrophotometer equipped with 
thermostatted cuvette holders, and measurements were made in the 
double beam mode (using 2 cuvettes, sample wavelength lambda^ = 
reference wavelength 1 ambda2).
2.4.1 Hepatic cytochrome P-450.
Based on; Omura and Sato (1 964).
Principle.
The reduction of the microsomal cytochrome P-450 with some 
crystals of sodium dithionite followed by gassing with carbon 
monoxide produced a coloured-complex whose spectrum is unusual 
for haemoproteins and is used for its quantitation.
Reagents.
66 mM Tris-HCl buffer, pH 7.4.
Sodium dithionite, crystals.
Carbon monoxide.
Method.
Analiquot of a microsomal suspension (20 mg microsomal 
protein/ml) was diluted to 2 mg microsomal protein/ml with 66 mM 
Tris-HCl buffer, pH 7.4.
The solution was mixed with a few crystals of sodium dithionite 
to reduce the cytochrome suspension. The solution was mixed by 
inversion and divided equally between two cuvettes, then scanned
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from 500 nm to 4 0 0 nm to obtain a base line. Through the sample 
cuvette, carbon monoxide was bubbled for 30 sec. The sample was 
rescanned and a difference spectrum of cytochrome P-450 was 
obtained.
In order to calculate the amount of cytochrome P-450 in the 
sample the peak height was measured at 450 nm and subtracted from 
that at 490 nm. This was then multiplied by the dilution factors 
and divided by the extinction coeficient 91 mM"^ cm" \  The answer 
given was in umol of cytochrome P-450/ml which was converted to 
give a final answer of the amount of cytochrome P-450 present in 
nmol/mg microsomal protein.
2.4.2 Hepatic cytochrome b^ _^
Based on: Omura and Sato (1964).
Principle.
The addition of the reducing equivalent of NADH to a 
suspension containing NADH-cytochrome b^ reductase results in the 
reduction of cytochrome b^ with an associate change in spectrum 
between 409 nm and 424 nm.
Reagents.
66 mM Tris-HCl buffer, pH 7.4.
11.5 mM NADH.
Method.
An aliquot of microsomal suspension was diluted with. 66 mM 
Tris-HCl buffer, pH 7.4 to give a final concentration of 1 mg 
microsomal protein/ml. The solution was then divided equally 
into two cuvettes, a base line was recorded between 440 nm and 
400 nm. To the sample cuvette 20 u 1 of 11.5 mM NADH was added and
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the sample was re-scanned.
The concentration of cytochrome b ^ was calculated by 
measuring the peak at 4 2 4 nm and subtracting that at 409 nm. The 
result was multiplied by the dilution factors and by the 
extinction coeficient 185 m M ” cm” . The final answer given was 
in umol/mg microsomal protein.
The normal range is 0.05 umol/mg microsomal protein.
2.4.3 Renal cytochromes P-450 and b^ _^
Based on; Orreniuse£ a (1 97 3).
Principle.
Sodium succinate is used as a reductant of haemoglobin and 
c y t o c h r o m e  c o x i d a s e  to avoid their i n t e r f e r e n c e  in the 
estimation of renal cytochromes P-450 and b^.
Regents.
Sodium dithionite, crystals.
0.25 M Sucrose in 20 mM Tris-HCl buffer, pH 7.4.
0.3 M Sodium succinate.
16.7 mM NADH.
Carbon Monoxide.
Method.
An aliquot of the microsomal suspension was diluted to 2 mg 
microsomal protein/ml with 0.25 M sucrose, 20 mM Tris-HCl buffer, 
pH 7.4. Then, 100 u 1 of 0.3 M sodium succinate were added and the 
solution was mixed by inversion and bubbled with carbon monoxide, 
for 30 sec. The mixture was incubated until maximal mitochondrial 
and haemoglobin pigmentation reduction was achieved. The sample
- 8 2  -
was divided equally into two cuvettes and a base line between 500 
nm and 4 0 0 nm was recorded. 20 u 1 of 16.7 mM NADH was added to 
the sample cuvette and re-scanned. A difference spectrum of 
cytochrome b ^  was obtained. Then a few crystals of sodium 
dithionite were added to the sample cuvette and re-sc-anned, 
resulting a difference spectrum from cytochrome P-450.
In order to calculate the amount of cytochromes P-450 and b^ 
in the sample the peaks at 450 nm and 427 nm were measured. These 
results were multiplied by the appropriate dilution factors and 
divided by 91 and 185 mM"^ cm ” ”'. The results were given in umol 
of cytochrome/ml which were converted to give a final value of 
the cytochromes present in nmol/mg microsomal protein.
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2.5 ASSAYS OF SOLUBLE ENZYMES.
2.5.1 Tryptophan pyrrolase.
Based on: Badawy and Evans (1975).
Principle.
The formation of kynurenine from L-tryptophan is carrried 
out for a coupled oxidation system consisting of two enzymes: a)
TP, which reacts with tryptophan producing N'-formyIkynurenine, 
which is hydrolyzed by b) a formylase, usually in excess in the 
liver, p r o d u c i n g  kynurenine. The k y n u r e n i n e  forme.d is 
proportional to the activity of TP and, can be measured by its 
absorption at 365 nm. Kynurenine formation can also be measured 
in the presence ("total enzyme activity") or in the absence 
( " h o l o -enzyme a c t i v i t y " )  of added haemin. The a p o - e n z y m e  
activity, calculated by difference, is used to measure the ratio 
of holo-enzyme/apo-enzyme activity, which indicates the degree of 
saturation of apo-enzyme.
Reagents.
0.25 M Sucrose in 20 mM Tris-HCl buffer, pH 7.4.
0.2 M Sodium phosphate buffer, pH 7.
0.03 M L-Tryptophan.
0.6 M Sodium hydroxide.
0.9 M Trichloroacetic acid.
0.36 mM Haematin hydrochloride in 0.1 M sodium hydroxide 
(1.17 mg/ 5ml).
Method.
A sample of homogenate (4.5ml) was diluted with 4.5 ml of 
0.25 M sucrose in 20 mM Tris-HCl buffer, pH 7.4. Then 3 ml of
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0.03 M tryptophan solution and 9 ml of sodium phosphate buffer, 
pH 7 and 15 ml of distilled water were added and mixed. The 
mixture was divided into two aliquots and 0.1 ml haemat i n 
solution was added to one aliquot, to give a final concentration 
of 2 uM. Samples (3 ml) of the assay mixture were incubated at 
37°C for 30, 40 , 50 and 60 min in a shaking water bath (120
osci1 lations/min) in stoppered tubes and in an O 2 atmosphere. The 
reaction was stopped at each of the above t ime-intervals by 
addition of 2 ml of 0.9 M trichloroacetic acid; the assay tubes 
were shaken for ahothcc 15 min and centrifuged at 2000 rpm for 20 
min. To 2.5 ml of the supernatant, 1.5 ml of 0.6 M NaOH were 
added. The kynurenine present was determined at 365 nm, and the 
concentration was calculated using an extinction coefficient of 
4540 M ~ ^ c m “ .^ TP activity was calculated from the increase in 
the with time during the linear phase and expressed as umol
of kynurenine formed g”  ^ (wet liver) of liver.
2 .5.2 5-Aminolaevulinic acid synthetase.
Base on; De Matteis e£ a 1. (1981).
Principle. '
This method is a slight modification of that of Condie and 
Tephly ( 1978) and Ebert e t  (1970). The condensation of
glycine and s u cciny1 -CoA to form 5-ALA is catalyzed by 5-ALAS, 
the first and rate limiting enzyme of haem synthesis. Its 
activity is determined by measuring the incorporation of (^^C) 
succinate into 5-ALA and by isolating (^^C) 5-ALA on a Dowex 50 
ion exchange column.
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Reagent s .
Reaction cocktail (Tris-glycine-EDTA):
I'M Tris-HCl buffer, pH 7.2.
1 M Glycine (120 ml).
0.1 M EDTA (90 ml).
1.6 mM Pyridoxal phosphate.
The pH was adjusted to 7.5 with 1 M NaOH. This solution was 
prepared fresh each week and stored at 4°C. Pyridoxal phosphate 
(7.9 mg/ 20 ml) was added to the cocktail on the day of the 
experiment.
4 mM Sodium succinate.
[2,3-^'^C2] Succinic acid was dissolved in 4 mM sodium 
succinate to achieve a specific activity of 2.73 uCi/umol.
5-Amino-[4-^ ]-laevulinic acid hydrochloride was dissolved 
in 10 mM HCl to achieve a specific activity of 1 uCi/ml.
Carrier 5-ALA: 16.3 mg/ 10 ml 0.1 M HCl.
1.8 mM ATP (5 mg/ml).
25% (w/v) Trichloroacetic acid.
1% (w/v) Trichloroacetic acid.
1 M Acetate buffer, pH 4.6.
0.1 M Acetate buffer, pH 3.9,
Methanol-0.1 M acetate buffer, pH 3.9 mixture (2:1) (v/v).
1 M HCl.
1 0 mM HCl.
1 M Sodium acetate.
A cetylacetone.
Ready-solv MP scintillant.
Equilibrated acetate: Equal volumes of 1 M acetate buffer
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(pH 4.6) and ethylacetate were mixed. The layers were allowed to 
separate and the top layer was collected.
Preparation of cat ion exchange resin.
Dowex 50 resin (AG 50W-X8, H form) 200-400 mesh, was 
converted to the sodium form by heating 2-3 times in 2M NaOH at 
50°C until no colour was observed in the wash. The resin was then 
washed extensively with water and equilibrated with 0.1 M acetate 
buffer, pH 3.9. The resin was added to chromatographic columns 
(20 cm X 1 cm). A resin column of 2 cm in height was used.
Method .
An aliquot (0.5 ml) of a 10% (w/v) whole organ homogenate 
was added to the incubation mixture containing 250 u 1 of the 
reaction cocktail. 100 u 1 sodium [2,3-^^C2] succinate, 150 u 1 
ATP. The combined reagents were incubated without shaking for 1 
hr. At the end of the i n c u b a t i o n  p e r i o d ,  250 u 1 of 
25% trichloroacetic acid were added to stop the reaction, 
followed by 50 u1 of carrier 5-ALA.
Isolation and counting of 5-ALA.
The reaction tubes were centrifuged and the supernatant 
collected in a clean tube, the pellet was resuspended with 1.5 ml 
of 1% t r i c h l o r o a c e t i c  acid and c e n t r i f u g e d  -again. The 
supernatants were pooled and 1.5 ml of 1 M sodium acetate buffer, 
pH 4.6 was added. The sample was applied to a chromatographic 
column and washed successively with 10 ml of 0.1 M sodium acetate 
buffer, pH 3.9, 10 ml of the methane 1- 0.1 M sodium acetate
buffer, pH 3.9 (2:1 v/v) mixture, and 10 ml of 10 mM HCl. The 
(^^C) 5-ALA was eluted with 5 ml 1 M sodium acetate into glass
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stoppered tube. Standards containing 5-amino-[4-^ ]-laev u linic 
acid or [2,3-”*^C2] succinic acid were run through the same 
process.
An aliquot of 0.5 ml of the eluate was taken for counting. 
The remaining 4.5 ml of the eluate were put into a stoppered tube 
and mixed with 4.5 ml of 1M sodium acetate buffer, pH 4.6, 1.5 ml
1 M HCl, and 100 u 1 of acetylacetone, then the mixture was put in 
a boiling water bath for 20 min. After cooling, the mixture was 
extracted with 4.5 ml of the ethylacetate equilibrated with 1 M 
sodium acetate buffer, pH 4.6. 2 ml of the ethylacetate phase 
were mixed with 3 ml of Ready-Solv MP in a scintillation vial and 
counted in a 1219 Rackbeta liquid scintillation counter (LKB 
Wallak, Finland).
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FIGURE 2.1. Relationship between the activity of ALA 
synthetase in rat liver homogenate (measured by the 
production of ^^C-ALA, according to De Mateis, et al., 
1981) and the protein concentration.
The line of best fit (y= 0.14 x - 0.34) was calculated
by regresion analysis (r= 0.96) .C a l c u l a - p oL f\4:s 
<2-)^ If» <2.r I m a n p o i n t s
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2.5.3 5-aminolaevulinic acid dehydratase.
Reference; Ibrahim e_t ( 1 978).
Principle.
5 -A L À D is a c y t o p l a s m i c  enzyme which c a t a l y z e s  the 
condensation of two molecules of 5-ALA to form porphobilinogen 
(PEG) with the loss of two molecules of water. The determination 
of PEG is based on its reaction with p-dimethyl-aminobenzaIdehyde 
(DMEA) (Ehrlich reagent) in acid solution to form a red compound. 
This method is based on that of Mauzerall and Granick (1956). 
Reagents.
0.05 M Sodium phosphate buffer, pH 6.6.
5mM 5-aminolaevulinic acid in 0.05 sodium phosphate buffer, 
pH 6.6, ( 8.4 mg/ml ).
0.1 M Mercuric chloride in 5% trichloroacetic acid, 
(1.36 g/50 ml).
Ehrlich reagent was prepared before use by mixing 600 mg 
DME4, 4.8 ml perchloric acid 70% and.18 ml glacial acetic acid, 
the mixture was shaken and completed to 30 ml with glacial acetic 
acid.
Method.
In two marked tubes E (blank) and T (test), 50 u 1 of 1 05000 
X g supernatant were added to an incubation medium containing 50 
ul 5 mM 5-AL4 in 0.05 M sodium phosphate buffer, pH 6.6, and 
diluted with 0.4 ml of sodium phosphate buffer, pH 6.6. To the 
b l a n k  tube, 0.8 ml of 0.1 M m e r c u r i c  c h l o r i d e  in 5% 
trichloroacetic acid was added before the 5-ALA solution. The 
mixture was incubated in a shaking bath (120 oscillations/ min)
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at 37°C for 1 hour. The reaction was terminated in the T tubes by 
addition of 0.8 ml 0.1 M mercuric chloride in 5% trichloroacetic 
acid. After the tubes had been placed in ice for 10 min, they 
were c e n t r i f u g e d  at 2500 x g for 10 min, 0.7 ml of the 
supernatant was removed to another set of tubes and an equal 
v o l u m e  of E h r l i c h  reagent was added. The a b s o r b a n c e  was 
determined within 15 min. The spectrum was recorded from 5 40 nm 
to 650 nm in a Lambda 5 spectrophotometer. The molar absorption 
of PEG at 550 nm is 6.1 X 10^.
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FIGURE 2.2 Relationship between the activity of the delta- 
aminolevulinic acid dehydratase in the rat liver 
cytosolic fraction, measured by the production 
of porphobilinogen and the the concentration of 
protein in the rat liver cytosol.
The line of best fit (y = 7-33 x - 1.71) was 
calculated by regresion analysis (r = 0.99).
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2.5.4 Biliverdin reductase.
\
Based on; Krasny and Holbrook (1977).
Principle.
The last step in the synthesis of bilirubin, the reduction 
of the a 1 pha-methene group of biliverdin, is catalyzed by the 
cytosolic enzyme biliverdin reductase, using NADPH as a cofactor. 
T h e  a c t i v i t y  of  t h i s  e n z y m e  c a n  be m e a s u r e d  
spectrophotometrica 11 y by following the rate of formation of 
bilirubin at 468 nm.
Reagents.
0.25 M Sucrose, 5.4 mM EDTA in 20 mM Tris- HCl buffer, pH
7.4.
60 uM Biliverdin.
27 mM NADPH.
Cytosol, 20 mg protein/ ml.
Method.
To an appropriate amount of cytosol in a test tube (usually 
1 ml for liver, 1.5 ml for kidney and 3 ml for testis), was added 
100 ul of biliverdin solution and corresponding amounts of 
sucrose/Tris-HC 1 buffer to make a total volume of 3 ml. The 
suspension was gently agitated to mix the content and divided 
equally between two 1.5 ml spectrophotometrio cuvettes having a 1 
cm light path. The cuvettes were preincubated for 5 min at 37°C 
in a thermostat ted cuvette holder. The reaction was initiated by 
the addition of 20 ul of NADPH to the sample cuvette and the same 
volume of buffer to the reference cuvette. The rate of bilirubin 
formation was determined by continuously recording for 5 min the
- 93 -
increase of optical density at 4 6 8 nm. Enzyme activity was 
calculated using a millimolar extinction coeficient of 30 m M “ ^cm“ 
 ^ and expressed as nmol of bilirubin formed per hour, per mg of 
cytosolic protein.
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2.6 MITOCHONDRIAL ENZYME ASSAYS.
2.6.1 Ferrochelatase.
2.6.1.1 Radiometric measurement of ferrochelatase.
Reference: Woods (1976).
Principle.
FC is an enzyme tightly bound to the internal membrane of 
the m i t o c h o n d r i a ,  and i n c o r p o r a t e s  a Fe^+ ion into a 
protoporphyrin group to produce haem. This method is based in 
the proportional incorporation of ^^Fe^"^ into protoporphyrin 
under anaerobic conditions to prevent Fe autooxidation, followed 
by further extraction with butanone and HCl to eliminate the Fe 
which has not been incorporated into haem.
Reagents.
0.25 M Sucrose, 20 mM Tris-HCl buffer, pH 7.5.
0.1 M Reduced glutathione in 150 mM Tris-HCl buffer, pH 7.5.
1 M and 0.1 M HCl.
i
Nitrogen.
Butanone.
0.1 M Ferric c h l o r i d e ,   ^^  F e ferr i c  c h l o r i d e  and 2 mM 
protoporphyrin IX solution.
Protoporphyrin IX solution.
Protoporphyrin IX (12.3 mg) is dissolved in 5 ml 0.5 M NH^OH 
and 1 ml 1% Tween 80 is added. Then, the solution is adjusted to 
pH 8 with 1 M HCl and the volume completed to 10 ml.
ferric chloride is prepared by mixing 0.1 ml of the 
radiolabel solution plus 2.9 ml of water. A solution of 0.1 mM 
ferric chloride is used as a carrier.
-  95 -
The working solution contains 0.1 mM Ferric chloride, ^^Fe 
ferric chloride and 2 mM protoporphyrin IX solutions in a 
proportion 2:1:1 (v/v).
Method.
In two Thunberg tubes marked B (blank) and T (test) were 
placed reaction mixtures containing 0.4 ml hepatic mitochondrial 
suspensions and 1.6 ml reduced glutathione in 150 mM Tris-HCl 
buffer, pH 7.5. To the blank 0.4 ml 1 M HCl was added. In the 
side arm 1.6 ml of the 0.1 mM ferric chloride, ^^ ferric chloride 
and 2mM protoporphyrin IX solution was placed. The mixture was 
incubated in a shaking bath (120 cycles/ min) at 37°C for 20 min. 
Then, the solutions were mixed by inversion and further incubated 
for 1 hr under s i m i l a r  c o n d itions. After c e n t r i f u g a t i o n ,  
supernatants were removed and extracted with 4 followed by 3 
volumes of butanone at 4°C. Pooled extracts were then extracted 
with 3 ml 0.1 M HCl and centrifuged at 1 000 rpm, 0.5 ml of the 
butanone supernatants were transferred to individual scintillant 
vials. Radioactivity was measured by adding 4.5 ml of Ready-Solv 
MP, mixed and counted s o l u t i o n  in a 1219 Rack beta l i q u i d  
scintillant counter (LKB Wallak). Standards were also run during 
each experiment.
2.6.1.2 Spectrophotometrie measurement of ferrochelatase. 
Reference: De Matteis and Gibbs (1972).
Principle.
The method used is a modification of that of Jones and Jones 
(1969). This method is based in the continuous incorporation of 
metal ions into protoporphyrins catalyzed by FC In this case
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mesoporphyrin IX and are employed as substrates because they
are readily used as such and, besides, Co^+ does not a u t o ­
oxidized under the reaction conditions.
Reagents.
0.25 M Sucrose.
0.2 M Tris-HCl buffer, pH 8.2.
50 uM Mesoporphyrin IX, 1% Tween 80 and 0.2 M Tris-HCl 
buffer, pH 8.2.
5 mM Cobaltous sulphate.
Method.
Mitochondrial suspension is washed once with 0.25 M sucrose 
and c e n t r i f u g e d  at 10000 X g for 10 min. The pel let is 
r e s u s p e n d e d  in 0.25 M sucrose. To 1 ml of m i t o c h o n d r i a l  
suspension (5 to 8 mg protein), 2ml of 50 mM mesoporphyrin IX, 1% 
Tween 80 and 0.2 M Tris-HCl buffer, pH 8.2 was added. The mixture 
was divided equally into two cuvettes and preincubated at 37°C 
for 5 min. The r e a c t i o n  was i n i t i a t e d  when 20 ul of 5 mM 
cobaltous sulphate was added. Then, the decrease of the 4 9 8 nm 
peak was monitored recording the spectra between 520 nm and 490 
nm. The c a l c u l a t i o n  was based on the m e a s u r e m e n t  of the 
absorbance at 498 nm minus that at 511 nm using an extinction 
coeficient of 7.5 m M “ ^cm” .^
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2.7 MICROSOMAL AND MONOOXYGENASE ENZYMES.
2.7.1 Haem Oxygenase.
Reference: Tenhunen _e^ a (196 9).
Principle.
T h i s  e n z y m e  c a t a l y s e s  the c l e a v a g e  of the h a e m  
(ferriprotoporphyrin) ring at the alpha-methene bridge, to form 
the linear tetrapyrrole b i l iverdin IX. Because of the broad 
absorption peak at 670 and low extinction coeficient of the 
b i l i v e r d i n ,  this product is not a d e q u a t e  to be a s s a y e d  
spectrophotometrical ly, so a source of NADPH-dependent biliverdin 
reductase is added in excess to the incubation mixture to 
quatitatively convert the biliverdin formed during the reaction 
to bilirubin, which is the measured spectrophotometrically, by 
following the rate of formation of bilirubin at 468 nm.
Reagents. I
0.25 M Sucrose in 20 mM Tris-HCl buffer, pH 7.4, containing
5.4 mM EDTA.
1.7 mM Haematinhydrochloride dissolved in 0 . 1 M  sodium 
hydroxide.
2 7 mM NADPH.
Microsomal suspension. 20 mg protein/ml.
Cytosol. 20 mg/ml.
Method.
To an appropriate amount of microsomal suspension in a test 
tube (usually 0.5 ml for liver and testis and 1 ml for kidney) 
were added r e s pectively 2.5 or 2.0 ml of 0.25 M sucrose in Tris- 
HCl buffer pH 7.4, containing 5.4 mM EDTA, 0.5 or 1 ml of cytosol
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and 44 ul of haemin hydrochloride, to make a total volume of 3.5 
ml. The suspension was gently agitated to mix the contents and 
then divided equally between two optical cuvettes. The cuvettes 
were preincubated for 5 min in a constant temperature cuvette 
chamber. The reaction was initiated by adding 20 ul of NADPH to 
the s a m p l e  cuvette. The rate of b i l i r u b i n  f o r m a t i o n  was 
determined by continuously recording (5 to 10 min) the increase 
in absorbance at 468 nm. Enzyme activity was calculated by using 
a millimolar extinction coeficient of 30 mM~^cm“  ^ and expressed 
as nmol of bilirubin formed per min per mg of microsomal protein.
In the case of rabbits, the cytosol of a. con-truL rat liver^ 
105000 supernatantjwas used as source of bilirubin reductase.
2.7.2 NADPH-cytochrome _c reductase .
Reference: Stroebel and Dignam (1978).
Principle.
NADPH-cytochrome P-450 reductase, a flavoprotein component 
of the.endoplasmic reticulum of liver and other organs, catalyzes 
the transfer of electrons from NADPH to cytochrome P-450, which 
is the native acceptor, and to a number of artificial acceptors 
including cytochrome c, dichlorophenolindophenol and ferri- 
cyanide. Thus, NADPH-cytochrome c reductase reflects the activity 
of NADPH-cytochrome P-450 reductase. Cytochrome P-450 reduction 
is difficult to perform routinely, thus cytochrome c reduction is 
used as an alternative.
Reagents.
0.1 M Tris-HCl buffer, pH 7.4.
-  99 “
33 uM Cytochrome c in 0.1 M Tris-HCl buffer, pH 7.4 
24 mM NADPH in 0.1 M Tris-HCl buffer, pH 7.4.
Method.
Microsomal suspension (0.1 mg protein/ ml), cytochrome c (33 
uM) and 0.1 M Tris-HCl buffer, pH 7.4 to give a final volume of 
3 ml which was divided equally into two optical cuvettes. The 
cuvettes were preincubated at 25°C for 5 min, and the reaction 
was initiated by the addition of 20 ul of 24 mM NADPH in 0.1 M 
Tris-HCl buffer, pH 7.4 to the sample cuvette. The reduction of 
cytochrome c was measured by monitoring the absorbance change at 
550 nm, and the rate of reduction calculated using an extinction 
coeficient of 18.5 mM"^cm“ \
2.7.3 7-Ethoxycoumarin-O-deethylase.
Reference: Ul l r i c h  and Weber (1972).
Principle.
7-Ethoxycoumarin is metabolized by hepatic microsomes to a 
sin g l e  major f l u o r e s c e n t  c o m p o u n d ,  7 - h y d r o x y c o u m a r i n  
( u m b e l l i f e r o n e ) .  The rate of r e a c t i o n  may be m e a s u r e d  by 
monitoring the linear increase in fluorescence with time.
Reagents.
66 mM Tris-HCl buffer, pH 7.4.
1 mM 7-Ethoxycoumarin.
1 mM 7-Hydroxycoumarin.
6.2 mM NADPH.
Method.
In a fluorimetric cuvette, 100 ul of microsomal suspension
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(about 20 mg/ml), 250 ul of 7-ethoxycoumar in (1 mM ) and 2.15 ml 
of 66 mM Tris-HCl buffer, pH 7.4 were mixed. The cuvette was 
placed, in the thermostat ted cuvette holder of a Perkin Elmer LS-5 
spectrofluorometer (Perkin-E 1 mer Corp., Norwalk, U.S.A.) and 
allowed to equilibrate at 3 7°C for 5 min. A base line was 
recorded. Then, the reaction was initiated by adding 20 ul of 6.2 
mM NADPH and mixing thoroughly. The increase in fluorescence was 
monitored at 450 nm for at least 3 min, using an excitation 
wavelength of 370 nm. Standards of 7-hydroxycoumarin were 
added to calibrate the reaction.
2.7.4 7-Ethoxyresorufin-O-deethylase.
Reference; Burke'and Meyer (1975) •
Principle.
The metabolism of 7-ethoxyresorufin into resorufin carried 
out by hepatic microsomes can be assayed by the continuous 
measurement of the rate of reaction followed by monitoring the 
increasing in fluorescence of the resorufin formed.
Reagents.
6 6 mM Tris-HCl buffer, pH 7.4.
50 uM 7-Ethoxyresorufin in methanol.
10 uM Resorufin in methanol.
3 1 mM NADPH.
Method.
In a fluorimetric cuvette are mixed the following 50 ul of 
microsomal suspension (about 20 mg protein/ ml), 2.45 ml of 66 mM 
Tris-HCl buffer, pH 7.4 and 10 ul of 7 - et hox yr e so r uf in in 
methanol. The mix is allowed to equilibrate at 37°C for 5 min in
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a thermostatted cuvette holder of a Perkin Elmer LS5 spectro- 
f 1 uorimet er . The reaction was initiated by adding 10 ul of 31 mM 
NADPH and mixing thoroughly. The production of resorufin was 
monitored by the increase in fluorescence at 586 nm during 2 min, 
using an excitation wavelength of 510 nm. Standards of resorufin 
were added to calibrate the reaction.
2.7.5 7-Pentoxyresorufin-Q-dealkylase
Reference; Hubert e_t a 1^ (1 985).
Principle.
The dealkylation of 7-pen toxyresorufin by the microsomal 7- 
pentoxyresorufin-O-deaIkylase is s e l e c t i v e l y  increased in rats 
induced with phenobarbit one , and produces a single fluorescent 
product, resorufin. The activity of this system is achieved by 
monitoring the rate of resorufin production by continuous 
measurement of its fluorescence.
Reagents.
66 mM Tris-HCl buffer, pH 7.4.
1 mM 7-pentoxyresorufin dissolved in dimethylsulphoxide
(200 ug/ 0.7 ml dimethylsulphoxide).
10 uM Resorufin, sodium salt in ethanol.
31 mM NADPH in 66 mM Tris-HCl buffer, pH 7.4.
Method.
50 ul microsomal suspension (20mg protein/ml), 10 ul of 1 mM 
7-pentoxyresoruf in and 2.45 ml Of 66 mM Tris-HCl buffer, pH 7.4, 
were mixed in a fluorimetric cuvette and allowed to equilibrate 
to 37°C for 5 min in a thermostatted cuvette holder of a Perkin
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Elmer LS-5 spectrofluorometer. A base line was recorded and 20 ul
of the 30 mM NADPH were added to the cuvette and mixed. The
increase in fluorescence at 586 nm was monitored using an 
excitation wavelength of 510 nm. Standards of resorufin were 
added to calibrate the reaction. Results were given as pmo 1 
resorufin per mg of microsomal protein per min.
2.7.6 Benzphetamine-N-demethylase.
Reference; Lu e^ a l . { 1970) .
Principle.
B e n z p h e t a m i n e  u n d e r g o e s  a e r o b i c  d é m é t h y l a t i o n  in the 
presence of NADPH and microsomes. The activity of benzphetamine- 
N-demethylase can be determined by the continuous measurement of 
the rate of NADPH oxidation followed spectrophotometrically. 
Reagents.
66 mM Tris-HCl buffer, pH 7.4.
0.2 M Tris-HCl buffer, pH 7.5.
0.1 M Magnesium chloride.
2% Semicarbazide hydrochloride, pH 7.0.
0.01 M Benzphetamine hydrochloride in 66 mM Tris-HCl buffer, 
pH 7.5.
13 mM NADPH.
Method.
Into two tubes labelled blank and test are mixed the 
following solutions, 2.55 ml of 0.2 M Tris-HCl buffer, pH 7.5, 
0.1 ml of 0.1 M magnesium chloride, 0.2 ml 2% semicarbazide 
hydrochloride, pH 7.0, 50 ul microsomal suspension (20 mg
protein/ ml) and 0.1 ml of 0.01M benzphetamine hydrochloride (in
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the blank this solution is substituted by 0.2 M Tris-HCl buffer, 
pH 7.5), The mixture is split equally into two cuvettes and 
allowed to equilibrate at 30°C for 5 min in an thermostatted 
cuvette holder. The reaction was initiated by adding 20 ul of 13
mM NADPH. The rate of NADP formation is followed in a Perkin
Elmer Lambda-5 spectrophotometer for 5 min. The increase - of NADP 
formation is calculated by using an extinction coefficient 
of 6.22 m M "  ^ c m " \  The value of the blank was subtracted from
that of the test assay.
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2.8 SERUM ENZYMES.
2.8.1 Alanine amlnot ras feras e^ ^
Reference; Var ley et alj_ (1980).
ZriËSlPlÊJL
The transfer of an amino group from L-alanine to 2- 
oxoglutarate, producing L-glutamate and pyruvate is catalyzed by 
L-alanine aminotransferase. The pyruvate produced is further 
reduced to lactate using NADH as electron donor, by lactate 
dehydrogenase. The fall in NADH concentration is followed at 
3 4 0 nm.
Reagent Sjj_
66 mM Tris-HCl buffer, pH 7.4.
150 mM 2-oxoglutarate (sodium salt).
Buffer-substrate solution: 6.25 mM EDTA, 0.5 M L-alanine
dissolved into 66 mM Tris-HCL buffer, pH 7.4.
W o r k i n g  solution; 7 mg NADH and 2 5 0 1.U. l a c t a t e  
dehydrogenase are mixed with 50 ml of buffer substrate solution.
This solution was prepared immediately before using.
Me t hodj^
The following solutions are placed in a cuvette; 1 ml of the 
working solution and 150 ul of serum, and allowed to equilibrate 
in a thermostatted cuvette holder at 3 7 ° C for 5 min. Then, the
reaction was initiated by adding 100 ul of 150 mM of 2-
oxoglutarate, mixing thoroughly and following the decrease in 
absorbance at 340 nm. The enzymic activity was calculated 
according to the formula;
ALT activity (U/l)= VoLury\e m-Ike. Cuve.tLe_ (w>l) X|0^
^ ' 3  VoW m g. Oj. S c ru m  OSec(
-  105 -
2.9 NON-ENZYMIC COMPOUNDS ASSAYS
2 .9 . 1 Bilirubin.
Reference: Var ley et alj_ (1980).
Ji'ttzo'tlzecj
The reaction between bilirubin and^su 1phani1ic acid produces 
azo-bi1irubin, a coloured derivative which is blue under alkaline 
pH conditions. A caffeine, sodium acetate, sodium benzoate 
reagent is used as an accelerating agent.
Reagen_ts_^
Caffeine reagent: 128 nmol Caffeine, 263 mmol sodium
benzoate, in 1000 ml of 0.9 M sodium acetate.
1.25 M Sodium potassium tartrate.
0.05 N Hydrochloric acid.
0.06 M Cysteine hydrochloride.
Diazo reagent: 75 umol sulphanilie acid and 6.6 umol sodium
nitrite in 0.05 M HCl.
Bilirubin reference solution.
Me_t h o d
Into two tubes labelled test and blank the f o l l owing 
solutions were mixed; 0.1 ml serum, 0.25 ml of 0.05 N HCl (blank 
tube only), 0.5 ml of caffeine reagent, 0.25 ml of diazo reagent 
(test tube only), 50 ul of cysteine hydrochloride reagent and
0.75 ml of s o d i u m  p o t a s s i u m  tartrate. The s o l u t i o n  was 
transferred to cuvettes and absorbance read at 600 nm. Serum 
total bilirubin was calculated directly from the absorbance 
readings according to the formula; Serum total bilirubin (mg/dl)= 
Absorbance X 13.2
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2.10 ELECTROPHORESIS AND IMMUN OELECTR OPHORESIS .
2.10.11 P£01e_in £ 1 ophori.s_^
Reference: Laemmli, (1970).
Reagent Sj_
Gel stock; 30g acry 1 amide (BDH Electra grade) and 0.8g N, 
N'-methylene bisacrylamide dissolved in 100 ml of distilled water 
(HIGHLY TOXIC). This was stored at 4°C in the dark (Stable for 
one month).
SDS stock solution; 10% sodium dodecyl (lauryl) sulphate 
dissolved in distilled water.
Running buffer; 18.17g Tris-HCl and 4 ml SDS stock were made 
up to 100 ml (pH 8.8).
Stacking buffer; 6.06g Tris-HCl, 4 ml SDS stock solution 
were dissolved in distilled water (80 ml) and the pH adjusted to 
6.8 with HCl before adjusting the final volume to 100 ml with 
distilled water.
E l e c t r o d e  buffer; 6.06g T r i s - H C l ,  28.8g g l y c i n e  were 
dissolved in 1 800 ml of distilled water and 20 ml of stock SDS 
solution added. The pH was adjusted to 8.3 with HCl and the final 
volume adjusted to 2 1 with distilled water.
Sample buffer; 3.78g Tris-HCl, 25g 2-mercaptoethanol, 75 ml 
g l y c e r o l ,  and 5 mg b r o m o p h e n o l  blue were d i s s o l v e d  in 
approximately 300 ml distilled water. The pH was adjusted to 6.8 
with HCl and the final volume adjusted to 500 ml with distilled 
water.
10% ammonium persulphate solution prepared immediately
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before use.
Gel stain: 250 ml propan-2-ol, 100 ml glacial acetic acid and 
650 ml of distilled water were mixed and 0.5 g of C o om a s i e blue R - 
250 added.
Gel destain: 1:1:8 mixture propan-2-ol, glacial acetic acid
and distilled water.
Gel storage: 30 ml glycerol and 20 mg sodium azide were
dissolved in 1 1 of distilled water (TOXIC).
N,N,N*,N '-tetramethylenediamine (TEMED).
Me_tbod_^
The running gel was prepared by mixing (for a 10% T gel) 10 
ml of running buffer, 13.3 ml gel stock and 16.6 ml distilled 
water. Polymerization was initiated by addition of TEMED (20 ul) 
and ammonium persulphate (240 ul).
The stacking gel was prepared by mixing (For a 3% T gel), 
2.5 ml of stacking buffer, 1 ml of gel stock and 6.5 ml of 
distilled water. Polymerization was initiated by addition of 
TEMED (20 ul) and ammonium persulphate (60 ul).
Samples were diluted to an approximate content of 1 rag 
protein/ml solution, using sample b u f f e r . F o l l o w i n g  dilution, 
samples were placed for 3 min in a boiling water bath to ensure 
complete solubilisation and cooled before application to the gel.
Once samples were applied to the gel wells and the buffer 
systems assembled, a current of 20 mA was applied until the 
bromophenol blue front reached the stacking gel/running gel 
interface, when the current was increased to 40 m A .
When the bromophenol blue front was within 0.5 cm of the gel 
margin the gel was removed and placed in stain overnight.
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The gel was destained until a clear background was obtained. 
NOTE: Polyacrylamide gel is formed from aerylamide and the
cross linking agent N, N'-methylene-bisacrylamide in the presence 
of ammonium persulphate as initiator and TEMED as catalyst. The 
reaction takes place via vinyl polymerization and gives a random 
coiled gel structure. For the definition of an aerylamide gel it 
is necessary to indicate the quantity of monomers, i. e. 
where T = Acrylamide and bisacrylamide monomers.
i. e. (a + b) 100 (%)
T = -------- --------
m
where a = Acrylamide (g).
b = Cross-linking monomer (g), and 
m = Volume of buffer.
2.10.11 Crossed £mmunoelectrophoresiSj^
Reference: Axelseii (1973).
Reagent Sj|_
Barbitone-acetate buffer pH 8.6; 11.3g diethyl barbituric
acid,88.8g diethyl-barbiturate sodium and 6 5g sodium acetate in 
10 1 of distilled water.
Tank buffer: 3 1 of barbitone-acetate buffer were
diluted with 2 1 of distilled water.
1% Agarose in barbitone acetate buffer.
Bromophenol blue; a small spatula tip of dye was dissolved 
in 100 ml of distilled water.
Coomassie brilliant blue stain: 450ml of 96% ethanol, 450ml
of distilled water, 100ml of glacial acetic acid were mixed and
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5g of coomassie brilliant blue R was added, mixed and left to 
stand overnight prior to filtering.
Destainer: 450 ml of industrial methylated spirit (or 96% 
ethanol) was mixed with 450 ml of distilled water and 100 ml of 
glacial acetic acid.
0.9% NaCl.
Method :
The electrophoresis tank was filled with tank buffer and the 
plates prepared. 10 ml of hot agarose (1% w/v) was spread evenly 
over each plate and allowed to set. Holes were cut 1.5 cm from 
each of the lower corners of the plate. The plates were then 
placed on a water cooled platform and the tank set up.
One drop of bromophenol blue was added to the right hand 
well of the plate and the sample was placed in the left hand 
well. 5 or 15 ul of sample was loaded depending if a 2 or 4 mm 
diameter well was used. Once samples were loaded 200 mV per 
plate was applied and electrophoresis was allowed to continue 
until the bromophenol tracker dye reached the far edge of the 
plate. The power was then switched off and the plates removed 
and trimmed.
Antiserum was pipetted into a test tube warmed to 5 0 ° 0. 
Sufficient agarose was added to make the volume up to 9 ml, mixed 
by inversion, poured onto the plate and allowed to set. The plate 
was then connected to the buffer system using clean wicks, the 
power was switched on and adjusted to give a constant voltage of 
45 volts. Electrophoresis was continued for at least 16 hr. The 
power was then switched off and the plates removed. Plates were
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then blotted with filter paper and pressed using a thick glass 
plate (approximately 500 g/plate) to press for about 10-15 min; 
after this, the plates were washed in 0.9% NaCl (1 hr), blotted 
again (10-15 min), washed in 0.9% NaCl for 2 hr, and finally 
washed in distilled water for 30 min before being dried in a 
current of hot air. The dried plates were then stained by 
immersion in coomassie solution (10 min) and then destained to 
achieve a slightly bluish background.
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2.11 HISTOLOGICAL PROCEDURES.
2.11.1 Fixation of £issues ^
Reference: Lillie' and Fulmer (1976).
2.11.1.1 Neutra 1-buffered 1
Slices of li.ver taken immediately after the death of the 
animal were immersed into a jar (the jar was labelled with the 
histopathology animal's accession number, date of the experiment 
and treatment of the specimen), containing 10 ml neutral buffered 
formalin, pH 7.4. The jar was gently shaken to avoid adherence of 
the tissue at the bottom of the container. The tissue was left 
for at least one week into the fixative before being processed 
for wax embedding.
2.11.1.2 Ros sman_^ s £ i x i  ve 
Reagent_^
90 ml absolute ethanol saturated with picric acid and 10 ml 
neutralized formalin.
Methodj^
In a labelled container (with the histopathology accession 
number written in it), small pieces of liver were fixed in ice 
cold Rossman's fixative for up to 6 hr. The Rossman's fixative 
was then decanted off and the tissue was then washed several 
times with 96% ethanol to remove the excess of fixative. If left 
too long in the fixative the tissue becomes too brittle to 
section.
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2. 11.2 Préparât i. on of par af f in^wax embedded s e c t i. o n s
Reference; Culling(1974).
Reagent s_^
Methanol.
Fibrowax.
Toluene.
Me t hodj^
The tissues were removed from the formalin after sufficient 
length of time to complete fixation. This procedure was carried 
out under an extractor hood. Liver tissue was trimmed to remove 
any excess of it, and pieces of approximately 5 mm in thickness 
were placed in a plastic processing container. Then, this 
container was covered with a metallic piece. The animal's 
histopathology accession number was written in the plastic 
processing container. The containers were placed in a tissue 
basket which was then fitted to the Histokinet te Automatic Tissue 
Processor (Columbia Hendry, Type E 7326). In this machine tissues 
were transferred automatically from one beaker of fluid to the 
next. The processes of dehydration, clearing and impregnation 
with wax were carried out as follows;
Dehy d ra t i.on_|_
70% Ethanol/water (v/v) 1 hr.
85% Ethanol/water (v/v) 1 hr.
95% Ethanol/water (v/v) 1 hr.
Absolute ethanol I, II and III 1 hr each.
C lear ing_^
Toluene I and II 1 hr each.
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Impregnation.
Paraffin Fibrowax at 58°C 1 hr each.
After this process the tissue containers were transferred to 
an embedding oven containing paraffin Fibrowax at 58°C. Then the 
tissue was removed from the plastic container using a pair of 
electrically heated forceps and placed into a metallic mould 
containing a small amount of soft wax. The tissue was orientated 
so that the surface to be cut rested on this layer of wax facing
the base of the mould. The mould was then filled with molten wax
and the plastic guard, with the animal’s accession number clearly 
printed in it, was placed on top.
After framing, the wax blocks were removed from the moulds. 
Excess wax was cut off the blocks and the block mounted into a 
Rotatory Microtome Reichert Jung. The block was trimmed until the 
tissue was exposed. Then, sections of 7 um thickness were cut.
The sections cut were floated on distilled water (50°C) to 
flatten out and were mounted onto slide single frosted edge, by 
half submerging the slide near the section and withdrawing it, so 
bringing the flattened section with .it. The a n i m a l ’s accession
number was clearly printed in the frosted edge of the slide.
Then, the slides were placed in a rack and dried in an oven at 
50°C for 2-3 hr.
2. 11.3 Haematoxyl_in and eosin stai.ning_^
Reference: Culling (1974).
Reagent Sj_
Harris haematoxy1 in.
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Acid alcohol. 1%HC1 in 7 0% methanol.
Scott's tap water. 0.2% potassium bicarbonate, 2% Magnesium 
sulphate in tap water (w/v).
1% Eosin in distilled water (w/v).
D.P.X.
Met hodj_
The process is schematically describe as follows:
Xyiene 1 and 11, to remove wax 2 min each.
Absolute methanol (Rehydratation process) 1 min.
80% Met hand/water (v/v) 1 min.
1 min.
1 min .
10 min .
Until sections areblue.
5-10 sec.
1 min.
60% Methanol/water (v/v)
Tap water (rinse)
Erlich's acid haematoxylin 
Tap water (washing)
Differentiate in acid alcohol.
Submerge in Scott's tap water 
At this step the s ections were exam i n e d  to ensure a 
sufficient differentiation. If not return to Scott's tap water. 
Counterstain with 1% aqueous eosin (w/v). 3-5 min.
Tap water (rinse)
85% Methanol/water (dehydration)
Absolute methanol 1 and 11.
Xylene 1 and 11
The sections were mounted in D.P.X. by placing a drop of the 
mountant on a clean covers lip, taking the slide directly from the 
xylene, inverting it over the coverslip and pressing gently, so 
the mountant spreads under the coverslip and air bubbles removed. 
Slides were examined using a Leitz Dialux 400 microscope at
30 sec.
1 min.
1 min each. 
1 min each.
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X60, X100 and X 250 .
2.11.4 Sections stained with periodic acid Sch_iff reagent 
study glycogen h is tribu t_ionj_
Reference: Culling(1974).
Reagent Sj_
1% Periodic acid.
Schiff reagent for the detection of aldehydes.
Mayer's haemalum.
0.1% Diastase.
Xylene.
D.P.X.
Me_thodj_
Two sections of the same block were passed through the d e - 
waxing process and brought into water. One slide of each tissue 
was labelled as "control". The control slide was incubated with 
1% diastase for 30 min at 37°C and then washed in running water 
for 5 min.
The slides (control and test) were exposed to periodic acid 
Schiff (PAS) for 5 min, washed gently in tap water and rinsed 
twice with distilled water. Then, the slides were transferred to 
Schiff reagent for 15 min, at the end of this period, the slides 
were washed again with distilled water. Finally, the slides were 
dehydrated in absolute ethanol for 1 min, cleared with xilene and 
mounted in D.P.X. The slides were examined in a Leitz Dialux 
microscope.
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2. 11.5 0 i_l red IÇ^^n^que for 1^2j:ds_^
Reference: C u 1 1 ing ( 1974 ) .
Reagen2Sj_
Stock oil red "0" (ORO), 0.5% in isopropanol.
Diluted ORO for use: 6 ml stock ORO added to 4 ml distilled
water, allow to stand for 5 to 10 min and then filtered.
Me t hodj^
Block of liver fixed in buffered neutral formalin were 
frozen, and sections (7um) cut on a cryostatted microtome, then 
mounted on gelatine-subbedded slides. The sections were rinsed 
briefly in 60% isopropyl alcohol, then stained in ORO working 
s o l u t i o n  for 15 min. A f t e r w a r d s  the s l i d e s  were q u i c k l y  
differentiated (1 to 2 sec) in 60% isopropyl alcohol and washed 
with water. Nuclei were counterstained with Mayer's Haemalum for 
3 to 5 min and washed with tap water and rinsed with distilled 
water. The slides were finally mounted with glycerin jelly.
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2.12 ELECTRON MICROSCOPY.
2.12.1 llÊÊUf for electron microscopy^
Reference: Price (1985).
Reagen^s_^
0.2 M Sodium cacodylate-nitric acid buffer, ph 7.4.
4% B u f f e r e d  g l u t a r a l d e h y d e :  g l u t a r a l d e h y d e
(volume = 400/concentrât ion) in 0.1 M sodium cacodylate buffer, pH
7.4.
Absolute ethanol.
2% Osmium tetroxide in 0.1 M sodium cacodylate buffer, pH
7.4.
Propylene oxide.
Epon 812.
Fixa t ionj_
Liver slices (1 mm thick) were cut immediately after the 
animals death, and cut into cubes (1 mm per side). The tissue was 
fixed in 4% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH
7.4 for 2-4 hr at room temperature. Then, the solution was 
decanted and the containers were refilled with sodium cacodylate 
buffer, pH 7.2 overnight.
Ê^bedd^ng^
The tissue was c o u n t e r f i x e d  in a 2% osmium t e t r o x i d e  
solution buffered in 0.1 M sodium cacodylate, pH 7.4 for 2 hr. At 
this point the blocks turn charcoal black. After 2 hr the osmium 
tetroxide is carefully removed and the tissue blocks dehydrated 
through a series of graded alcohol according to the following 
scheme. Each solution was left in contact with the tissue for at
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least 10 min.
25% (v/v) Ethanol. Twice.
50% (v/v) Ethanol. Twice.
75% (v/v) Ethanol. Twice.
90% (v/v) Ethanol. Twice.
Absolute ethanol. Twice.
Ethanol and propylene oxide (1:1). Twice.
Propylene oxide. Twice.
The tissue blocks were transferred from propylene oxide 
solution to a mixture of propylene oxide and Epon 812 resin (1:1) 
for 60 min to a llow initial impregnation of the tissue with the 
resin.
Small blocks of tissue were transferred to Epon 812 resin- 
filled truncated capsules using a microspatula and allowing 2-3 
blocks per capsule. The capsules were then placed in an oven at
60°C for 40 hr to a l l o w  the resin to polymerise. Finally, The
capsules were removed from the oven, the resin blocks taken out 
of the capsule and the blocks were then prepared for cutting.
lissue blocks for examination under an eieç i ron
The resin block was initially trimmed then mounted into an 
ultra microtome (Reihardt-Jung, Austria). The block was further 
trimmed to expose the tissue and sections were cut using a 
diamond knife (Du Pont, U.K., Herts.) to a thickness of 700 A 
(silver-grey in colour). In order to mount the sections, they 
were floated in distilled water and mounted onto copper grids; 
blotted dry and placed in a number of grid box.
CHAPTER THREE
RESULTS.
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3. RESULTS.
3.1 SPECIES DIFFERENCES IN THE HAEM METABOLISM AND MONOOXYGENASE
ENZYMES.
3.1.1 Haem me^abolism^
Table 3.1.1 shows some differences in the activity of enzyme 
involved in haem metabolism between rat and rabbit. 5 -ALAS 
activity in rat liver, kidney and testicles was found to be 
respectively 16.8, 12.7 and 20.5 fold greater than the activity 
found in the corresponding organs in the rabbit.
In contrast, 5-ALAD and ferrochelatase activities were 
similar in the liver and kidney of both species, but testicular 
5-ALAD and FC activities were 2.5 and 2.0 fold grater in rabbits 
than in rats.
HO was 3.7 and 6.7 fold more active in rat liver and kidney 
than in the corresponding rabbit organs, whereas HO activity in 
kidney was not significantly different in the two species.
Biliverdin reductase was not detectable in the rabbit 
cytosolic fractions. •
3.1.2 Monooxygenase enzymes^
Table 3.1.2 compares the microsomal cytochrome P-450 content 
in various organs and monooxygenase enzyme activities in liver 
between rat and rabbit. No difference was found in the cytochrome 
P- 4 50 content in liver and testicles of both species , but the 
cytochrome content in kidney was 3 fold greater in rats than in 
rabbits .
ECOD activity was 1.8 fold higher in liver microsomes of
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rabbit than those of rat, but EROD was 1.6 times more active in 
rat than in rabbit.
The hepatic microsomal cytochrome b^ content was found to be
2.5 fold greater in rabbits than in rats, and as far as the 
kidney content is concerned, it was 3.5 fold greater in rats than 
in rabbits. No difference was found in the testicular content 
between the two species.
-  122 -
m
CD
(h ♦ *O * Ü3in d O
ai o
+1
u + 1 +1
+ 1
+j 03 Ü3 CD
n O \n CD
ai
K •K' M M O
* t-J
o <1
ri o
Ci o
> +1 + 1
01 +1 +ic ■ 03 t l
"O 43 ri o N
ai N' o O
K' 03 4" r-1
O *-• O o
+ 1 + 1 + 1 41
L
QJ. r-1 43 43
> o C r-1 <r
_1 03 43 T-) o
T3 43
C m r-1 D3ni 01 O' o
d O•+J u + 1 +1
iy 41 41
L: ■p 43 ùl
03 N r-1 Ü3
ai 01
JZ i- H N 43
c <-
O Kj
in O
0! o O
> + 1 4101 41 41
C r-1
> •o <■ <- O'
•p M N o O
Lî
lu
û:
m r-1
e CD 11
> 03 43 r-1
N r-1
C O o d
CJ •n
41 41 41
e L 03
Ul 01 O' <- o
> nr O' O' N
Kl
0 N O y
r-1
CM
ô
+ 1
N
n
UT
+1
o
'ôM
N
K*
+1
«
dr-j
QJ 0!
e. 03 03
01 Oi lï ». ^lu 4J P  K! V Ci
IC Û! 133 k 03
J= L iC-
P T3 P C
1= > ti 01 ir «t
> j: 03 01
01 01 01 > TD 01
Kl Tj r i_ ■0
01 u 0 01 p
li.1 E <r 0 > u
_! > _j L e 3
cr.t N <r <r L 03 XI
C 1 ! 0! . lO 01
t- ixi LO Ü'I li. X tri L
c G
p
IJ3
ei p
p
L G
J= > L
'V p
C C
33
03 G
P 1_ G •
O ei C
L 03 C
CL 133 -M
01 P
U E lu
>
l/l L
0 fÜ
01 , 2 01
Cl P
P n O
X p
u 43,
S3
en J3 P
E (S G
'v.. L G (0 o
c G G
01 C 133 . d
en P
0 U P V
C o 2 133
X P CL
G P  *
G L C *
JD je G
0 p C
je 01
a p P P
•x. 0 L lu
Cl G L o
CL > >
p V
r-3 C
0  G > a
E -M P 03 *
C P p C
ni u M- 0 p
r -1 L 133 G G
0 p L
a G G (S
L U > C
0 4- L L
. U 2 G p
c O G G G
G P G
G 0 2
n P 05
G 0 tÜ 01 G
IL Z >
£> P 4- en
01 a 0 en c
L L c
je G
L 'x. Q p p• je c 0 c
L  \ L 0 G
je  c G P CD a L
'n, ri P C G G
c  w G 0 41 G 4-
.-■H P L u L G
01 0 CL I X L P
p  L ns G
0  CL U L
L m 4- G P
Cl rH E 0 E
m 0 C 0 4"
G -M . G c 0! L r-1
p  L O 0 > 4-
II! "D L p
C C U p p i P G
G O u C p î
en je E 03 G G uc
o u L L L G . ici
e 0 en P G G 4--
o P E 4- Jl
je  -M U G 4- ici 01
E c P p L
en P u
E en p G 2 01 2
E 2 G 03 >-• p
<r L. 0 G 01
_i e P ■ L P p
cr G > r G
1 135 U G G p 2
0 1  je P > U Cl
U G" z 01
P 4-
0  Cl G p G m
E e E lO C Cl e
CL c C CL en
111
t-H Kl <- je <r Cfj z cî
O'
U 1 1 + 1 . .
p +1 1 1 c G
(0 p 1 1 N •H P
L G 10 • 1 10 e
G o O P
4- s. P
C o O c G
H L
* G
> * P C
P * 4) 0
* 10 L
> CD O O. G
> O C
P . G 1 1 O 0
U C O 1 1 ta
m P 1 1 + 1 e p
m + I 1 1 0 G
G M 1 ! CM G >
G 10 1 1 r-1 0 L
e L G
> d o U G
N m P
C e 0
G * * . C
4) * * n> 43 th
P N 43 E G O
C <E O 4" O X P P  •
G C ■ 0 G O
P L o O O d L G
C G L a G V
G > +1 +1 + 1 +! G
a - E -a
G a: P M N O 3 G p  *
P ül 03 O N 0 e G *
U 0
G d O 4" O > G
G 0 C 03
ni 0 L G O
c 43 L U
G O P G O
en G O > E P
> G 1 1 % G V
O 1 1 1 en L
0 U ! 1 •N E CL
0 1-1 +1 1 1 a \ C *
c P 1
0 G 4- 1 1 0 O P
E G 10 z E 6 G G
H o C C C
P 0 p
C o M 4" rl G
ni P  L
G
o w O' > C
Ü1 H o L -H
Ÿ o o G1 1 1 G G
CL > o 1 o P  G
G 1 1 0 3
G C +1 1 +1E P 1 1 03 G
0 1 1 N >
L <E ü O' N C 4-
P o O 0 en
U E c
0 o O
p N. (3 p
> C c
u 0
G 03 CL
4- a: 03 03 03 . M P G0 . O W 4) O 0 4-1 GL L
p L d O O O CL IX L
c G 0
G > +1 +1 + 1 + 1 r-1 G U
P G G
C P 10 m N O' C E - E
0 o N M 0 C 0
u G G G L
o o CD 6 P 0 > 4-
0 L H
m L U en p
E a r4 c
0 E G G
G L L
0 G o> G G
L 1 ■ E E 4-
U 1 O O V. G 4-
o o 1 G C P  M
Z 03 1 C 0 r4 P
4" c L 4- 3
1 4- 03 U 3 G >
n 0_ L 3 P L G r-1
G C4 L 10 E O L P
G E G 0 G G G C
E 3 G G G E en G G G
M 0 0 m G «C O E CH > U
L U L L s» 0 M
P ÜJ P > > > > P P  4-
Ul z > U p P U 0 0 G r«
p P > <r 0 0 p 0 P 0 E E C
CCI P M tn p p G P G p C CL
<[ <0 Z tn > p G P G >'
H- L ÜJ <r u ÜJ P 111 P u 10 <r 03
Q
cn
c
GP
G
LO
4-
G
P
L
P
<-N
PGPGGP
G
L
G
2
-  123 -
- 124 -
3.2 ARSENIC EFFECT ON THE HEPATIC MORPHOLOGY OF THE RAT.
3.2.1 Hepatic histopatho logical changes produced by £he treatment 
w^th sod_ium 2££C£i.£Ç_L
General morphology. An extensive vacuolation of the periportal 
areas was observed twelve hr after the administration of a 
subcutaneous dose of As 111 (75 umol/kg body weight) to rats
which persisted until 48 hr after arsenic administration. 
However, no changes were observed at times between 2 and 6 hr.
Plate 3.2.1 shows a centrilobular area of a section of a 
normal liver stained with haematoxylin and eosin (H and E).
•
À*'
. .
1*
m
PLATE 3.2.1 Centrilobular area o f a control rat, fasted 8 hr 
and killed 16 hr after an intraperitoneal administration of 
normal saline. H and E stained section.
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Glycogen distribution^ The treatment with As III (75 umol/kg body 
weight) affected the distribution of glycogen in the liver. 
Plate 3.2.2 shows a control liver section in which glycogen was 
enzymically digested with diastase, and then stained with PAS 
reagent. Plate 3.2.3 shows an even distribution of glycogen in a 
liver section taken from an unfasted control rat stained with 
PAS.
Plate 3.2.4 shows the effect of treatment with As III on the 
hepatic glycogen content. A decrease in the overall glycogen 
content was found. The fall in concentration was greater in the 
midzonal area, although the hepatocytes of some areas still 
showed a bright red colour due to the glycogen being stained with 
periodic acid Schiff reagent.
Li£Ad distribution. Plate 3.2.5 shows the appearance of a control 
rat starved 8 hr before an intraperitoneal administration of 
normal saline and killed 16 hr afterwards. Only a small amount of 
lipid can be seen.
Lipid droplets appeared to accumulate in the periportal area 
of livers of rats treated with As 1 1 1 ( 7 5  umol/kg body weight). 
Plate 3.2.6 shows a small periportal lipid accumulation in a 
liver section taken from a rat fasted 8 hr before and killed 16 
hr after an intraperitoneal administration of As III. The lipid 
droplets were marginally distributed in the cytosol.
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PLATE 3.2.2 PAS stain of a liver section taken from a control 
fed rat, predigested with diastase.
■' V*
IT
PLATE 3.2.3 PAS stain of a liver section taken from a control 
fed rat .
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PLATE 3.2.5 ORO stain of a liver section taken from a control rat 
fasted 24 hr before death.
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PLATE 3.2.6 Effect of sodium arsenite on the distribution of 
lipids in a liver section taken from a rat fasted for 24 hr. ORO 
stain section.
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3.2.2. His t opa tho 1 ogi-ca 1 changes produced by sodium arsenite on 
the liver of rats pre_treated w_ith cytochrome P-450 inducers. 
Phenoba'r bi. t onej^
General morpho 1 ogy^^ PB administration (0.3 mmol/kg body weight 
daily for three days) produced an increase in the eosinophilia 
of the hepatocytes near the central vein. This appearance 
persisted longer than 36 hr.
When PB preinduced rats were treated with As III (75 umol/kg 
body weight), two effects were found 16 hr after arsenic 
administration, a hydropic degeneration of the hepatocytes in the 
centrilobular area, and a marked increase in vacuoles in the 
periportal area.
The plate 3.2.7 shows a hydropic degeneration area around 
the central vein, and a heavily vacuolated area in the periportal 
zone. P l a t e s  3.2.8 and 3.2.9 show in detail h e p a t o c y t e s  
undergoing hydropic degeneration process and necrosis.
Plate 3.2.10 shows'an extensively vacuolated area around the 
periportal region of a liver section of a PB pretreated rat dosed 
with As III 16 hr before death.
This process was reversible, and no changes were found in 
sections of liver from rats given PB-As III after 36 and 48 hr 
after arsenic administration. Results are summarized in table 
3.2.1.
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PLATE 3.2.7 Centrilobular hydropic degeneration and periportal 
vacuolar accumulation produced by sodium arsenite in rats p r e ­
treated with phenobarbitone. H and E.
' • % /  , r ^
&
# *
t
*f -  ^  "  * A i
' ' » 1 / O .
- ^ ^
I. " ' ' A.
• « ■ » • S'i. W
PLATE 3.2.8 Centrilobular hydropic degeneration and cell necrosis 
in a liver section taken from a fasted rat preinduced with 
phenobarbitone and dosed with sodium arsenite. H and E.
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PLATE 3.2.9 Centrilobular hydropic degeneration produced by
sodium arsenite in a rat pretreated with phenobarbitone. H and E
stain.
PLATE 3.2.10 Extensive vacuolation around the periportal zone 
produced by sodium a r s e n i t e  in a rat p r e t r e a t e d  with 
phenobarbitone. H and E stain. Microgra_ph vjitKout filter.
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The intraperitoneal administration of As III (75umol/kg body 
weight) produced an extensive vacuolation in the periportal area 
in the liver of rats pretreated with 3-MC (0.75 mmol/kg body 
weight daily for 3 days).
The intraperitoneal administration of As III (0.75 m m o 1 / kg 
body weight) produced an extensive vacuolation in the periportal 
area in rats pretreated with ISO (5 mmol/kg body weight daily for 
3 days), which was similar to that produced in the PB and 3-MC 
pretreated rats.
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G ly££S££ £i£2£i:£ut i.onj_ PB (0.3 mmol/kg body weight daily for 3 
days) treatment produced a depletion in the glycogen content in 
the periportal hepatocytes, but levels were normal near the 
central vein, as shown in plate 3.2.11.
When As III (75 umol/kg body weight) was administered to PB 
treated rats, no glycogen was found as it can be observed in 
plate 3.2.12. Results are summarized in table 3.2.1.
LiPid d i s t r j^ b u£ i. on_^  PB pretreatment produced no effect on the 
lipid accumulation in rat liver, as shown by ORO stain sections 
(plate 3.3. 13).
As III (75 u m o l / k g  body weight) a d m i n i s t r a t i o n  to PB 
pretreated rats produced an extensive lipid accumulation in 
periportal areas as it is shown in plate 3.3.14. Results are 
summarized in table 3.2.1.
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3.2.11 Glycogen distribution of a liver section taken from a rat 
pretreated with phenobarbitone. PAS stain.
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PLATE 3.2.12 Effect of the treatment with sodium arsenite on the 
hepatic g l y c o g e n  d i s t r i b u t i o n  of a rat p r e t r e a t e d  with 
phenobarbitone. PAS stain.
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PLATE 3.2.13 Lipid distribution in a liver section of a fasted 
rat treated with phenobarbitone. ORO stain.
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PLATE 3.2.14 Effect of the treatment with sodium arsenite on the 
hepatic lipid distribution of fasted rats pretreated with 
phenobarbitone. ORO stain.
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3.2.3 Hepatic çytolog_ical changes produced by the admi.nistra_t^on 
of ood_ium ar^en_ite to ra_ts pre^rea^ed with e_i_t_her normal saline 
or phenobarbitone.
To provide a better way to compare the effects of sodium 
arsenite on rats dosed with normal saline or pretreated with 
substances known as inducers of hepatic microsomal cytochrome P- 
450, the electron micrographie findings will be treated as a 
whole, and micrographs of controls can thus be compared directly
with those of the treated liver sections.
Çytolog^çal effects of sodium e£seni.te on rat livers _16 hr 
ÊflÊE Ê^mlnistrat^on^^
Plate 3.2.15 shows an electron micrograph of a liver section
taken from a control animal which had been fasted 8 hr before and
killed 16 hr after the administration of normal saline.
In this electron micrograph, the main features are: a total 
loss of glycogen, and an apparent increase in the number of 
organelles, as if a .mitochondria 1 proliferation had taken place.
The quantity of lipid vacuoles varied depending on the 
region under observation. In the case of the micrograph inserted 
here, some vacuoles of variable size are shown. The general 
aspect of the s t a r v e d  l i v e r  p r e p a r a t i o n  a l l o w s  an easy 
localization of the Golgi complex scattered around the bile 
canaliculus, the latter remains closely intendigitated.
Plate 3.2.16 shows an electron micrograph of a liver section 
taken from an As III (7 5 umol/kg body weight) treated rat. A 
dilation of the bile canaliculus is observed, this fact is one of 
the most consistent changes found in As III treated rats. 
Mitochondria appear swollen and because of this, some of them
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seem to be less electron dense. The mitochondrial structure 
(matrix and cristae) appear disorganized. Further degradation 
results in the formation of myelinic figures inside this 
organelle.
Plate 3.2.17 is an electron micrograph of a liver section of 
a^rat treated with PB (0.3 mmol/kg body weight). This electron 
m i c r o g r a p h  shows an a p p a r e n t  i n c r e a s e  in the number of 
mitochondria, the majority of them are swollen and some have 
started a myelination process. There are some vacuoles present 
with lipidic appearance.
Plate 3.2.18 is an electron micrograph of a liver section 
taken from a rat coadministered As III and PB. This plate shows a 
great increase in lipid droplets which appear to be localized in 
the periphery of the hepatocytes. The number of mitochondria seem 
to be greater than in controls. There is also a clear dilation of 
the bile canaliculi, and some myelinated figures can be seen in 
their lumen.
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PLATES.2.15 Electron micrograph of a liver section taken from a
control rat fasted for 2 4 hr.
PLATE 3.2.16 Electron micrograph of a liver section taken from a
rat fasted for 8 hr before an administration of sodium arsenite 
(75 umol/kg body weight) and sacrificed 16 hr later.
PLATE 3.2.17 Electron micrograph of a liver section taken from a 
rat treated with phenobarbitone (0.3 mmol/kg body weight/day) 
daily for 2 days and fasted for 2 4 hr before sacrifice.
PLATE 3.2.18 Electron micrograph of liver section taken from a 
rat treated with phenobarbitone (0.3 mmol/kg body weight/ day) 
daily for 2 days. Then the rat was fasted for 8 hr before a 
sodium arsenite dose (75 umol/kg body weight) and killed 16 hr 
later.
Abbreviations:
Nucleus (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculus (B), lysosomes (L), Golgi complex (G), peroxisomes 
(P), collagen fibres (C), glycogen (GY), and erythrocyte (E).
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observed 36 hr af_ter treatment w^th sod_ium i^ n
ra^s pretreated wi_th normal sali.ne or with phenobarbitone.
Plate 3.2.19 shows an electron micrograph of a liver section 
taken from a control rat which has been fasted for 24 hr and 
injected with normal saline 36 hr before death. Because rats were 
allowed food 16 hr following the saline administration, glycogen 
granules are present, and also some lipid droplets. The bile 
canaliculus presents a highly convoluted and interdigitated 
aspect.
Plate 3.2.20 shows an electron micrograph of a liver section
taken from a rat treated subcutaneous ly with As III (75 umol/kg
body weight) 36 hr before death. Some glycogen remained in the 
cytosol. Mitochondria appeared swollen and some presented 
myelination. The bile canaliculus appeared dilated and containing 
some myelin figures. The rough endoplasmic reticulum stacks 
appeared to contain a grater number of layers and were larger in 
size.
Plate 3.2.21 shows an electron micrograph of a liver section
of a PB treated rat (0.3 mmol/kg body weight daily for 3 days)
shows swollen mitochondria, with a low electron dense appearance, 
some seem to undergo degradation. Glycogen appears in the same 
proportion as that present in the control micrograph (plate 
3.2.19).
The plates 3.2.22 to 3.2.24 are electron micrographs of 
liver sections taken from rats pretreated with PB and As III. 
They show different aspects of the effects of the combined 
treatment. In the plate 3.2.22 some dilated bile canaliculi are 
present, in them the microvilli are dilated, in the lumen of this
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some myelinated figures are observed. Mitochondria, on the other 
hand, present a variety of shapes, some appear condensed, very 
electron dense, others seem more like normal ones, and others 
appear swollen and of a bigger size. The latter appear degraded 
and some present myelin figures. Some core less peroxisomes are 
also present. The glycogen content seems poorer than in the 
previous micrographs, and the rough endoplasmic reticulum is not 
organized in well defined stacks. On the contrary, it consists of 
a few layers and some ribosomes seem to be detached and floating 
in the cytosol.
In plate 3.2.23 the myelination of mitochondria and smooth 
endoplasmic reticulum is evident. In this micrograph some lipid 
vacuoles are also present. The presence of this pathologic 
features is not consistent throughout the hepatic tissue, indeed 
in some sections of the liver may show normal characteristics, as 
in the case of plate 3.2.24, which shows a better general 
cellular appearance and organization than that of plate 3.2.23.
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PLATE 3.2.19 Electron micrograph of a liver section taken from a 
control rat.
PLATE 3.2.20 Electron micrograph of a liver section taken from a 
rat treated with sodium arsenite (75 umol/kg body weight), and 
sacrificed 36 hr after arsenic administration.
PLATE 3.2.21 Electron micrograph of a liver section taken from a 
rat treated with phenobarbitone (0.3 mmol/kg body weight/day) 
daily for 3 days and s a c r i f i c e d  36 hr after the last 
phenobarbitone administration.
PLATE 3.2.22, 3.2.23, and 3.2.24 Electron micrographs of a liver
sections taken from rats treated with phenobarbitone (0.3 
mmol/kg body weight/day) daily for 3 days and dosed with sodium 
arsenite (75 umol/kg body weight/day) sacrificed 36 hr after 
arsenic administration.
Abbreviations;
Nucleus (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculus (B), lysosomes (L), Golgi complex (G ) , peroxisomes 
(P), collagen fibres (C), glycogen (GY), and erythrocyte (E).
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Hepatic cytological effects 48 hr after the treatment wi.th sod_ium
ÊEÊÊ5Î1Ê in rats.
Plate 3.2.25 shows the general features of a liver section 
taken from a control rat 48 hr after dosed with normal saline. In 
spite of some myelinated organelles, the aspect of this section 
is one of a well organized hepatocyte.
Plate 3.2.26 is an electron micrograph of a liver section 
taken from an As III treated rat, which despite the treatment 
involved, looks like a normal liver. The cytosol comtains a amount of
glycogen, the mitochondria are uniformly stained, and although 
there appear to be more rough endoplasmic reticulum stacks, they 
seem well organized.
Plate 3.2.27 is the electron micrograph of liver taken from 
a PB treated rat. Here, 48 hr after the last PB administration 
the mitochondria are still swollen and appear proliferated, the 
matrix appears very light and even the cristae are set apart. A 
dilated bile canaliculus is present but does not contain myelin 
figures. The rough endoplasmic reticulum appears hypertrophic.
An electron micrograph of a liver section of a PB- As III 
treated rat is presented in plate 3.2.28. Here, a complete 
depletion of glycogen is oL^served^ the mitochondria appear 
condensed, and some are very deteriorated and myelinated. A 
hypertrophy of the rough endoplasmic reticulum is evident, but is 
less abundant than in the previous plate. There is also a 
proliferation of peroxisomes. The smooth endoplasmic reticulum 
also appears hypertrophied.
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PLATE 3.2.25 Electron micrograph of a liver section taken from a 
control rat.
PLATE 3.2.26 Electron micrograph of a liver section taken from a 
rat dosed with sodium arsenite (75 umol/kg body weight) and 
sacrificed 48 hr later.
PLATE 3.2.27 Electron micrograph of a liver section taken from a 
rat a d m i n i s t e r e d  with p h e n o b a r b i t o n e  (0.3 m m o l / k g  body 
weight/day) daily for 3 days and sacrificed 4 8 hr after the last 
phenobarbitone administration.
PLATE 3.2.28 Electron micrograph of a liver section taken from a 
rat treated with phenobarbitone (0.3 mmol/kg body weight/day), 
for 3 days, then dosed with sodium arsenite (75 umol/kg body 
weight) and sacrificed 48 hr after arsenic administration.
Abbreviations:
Nucleus (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculus (B), lysosomes (L), Golgi complex (G), peroxisomes 
(P), collagen fibres (C), glycogen (GY), and erythrocyte (E).
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in the hi. le çanalicul^ produced by _the administration 
of sodium a£sen_ite_^
Bile canaliculi of control rats is normally observed as an 
intercellular space with interdigitated microvilli, usually the 
Golgi complex is near this structure, as can be seen in the plate 
3.2.29, which is a micrograph taken from a control rat.
Treatment with As III invariably produced a dilation of the 
bile canaliculi, which remained 48 hr after treatment. The 
canaliculi usually contained some myelinated fig ures denVc-cl 
either from deteriorated mitochondria or endoplasmic reticulum. 
Plate 3.2.30 shows this characteristic feature.
PB pretreatment also produced dilated bile canaliculi, 
sometimes containing myelin figures, but never of the size and 
with the amount of m y e l i n  that the ar s e n i c  treated l i v e r  
preparations showed.
P r e t r e a t m e n t  with PB- As III a d m i n i s t r a t i o n  u s u a l l y  
exacerbated this condition. Plate 3.2.31 shows an electron 
micrograph of a liver preparation taken from a PB- As III treated 
rat, in which the Golgi complex is also clearly seen.
The administration of As III produced swollen mitochondria 
as is shown in plate 3.2.30, but PB produced a greater effect. 
When As III was administered to PB pretreated rats, mitochondria 
appeared condensed.
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PLATE 3.2.29 Electron micrograph of the liver of a control rat. 
PLATE 3.2.30 Electron micrograph of a liver section taken from a 
rat treated with sodium arsenite (75 umol/kg body weight) and 
sacrificed 36 hr after arsenic administration.
PLATE 3.2.3 1 Electron micrograph of a liver section of a rat 
treated with phenobarbitone (0.3 mmol/kg body weight/day) for 3 
days and sodium arsenite (75 umol/kg body weight) and sacrificed 
36 hr after arsenic administration.
Abbreviations:
Nucleus (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculus (B), lysosomes (L), Golgi complex ( G ) , peroxisomes 
(P), collagen fibres (C), glycogen (GY), and erythrocyte (E).
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of sod i.urn a£sen^_te ££ li£££s of £ats P££t£eated W£_th 2 
of phenobarbitone.
As III administration to rats pretreated with PB for 2 days 
produced hepatic changes similar to those seen in rats pretreated 
with PB for 3 days. Here again the dilatation of the bile 
canaliculus was the most characteristic change caused by As III 
administration, and again they contained myelinic figures. The 
mitochondrial changes were also similar to those previously 
observed in PB + As III treated rats.
P late 3.2.32 is a hig h e r  m a g n i f i c a t i o n  of a l i v e r  
preparation taken from a control rat.
Plate 3.2.33 is an electron micrograph of a liver section 
taken from an As III treated rat. It shows a dilated bile 
canaliculus containing myelin figures. The rough endoplasmic 
reticulum also appears to be degranulated.
The rough and smooth endoplasmic reticulum induction by the 
PB treatment is observed in the electron micrograph of plate
3.2.34. In this case, mitochondria have a normal appearance.
A greater rough endoplasmic reticulum disorganization and 
degranulation, as well as smooth endoplasmic reticulum induction 
and core less peroxisome proliferation is shown in the plate
3.2.35.
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PLATE 3.2.32 Electron micrograph of a liver section taken from a 
control rat fasted for 2 4 hr before sacrificed.
PLATE 3.2.33 Electron micrograph of a liver section of a rat 
fasted 8 hr before an administration of sodium arsenite (75 
u m o l / k g  body weight), and s a c r i f i c e d  16 hr after a r s e n i c  
administration.
PLATE 3.2.34 Electron micrograph of a liver section taken from a 
rat treated with phenobarbitone (0.3 mmol/kg body weight/day) for 
1 day and fasted for 24 hr before death.
PLATE 3.2.35 Electron micrograph of a liver section taken from, a 
rat treated with phenobarbitone (0.3 mmol/kg body weight/day) ,for 
1 day and dosed with sodium arsenite (75 umol/kg body weight). 
Rats were fasted for 8 hr before arsenic treatment and sacrificed 
16 hr later.
Abbreviations:
Nucleus (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculu.s (B), lysosomes (L), Golgi complex ( G ) , peroxisomes 
(P), collagen fibres (C), glycogen (GY), and erythrocyte (E).
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or t£eatmen_t wi.£h sodium ££seni.te on the cy_tology of 
fed £0£2Î£.Ë£££.Ë ££^ induced Phenoba£bi£one rats.
Plate 3.2.36 shows a section of the liver of a control rat. 
Glycogen is clearly visible and is distributed all over the cell. 
Mitochondria are evenly stained presenting a uniform aspect. The 
rough endoplasmic reticulum is well organized and forming regular 
stacks. No change is observed in the bile canaliculi.
Plate 3.2.27 shows an electron micrograph of a liver section 
taken from an As III treated rat. The effects of the arsenic 
treatment are similar to those previously observed in fasted rats 
treated with As III as well. The most important feature here is 
the small amount of glycogen distributed in the cytosol of the 
hepatocyte, in comparison with the control micrograph.
Plate 3.2.38 is an electron micrograph of a section liver
taken from a PB treated rat. All the features described for the
p r e v i o u s  fasted PB t r e ated rats are found here. The main 
characteristic is the presence of a smaller amount of glycogen in 
the preparation than that found in control rats.
In plate 3.2.39 an electron micrograph of a liver section
taken from a PB- As III treated rat is shown. The main features
are: a total loss of glycogen, a total disorganization of the 
rough endoplasmic reticulum, and a vésiculation of the smooth 
endoplasmic reticulum. The mitochondria appear at different 
degrees of degradation and myelination, some autolysosomes 
contain debris which recall the shape of mitochondria and some 
other electron dense bodies. T h e  table 3.2.2 summarizes the 
results .
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PLATE 3.2.36 Electron micrograph of a liver section taken from a 
control rat fed with a control diet.
PLATE 3.2.37 Electron micrograph of a liver section taken from a 
rat fed with a control diet and dosed with sodium arsenite (75 
umol/kg body weight) 16 hr before sacrificed.
PLATE 3.2.38 Electron micrograph of liver section taken from a 
rat fed with a control diet and dosed with phenobarbitone (0.3 
mmol/kg body weight/day) daily for 3 days and sacrificed 15 hr 
after the last phenobarbitone administration.
PLATE 3.2.39 Electron micrograph of a liver section taken from a 
rat fed with a control diet and dosed with phenobarbitone (0.3 
mmol/kg body weight/day) then treated with sodium arsenite (75 
umol/kg body weight) 16 hr before sacrificed.
Abbreviations :
Nucleus (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculus (B), lysosomes (L), Golgi complex ( G ) , peroxisomes 
(P), collagen fibres (C), glycogen (GY), and erythrocyte (E).
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of the trea_tment w_ith sodj^um a£senj^_te i n  ^sosaf role
PEÊÈEÊÊlËd rats.
The ISO pretreatment (5 mmol/kg body weight daily for 3 
days) produced an increase in the number of organelles and in 
particular that of the smooth endoplasmic reticulum. Besides, it 
produced an increase in the number of core peroxisomes, as it can 
be seen in the plate 3.2.40.
When As III was administered to ISO pretreated rats (plate 
3.2.4 1). The number of core peroxisomes was greater than in the 
previous section. There was also an increase in lipid vacuoles, 
and the rough endoplasmic reticulum was induced and highly 
disorganized.
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PLATE 3.2.40 Electron micrograph of a liver section of a rat 
treated with isosafrole (5 mmol/kg body weight/day) for 3 days 
and fasted for 24 hr before sacrificed.
PLATE 3.2.41 Electron micrograph of a liver section taken from a 
rat treated with isosafrole (5 mmol/kg body weight/day) daily for 
3 days, then the rat was fasted for 8 hr before a dose of sodium 
arsenite (75 umol/kg body weight) and sacrificed 16 hr later.
Abbreviations;
Nucleus- (N), mitochondria (M), rough endoplasmic reticulum 
(R), smooth e n d o p l a s m i c  r e t i c u l u m  (S), m y e l i n  (MY), bile 
canaliculus (B), lysosomes (L), Golgi complex (G), peroxisomes 
(P), VÆ.CUO les r (sf), and erythrocyte (E).
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3.3 BIOCHEMICAL EFFECTS OF SODIUM ARSENiTE.
3.3.1 E£ fec_t of on haem me£abol£sm^
Haem oxygenase^
Hepatic haem oxygenase was induced at each of the time 
points studied, regardless of the dose regimen to which the rats 
were exposed. In each case the v a l u e s  were s t a t i s t i c a l l y  
different from controls (table 3.3.1).
Fasted rats, which were injected subcutaneously with As III, 
at 1b hr before death, showed a 16.3 times increase in tne HO 
activity. Rats pretreated with corn oil, and fasted for 8 hr 
before deatn, also showed a 16.2 times increase in the activity 
of this enzyme too, and unfasted rats showed a similar induction 
to that of the other groups.
Although the enzyme activity had decreased after 24 hr, some 
induction still remained 48 hr after arsenic administration. 
5zAElHol5fvulinic ac£d dehydratase^
The activity or' the 5-ALAD was not affected by treatment 
with sodium arsenite after 24 hr, but the activity increased by 
36% after 36 hr, and up to 55% after 48 hr (table 3.3.2). When 
the latter time points were compared with their own controls (36 
hr: 7.29 + 0.89, and at 48 hr 8.34 + 0.86) such increase in
activity was not statistically significant. Furthermore, fasted 
corn oil treated rats given arsenic showed no effect on the 5- 
ALAD activity.
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TABLE 3.3.1 Time cou r s e -response to treatment with sodium 
arsenite of the activity of hepatic microsomal haem oxygenase in 
fasted; pretreated with corn oil, or unfasted rats.
P R E T R E A T M E N T  HA EM OXYG E N A SE ^
/TIME AFTER Control Treated
DOSE (hr).
Fasted 8 hr before arsenic administration.
1 6 1 .46 + 0.3 7 (5) 23.8 + 3.57**(5)
% %
24 3.82 + 0.63 (3) 8.72 + 0.66 (3)
36 1.15 + 0.22 (5) 1.92 + 0.38*(5)
48 2.88 + 0.37 (5) 8.71 + 3.68*(5)
w ith _co£n o£_l for 3 days and[ fasted for 8^ hr b£for_e 
arsenic administration.
16 1.13 + 0.33 (3) 18.34 + 2.44 (5)
Unfasted.
16 1.77 + 0.96 (5) 15.5 + 4.05 (5)
1 nmol Bilirubin/mg microsomal protein/min.
All above results are given as X + S . D .  of the number of 
observations in parentheses.
Differs from controls at *p < 0.05; p < 0.01; ***p < 0.005.
The results are pooled from different experiments.
Rats were fasted 8 hr before and killed at specified times after 
a subcutaneous administration of sodium arsenite (75 umol/kg body 
weight). Controls received an injection of normal saline.
Rats were allowed food when experiments lasted more than 24 hr.
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TABLE 3.3.2 Time c o u r s e -response of rat hepatic cytosolic 5- 
am i n o 1 a e V u 1 inic acid dehydratase activity to treatment with 
sodium arsenite.
Time 
( hr )
5-Aminolaevulinic acid
dehydratase .
0 5.97 + 1 .06
1 4.75 + 0.39
2 5.27 + 0. 80
4 5.05 + 0.30
6 5. 10 + 0.65
1 2 6.10 + 0.6 7
16 6.25 + 0.20
24 5.82 + 0.28
36 8. 12 + 0.94
48 9.25 + 1 .88
pretreatment for 3 days.
16 8.37 + 1 .60
^Rats were fasted 8 hr before an administration of sodium arsenite 
( 7 5 . u m o l / k g  body weight) and were a l l o w e d  food when the 
experiment, lasted longer than 16 hr after arsenic administration.
2 nmol porphobilinogen/mg cytosolic protein/hr
A l l  above r e s u l t s  are g i v e n  as X + S. D. of at least 3 
observations. Greater number of observations in parentheses.
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Tryptophan py££Olasej^
ttfoob o£ sodium arsenite^ The treatment with As III produced a 
dose responsive decrease in the percentage of the haem saturation 
of tryptophan pyrroiase (TP), as shown in table 3.3.3. When a 
dose of As ill (75 u m o i / k g  body weight) was a d m i n i s t e r e d
subcutaneously a 50% decrease in the ratio was found 1b hr after.
The holo-enzyme activity in rats treated with As III at 
doses of 25 umol/kg body weight or above, was less than that in 
tne control rats. A slight but not significant increase in the 
activity was found in rats dosed with 12.5 umol/kg body weight. 
The total enzyme activity was no different from control values 
in rats given As III at 25, 50, or 75 umol/kg body weight, but at
12.5 umol As ill/kg body weight it was increased.
BfTec£ of sod_ium ££ ]. e n i.£e_^  The treatment with Se iV produced a 
dose related decrease of the percentage of the haem saturation of 
TP, as snown in table 3.3.4. Wnen a dose of Se iV ( lO umol/kg
body weight) was administered subcutaneously, a bO% decrease in
the ratio was found 1b hr after. The holo-enzyme activity at
a dose of Se IV of 1.25 umol/kg body weight was similar to the 
control, but that activity decreased at higher doses. The total 
enzyme activity was no different from the control values.
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TABLE 3.3.3 D o s e -res p onse effect of treatment with sodium
arsenite on the activity of hepatic tryptophan pyrroiase in rats.
Dose^ Holoenzyme^ Apoenzyme^ Total Enzyme^ % Saturation^
0 3.16 + 0.86 4.72 7.88 + 2.16 40.45 + 2.13
12.5 4.10 + 0.33 6.94 11.04 + 0.82 37.17 + 0.29*
25 1.62 + 0.17 3.43 5.05 + 0.82 32.04 + 0.29**
50 2.24 + 0.40 6.26 8.58 + 1.78 26.74 + 2.65
75 1.64 + .017 6.94 8.58 + 1.62 19.49 + 2.48
1 umol So dium a r s e n i t e / k g  body weight, i n traperitoneally 
administered. Rats were fasted for 8 hr before, and killed 16 hr
after arsenic administration. Controls received an injection of
normal saline.
2 umol Kynurenine/g wet liver/hr.
3 Holoenzyme activity (100)/total enzyme activity.
All above results are given as X + S. Di (Control observations;
n = 21, and test observations: n = 4)
Differs from control at: * p < 0.05; * * p < 0.01.
(Taken from Albores, 1984)
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TABLE 3.3.4 Dose-response effect of treatment with sodium 
selenite on the activity of hepatic tryptophan pyrroiase in rats.
Dose ^
p
Holoenzyme
p
A poenzyme Total 2enzyme % Saturation
0 3.16 + 0.86 4.72 7.88 + 2.16 40.45 + 2.13
1.25 3.16 + 0.45 5.76 9.56 + 0.37 39.68 + 3.86
2.50 2.82 + 0.27 5.36 8.18 + 1.26 34.82 + 1 .95
5.00 1 .87 + 0.49 4.20 6.09 + 1 .67 30.86 + 0 . 76
10.0 2.00 + 0.74 7.14 9.14 + 2.32 2 1.22 + 2.70
1
umol Sodium s e l e n i t e / k g  body w e i g h t , s u b c u t a n e o u s l y  
administered. Rats were fasted 8 hr before, and k i l l e d  16 hr 
after the intraperitoneal selenium administration. Controls 
received an injection of normal saline.
2 umol Kynurenine/mg wet liver/hr.
3 Holoenzyme activity (100)/Total enzyme activity.
All above results are given as X + S. D. (Control observations: 
n = 21, test observations n = 4).
Differs from control at *p < 0.01.
(Taken from Albores, 1984).
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MÇÇal^Çhelatàse^
M e t a l  c h e i a t a s e  a c t i v i t y  was not m o d i r i e a  by the 
administration of sodium arsenite, as shown in the table 3.3.5.
TABLE 3.3.5. Effect of treatment with sodium arsenite on the 
metai-chelatase activity of unfasted rats.
CONTROL TREATED
Metal-chelatase^ A.U2 + 0.48 4.05 + 0 . 3 6
 ^ nmol Co+^ Mesoporphyrin/mg mitochondrial protein/min.
The above results are given as X + S.D. of 5 observations.
Rats were dosed with Y5 umol/kg body weight, 16 hr before death. 
Controls received an injection of normal saline.
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ü£le volume excretion^
The biie volume ex ere tea in a 24 nr period was measured in 
bile düct-cannulated rats, in which a glass container with an 
exteriorized arm through the back of the animal was placed in the 
abdomen of tne animal.
The bile volume produced by arsenite treated rats was 1U% 
smaller than that produced by controls, but this difference was 
not statistically significant (table 3.3.b).
TABLE 3.3.6. Bile v o l u m e  e x c r e t e d  in 24 hr by bi l e  duct- 
cannulated rats treated with sodium arsenite.
CONTROL TREATED
Bile volume (ml/24 hr) 7.27 + 4.8 (7) 6.61 + 1.7 (5)
The results are given as X + S.D. of the number of observations 
in parentheses.
Rats were bile duet-cannu1 a ted and the cannula connected to a 
glass container with an exteriorized arm through the back, and 
placed into the a b d o m e n . T w o  days after surgery, rats were 
intraperitoneally dosed with sodium arsenite (7b umol/kg body 
weight) and bile volumes were withdrawn from the container at 
pre-established times. Controls, received an injection of normal 
saline.
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Bilirubin excretion_^
Excretion of oiliruDin during a 2 4 nr period was measured in
bile duct-cannulated rats. Control rats produced variable amounts
of bilirubin throughout all this period, as shown in table 3.3.7, 
and figure 3.3.1. The greatest bilirubin concentration was 
e x c r e t e d  by c o n t r o l  rat s  4 hr a f t e r  an s u b c u t a n e o u s  
administration of normal saline, and the lowest concentrations 
occurring 12 hr afterwards.
The rats treated witn As ill showed an increase in bilirubin 
e x c r etion 6 to 12 hr after arsenic a d m i n i s t r a t i o n .  This 
difference when compared against control rats excretion was 
statistically significant. Aithougn the bilirubin excretion was 
st i l l  increased after 16 nr, this v a l u e  was no l o n g e r  
significantly different from control. Bilirubin excretion 
returned to control values after 24 hr. These results are 
presented in table 3.3.7 and figure 3.3.1.
5zA2l52zi--ÇzAlzlÊfvulinic aç£d^
Tne excretion of the -label in bile duct-cannulated rats 
dosed subcutaneously with 5-amino-[^^C-4]-laevulinic acid and 
also dosed either with normal saline [controls] or As III (7b 
umol/kg body weight) [treated] was measured. Tne results are 
snown in table 3.3.7, and figure 3.3.2.
Tne control rats excreted the label in a hyperbolic fasnion,
as shown in figure 3.3.2. Twenty four hours after dosing, the
remaining radioactivity was only 6.2% of the initial value.
Figure 3.3.2 also snows the excretion of the radioactive 
label in bile duct-cannulated rats dosed with As III (7b umol/Kg
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body weight). One hour a f t e r A s  III a d m i n i s t r a t i o n ,  a 
statistically significant decrease of radio label excretion (42% 
compared with controls) was observed. Then, 4 hr later the
excretion increased (1.51 fold), and peaked at 6 hr after dosing 
(3.1 fold). Finally, the label excretion decreased towards
control values.
When the bilirubin and the label excretions of
control and As III treated animals were expressed as percentages
of the control at each time point (figure 3.3.3), the [^^C]-label
e x c r e t i o n  was g r e a t e r  and a p p e a r e d  e a r l i e r  than that of 
bilirubin. Thus, the radio label excretion increased after 4 to 6 
hr, and peaked after 8 hr of an As III administration, while 
bilirubin peaked 12 hr after dosing. The radio-label excretion 
remained higher than that of bilirubin during the rest of the 
experiment.
The r a d i o - l a b e l  content in c y t o s o l i c  and m i c r o s o m a l  
fractions of control and As III treated rats is shown in table 
3.3.8. The radio-label content in the cytosol of arsenic treated 
rats decreased by 56%, and in the microsomes by 53% when compared 
with control values.
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TABLE 3.3.7 Time-course of the effects of treatment with sodium arsenite on
14
the excretion of bilirubin and C-ra.diolabel in the bile of bile-duct 
cannulated rats.
Time C O  N
1
(hr). Bi1irubin
T R 0 L
14 2
C-Label
6
8
12
16
24
5.61 ± 0.49 (16) 20327 ± 1300 (11)
7.31 ± 0.82 (6)
5.12 ± 0.48 (S) 
7.25 ± 0.89 (9) 
6.33 ±0.47 (8) 
6.36 ± 0.54 (8) 
4.87 ± 0.51 (8)
5.78 ± 1.03 (7) 
5.01 +0.51 (7)
23108 +2104 (6) 
17986 +774 (6)
10827 +. 863 (6)
7393 • + 1082 (6) 
5932 + 1277 (6)
4771 + 1063 (6)
3620 + 1013 (6)
1440 + 334 (4)
T R E A 
Bilirubin
6.79 + 0.95 (4) 
5.55 + 1.99 (7) 
6.76 + 1.87 (7) 
9.22 + 0.94 (7)
¥ r ¥ r ¥ r
11.6 +1.15 (6)
*
12.2 + 2.5 (5)
10.7 + 3.35 (5)
6.12 ± 2.2 (4)
T E D 
14
C-Label
13253 + 1518 (5)
*
10817 + 1731 (4) 
16412 + 3608 (4) 
22924 + 900 (3)
18769
14299
9689
3803
(2)
(2)
(2)
(2)
1 mg Bi 1 irubin/"dl bile. 2 DPM/ml
All above results are given as X + S. E. of the observations in parentheses.
*■ * *  * * *
Differs from control p < 0.05; p < 0.01? p < 0.005.
Rats were bile duct-cannulated and connected to a glass container with an
exteriorized arm through the back placed in the abdomen.
14
5-AminoC C-431aevulinic acid'(3uCi) was administered intraperitoneally, then 
1 hr later rats were dosed subcutaneous!y dosed with sodium arsenite (75 
umol/kg body weight). Controls received an injection of normal saline.
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TABLE 3.3.8 Effect of the treatment with sodium arsenite on the 
content of [  ^ ]-labe1 in hepatic subcellular fractions of bile
duct-cannulated rats dosed with 5-ami no-[ ^^C-4]1aevu1 inic acid.
CONTROL TREATED
Cytosol 1 1 13. 7 + 29. 5 (5) 49.6 ( 46 .3, 52.9)
Microsomes^ 728.1 + 169.3 (5) 340.2 (386,312)
1 DPM/mg cytosolic protein. 2 DPM/mg microsomal protein,
All above given as X. + S. D . of 5 observations, or X of two 
observations.
Rats were bile duct-cannulated and connected to a glass container 
with an exteriorized arm through the back and placed into the 
abdomen.
5-Amino-[ ^ ^ C - 4 ] - l a e v u l i n i c  acid (3 u C i ) was a d m i n i s t e r e d  
intraperitoneally 1 hr before subcutaneous administration of 
sodium arsenite (75 umol/kg body weight). Controls receive dan 
injection of normal saline.
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F I G U R E  3.3.1. E f f e c t  of t r e a t m e n t  w i t h  s o d i u m  a r s e n i t e  on the
biliary excretion of bilirubin in bile d u c t - c annulated rats.
<u 
_o
•o
c
-Û  
Z3 
S-
cn
E
15
5
JL
0
0 2 4 6 8 12
T i m e  a f t e r  d o s i n g  w i t h  a r s e n i c  ( h r ) ,
Rats were bile duct-cannulated and bile was chronically collected 
as described in Materials and Methods chapter. Two days after 
cannulation animals were dosed subcutaneously with sodium 
arsenite (75 umol/kg body weight) [ O ]. Controls received an 
injection of normal saline [•].
All data points above are given as X + S.E.of at least 7 control 
and 4 test observations.
 ^  ^^  ^
Differ from controls p < 0.05, p < 0.01, and p < 0.005.
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FIGURE 3.3.2. Effect of treatment with sodium arsenite on the
1 Abiliary excretion of [ ]-1ab e 1 in bile duct-cannulated rats
pretreated with 5-amino-[^^C]-laevulinic acid.
o
o
o
X
o .
Q
20-
10-
0
12 16
Time after arsenic dosing (hr)
2 4
Rats were bile duct-cannulated and bile was chronically collected 
as described in Materials and Methods chapter. Two days after 
cannulation animals were dosed intraperitonea 1 ly with 5-amino-
[4-C^^]-laevulinic acid (3 uCi), then 1 hr later rats were 
subcutaneously dosed with sodium arsenite (75 umol/kg body 
weight) [o]. Controls receive and injection of normal saline [•].
A l l  data points above are given as X + S. E. of at least 7 
control and 4 test observations.
Differ from controls *p < 0.05, ** < 0.01, and *** < 0.005.
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F I G U R E  3.3.3. E f f e c t  of t r e a t m e n t  w i t h  s o d i u m  a r s e n i t e  on the
b i l i a r y  e x c r e t i o n  of b i l i r u b i n  ( O) and [ ^ ^ - C ] - l a b e l  {•) in b i l e
duct-cannulated rats injected with 5 - a m i n o - [ ^ ^ C ] - l a e v u l i n i c  acid.
8
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Time after arsenic dosing (hr)
— I
2 4
Rats were bile duct-cannulated and bile was chronically collected 
as described in Materials and Methods chapter. Two days after 
cannulation animals were dosed intraperitoneally with 5 -amino-
[4-^^C]-laevulinic acid (3 uCi), then 1 hr later rats were 
subcutaneously dosed with sodium arsenite (75 umol/kg body 
weight). Controls received an injection of normal saline.
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Bile 1mm u n o e 1 e c t r 0 p h o r e s i.
Plate 3.3.1 shows the immunoelectropherogram of two bile 
samples taken two hr after a subcutaneous administration of (a) 
normal saline, and (b) As III (75 umol/kg body weight) to a bile 
duct-cannulated rat.
In the bile of the As III treated rat, increased amounts of 
albumin and haptoglobin, among many other proteins, were found. 
In contrast, the peak of secretory component. Which was clearly 
visible as a large peak in the control rat was markedly reduced 
in the As III treated rats.
In table 3.3.9, the effect of treatment with As III on the 
excretion of albumin and haptoglobin (in a semi-quantitative way) 
is shown. The albumin biliary excretion in control rats varied 
from 4.0 to 13.5, while in the As III treated rats,-6he excretion 
ranged from 3.65 to ,40. In the case of haptoglobin, the excretion 
by the control rat was from 0 to 3.6, while in the arsenic 
treatment the excretion peaked 2 hr after treatment at 10.
In figure 3.3.4 the effects of arsenic on the excretion of 
albumin and haptoglobin are expressed as a percentage of control 
at each time point. It shows that haptoglobin excretion was 
greater than that of albumin, both appear increased 2 hr after As 
III dosing, then peaked at 4 hr and returned to normal levels 12 
hr after As III administration.
Haptoglobin content was steady during the 24 hr of the 
experiment in the control bile cannulated rats, while 7.8, 10 and 
4 fold increases were found 2, 4, and 6 hr after arsenic
administration.
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P L A T E  3.3.1. B i l e  i m m u n o e 1 e c t r o p h e r o g r a m s  of (a) c o n t r o l ,  a n d  (b)
s o d i u m  a r s e n i t e  d o s e d  b i l e  d u c t - c a n n u l a t e d  r a t s,  u s i n g  a n t i - r a t
b i l e  s er u m.
Bile duct-cannulated rats, connected to a glass container with an 
exteriorized arm through the back and placed into the abdomen 
were dosed subcutaneously with normal saline , or sodium 
arsenite (75 umol/kg body weight). The samples shown here were 
taken 2 hr after treatment, and processed as indicated in the 
Materials and Methods Section.
1) A l b u m i n ,  2) C o m  po n eni: , 3 )  H'-i.piiogloblr) .
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T A B L E  3.3.9. E f f e c t  of t r e a t m e n t  w i t h  s o d i u m  a r s e n i t e  on the
b i l i a r y  e x c r e t i o n  of a l b u m i n  and h a p t o g l o b i n  in b i l e  duc t
cannulated rats.
TIME ALBUMIN^
Control Treated
HAPTOGLOBIN^ 
Control Treated
0
2
4
6
12
24
4.50
13.5 
9.80 
13.3
12.5 
4.00
3.65 
40. 0
35.0 
15.5 
8 . 1 0
4.00
N. D 
1 .28 
N. D 
1 .50 
3.60 
3.3 0
N. D 
1 0 . 0  
1 0 . 0  
6 . 00 
2.00 
2.32
hr after arsenic administration
Area under the peak.
Rats were bile duct-cannulated and connected to a glass container 
with an exteriorized arm through the back placed into the 
abdomen. Two days after surgery, rats were then dosed 
subcutaneously with sodium arsenite (75 umol/kg body weight). 
Controls recived an injection of normal saline.
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FIGURE 3.3.4 .Effect of treatment with sodium arsenite on the 
biliary excretion of albumin (• ), and haptoglobin (o )> as 
measured by the area under the curve of b i l e - a n t i - b i l e  
immunoe1ectropherograms of bile-duct cannulated rats.
o
o
+j
cn
CL
0 2 4 6 12
Time (hr)
Rat was bile duct-cannulate and bile was collected as described 
in Material and Methods chapter. Two days after cannulation rats 
were dosed subcutaneously with sodium arsenite (75 umole/kg body 
weight). Control received an injection of normal saline, its
bilirubin and haptoglobin biliary excretions were considered as 
100% at each time point.
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3.3.2 The effect of treatment with sodium arsenide on the 
hePÊliÇ Microsomal cytochrome 50 and wonooxygenase system.
Effect of As III t r ea_tmen^ on cytochrome P^AEf and on the mono^ 
oxygenase activity Çf rats subjected t2 ffffÊZÊBf regimens.
fBSfcf rats. The effect of As III administration on rats fasted 8 
hr before, and measured 16 hr after dosing is shown in table 
3.3.10. Administration of As III produced a statistically 
significant decrease (28%) in cytochrome P-450 content, and also 
in the activity of the monooxygenases assayed in this study.
EROD was the most affected of the enzymes studied, since it 
showed a 50% decrease in activity, folio we d b y  PROD (38%), EROD 
(31%), and BPND (8%).. As 111 produced no effect on the activity 
of NADPH-cytochrome c reductase.
Corn oil_^ The effect of As 111 on cytochrome P- 450 content of 
rats treated with corn oil for 3 days, then fasted for 8 hr 
before arsenic administration and killed 16 hr afterwards is 
shown in table 3.3.11. The cytochrome P-450 content decreased by 
25% in arsenic dosed rats. The monooxygenase enzymes were also 
affected. BPND showed the greatest decrease (28%), although this 
difference was not statistically significant, followed by ECOD 
decrease (25%), in which the difference was statistically 
significant, and EROD fell by 17%. As 111 produced no effect on 
the activity of NADPH-cytochrome c reductase.
UnfÊÊlÊE The effect of As 111 on the hepatic cytochrome P-
450 content and monooxygenase activities of unfasted rats killed 
16 hr after arsenic administration is shown in table 3.3.12. As 
111 produced a decrease (14.5%) in the cytochrome P-450 content.
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The monooxygenases activities were also affected. The greatest 
decrease was shown by BPND (28%), followed by EROD (22%), and 
ECOD (17%). All those d i f f e r e n c e s  were s t a t i s t i c a l l y  
significant. PROD activity fell 50% after As 111 treatment, but 
this difference was not statistically significant.
FBStfd^unfasted differences. Fasting produced no differences as 
far as the hepatic microsomal content of the cytochrome P-450, 
and the ECOD, and PROD activities were concerned, but starvation 
produced a 28% decrease in EROD activity, and a 1.9 fold increase 
in BPND activity (tables 3.3.10 and 3.3.12).
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TABLE 3.3.10 Effects of treatment with sodium arsenite on hepatic
content of microsomal cytochrome P-450 and on monooxygenase
activity, in fasted rats.
C O N T R O L  T R E A T E D
Cytochrome P-450^ 0.64 + 0.03 (15) 0.46 + 0.025**(16)
Ethoxycouraarin-0-
deethylase^ 0.61 + 0.08 (15) 0.42 + 0.071**(12)
Ethoxyresorufin-0-
deethylase^ 9.00 + 1.56 (15) 4.42 + 1.65**(15)
Benzphetamine-N-
demethylase^ 6.75 2.5 (6) 6.16 + 2.04 (5)
Pentoxyresorufin-0-
dealkylase^ 2.72 + 0.90 (8) 1.68 + 0.75 (8)
NADPH-Cytochrome c
reductase^ 19.8 + 0.90 (10) 15.52 + 3.92 (9)
1 nmol/mg Microsomal protein.
2 nmol 7-Hydroxycoumarin/mg microsomal protein/min.
3 pmol Resorufin/mg microsomal protein/min.
4 nmol NADP/mg microsomal protein/min.
5 nmol cytochrome c reduced/mg microsomal protein/min.
All above results are given as X + S. D. of the number of 
observations in parentheses.
Differs from control data: *p < 0.05; **p < 0.01.
Rats were fasted 8 hr before and k i l l e d  16 hr a f t e r  an 
intraperitonea1 admininistration of sodium arsenite (75 umol/kg 
body weight). Controls received an injection of normal saline
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T A B L E  3.3.11. E f f e c t s  of t r e a t m e n t  w i t h  s o d i u m  a r s e n i t e  on
h e p a t i c  m i c r o s o m a l  c o n t e n t  of c y t o c h r o m e  P - 4 5 0  a n d  on
mo nooxygenase activity, in rats pretreated with corn oil.
C O N T R O L  T R E A T E D
Cytochrome P-450^ 0.69 + 0.1 (7) 0.46 + 0.08**(7)
EthoxyCOumarin-0-
Q * *
deethylase^ 0.528 + 0.1 (7) 0.34 + 0.1 (7)
Ethoxyresorufin-0-
deethylase^ 9.2 + 1.92 (7) 7.62 + 3.22 (7)
Benzphetamine-N-
demethylase^ 4.6 j- 1 . 39 (5) 3 .28 j- 1.46 (3)
NADPH-cytochrome c
reductase^ 18.1 + 4.14 (6) 22.0 + 9.73 (3)
1 nmol/mg Microsomal protein.
2 nmol 7-Hydroxycoumarin/mg microsomal protein/min.
3 pmol Resorufin/mg microsomal protein/min.
4 nmol NADP/mg microsomal protein/min.
5 umol NADPH-Cytochrome c reduced/mg microsomal protein/min.
All Above results are given as X + S. D. of the number of 
observations in parentheses.
Differs from control at: * p < 0.05; * * p < 0.01.
Rats were administered intraperitonea 1 ly with corn oil for 3 days 
and fasted 8 hr before a subcutaneous administration of sodium 
arsenite (75 umol/kg body weight). Animals were sacrificed 16 hr 
later. Controls received an injection of normal saline.
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TABLE 3.3.12 Effects of treatment with sodium arsenite on hepatic
m i c r o s o m a l  c o n t e n t  of c y t o c h r o m e  P - 4 5 0  and on m o n o o x y g e n a s e
activity, in unfasted rats.
C O N T R O L  T R E A T E D
Cytochrome P-450^ 0.62 + 0.07 0.53 + 0.07
Ethoxycoumarin-0-
deethylase^ 0.62 0. 06 0 . 52 + 0 . 08*
Ethoxyresorufin-0-
deethylase^ 14.3 + 2.55 11.1 + 0.08*
Benzphetamine-N-
Demethylase^ 3.46 _+ 0 . 41 2.47 + 0 . 83*
Pentoxyresorufin-0-
dealkylase^ 2.71 ±  0.46 1.31 + 0.10
1 nmol/mg Microsomal protein.
2 nmol 7-Hydroxycoumarin/mg microsomal protein/ min.
3 pmol Resorufin/mg microsomal protein/min.
4 nmol NADP/mg microsomal protein/min.
All above results are given as X + S. D of 5 observations.
Differs from controls at *p < 0.05.
Animals were killed 16 hr after a subcutaneous administration of 
sodium arsenite (75 umol sodium arsenite/body weight). Controls 
received an injection of normal saline.
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lîMe^çourse study of _the effec_t of EfÊÊlMent w_ith sodium a£senj.te 
on cytochrome P-^50 consent and on monooxygenase activity.
The effect of As III on the content of microsomal cytochrome 
P-450/ and on ECOD and EROD activities is shown in table
3.3.13 and in figure 3.3.5.
ÇyloÇhfOMe P-450. The cytochrome P-450 content decreased at 
each time points, these decreases being between 5 and 12% during 
the first 4 hr after As 111 administration, the decrease was 14% 
after 6 hr, and up to 28% after 12 hr. The greatest decrease 
(35%) was found 24 hr after As 111 administration. The cytochrome 
P-450 levels recovered partially at 36 and 48 hr after A 111 
ad m i n i s t r a t i o n ,  where the d e c r e a s e s  were 26.6 and 13.4% 
respectively .
ECOD. The ECOD activity remained steady during the first 12 
hr after the administration of As 111 (75 umol/kg body weight). 
Then, 31, 37, and 8% decreases were observed 16, 24, and 48 hr 
after arsenic administration, respectively. The greatest effect 
was found after 24 hr.
ERODj_ The EROD activity remained steady 6 hr- after As 111 
administration; although -thers ai 6% decrease in the enzyme 
activity after 1 h r , this difference was not significant. 25, 
50, 57, and 46% decreases were observed after 12, 16, 24, and 48 
hr after arsenic administration. The greatest effect was found 
after 24 hr of treatment.
In table 3.3.14 the content of the cytochrome P-450, and the 
a c t i v i t y  of ECOD and EROD in c o n t r o l s  were c o m p ared, no 
significant differences were found, except in the 24 hr EROD-time 
point, at which a 43% decrease in activity was found.
— 19^ “
When t h e t i m e - p o i n t  control values were compared with the 
corresponding values in As Ill-treated rats, the differences 
shown in table 3.3.12 were still significant.
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TABLE 3.3.13 Time cour s e -response to treatment with sodium 
arsenite of the liver microsomal content of cytochrome P-450 and 
on monooxygenase activity, in rats.
Time Cytochrome P-450^. Ethoxycoumarin-0- Ethoxyresorufin
(hr) deethylase 2 ^ -0-deethylase^.
0 0.64 Hh 0.03(13) 0.6 1 + 0 . 08 (15) 9.00 + 1.56 (15)
1 0.56 + 0 . 0 5 * ( 3 ) 0.58 + 0. 10 (3) 7.58 + 0 . 5 6  ( 3 )
2 0.59 + 0.07*(6) 0.59 + 0 .08 (6) 10.47 + 1.6 (6)
4 0.61 + 0.07 (5) 0.64 + 0.09 (5) 8.59 + 0.88 (5)
6 0.5 5 + 0.08*(61 0.62 i. 0.04 (6) 8.66 + 2 . 6  ( 6 )
12 0.44 + 0.03**(3) 0.64 + 0.03 (3) 6.71 + 0.05*(3)
16 0.46 + 0.02 (16) 0.42 + 0.07**(12) 4.42 + 1.65 (15)
24 0.415 +; 0.03 (6) 0 . 3 9 + 0.03 (6) 3.84 j.
% *
1 . 0 0  ( 6)
36 0.47 + 0.05**(5) N . A. N . A .
48 0.554 + 0.10*(5) 0.50 + 0.08* (5) 13.2 + 5 . 4 * ( 5 )
1 nmol/mg Microsomal protein.
2 nmol 7-Hydroxycoumarin/mg microsomal protein/min .
3 nmol Resorufin/mg microsomal protein/min.
N. A. Non available.
All above results are given as X _+ S. D. of the number of 
observations in parentheses.
Differs from controls at:*p < 0.05; **p < 0.01.
Rats were fasted for 8 hr before a subcutaneous administration of 
sodium arsenite (75 umol/kg body weight) and then killed at the 
times specified above. Rats were allowed food when the experiment 
lasted longer than 16 hr. Controls received an injection of 
normal saline.
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FIGURE 3.3,5 T  - t'cz.spensc.-cyrv^. t o treatment with sodium 
arsenite of the hepatic microsomal cytochrome P-450 content and 
monooxygenase enzyme activities in rats.
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Rats were fasted 8 hr after a subcutaneous administration of 
sodium arsenite (75 umol/kg body weight), then animals were 
sacrificed at the times above specified. Rats were allowed food 
when experiments lasted longer than 24 hr.
The statistical analysis of this figure is given in table 3.3.13.
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BPNDj_ Table 3.3.15 shows the effect of arsenic treatment on 
the activity of BNPD. In control rats, The greatest activity was 
found after 6 hr of starvation, consequently such activity 
decreased, and after 48 hr it was only 44.5% of the previous 
value.
When the activity in As Ill-treated rats was compared with 
control values, a decrease was noted at all time points, except 
after 48 hr for which no significant difference was found. The 
g reatest decr e a s e  (70%) was found 2 4 hr after As III 
administration, then the activity was recovered.
N^^PH^cytochrome c reductase). Variable control values were 
found at different time points, as shown in table 3.3.15. A 56% 
decrease in the enzyme's activity was found 48 hr after As III 
administration, this effect was statistically significant.
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TABLE 3.3.15. Time c o ur s e - re s p o ns e to sodium arsenite of the 
hepatic benzphetamine-N-demethy l a s e , and NADPH-cytochrome c (P- 
450) reductase activities, in rats.
Time Benzphetamine-N-demethylase NADPH-cytochrome c (P-450)
(hr) reductase^
Control Treated Control Treated
16 7.2 + 2.5 (10) 6.7 + 1 .9 (10) 19.8 + 2.9 (10) 17.5 + 3.9 (9)
24® 5.5 (2) 1 .7 (2) 30.5 + 6 . 4 (3) 21.5 + 1 .5 (3)
36® 5.3 + 1 .5 (5) 3.7 + 0.9 (5) 14.1 + 2.6 (5) 14.9 + 2. 1 (5)
48® 3.2 + 0.5 (5) 3.6 + 1.6 (5) 54.5 + 14.4 (5) 34.8 + 10. 8*(5)
1 nmol NADP/mg microsomal protein/min.
2 nmol NADPH-cytochrome c reduced/mg microsomal protein/min.
^Rats were allowed food 16 hr after arsenic administration.
Rats were fasted for 8 hr before an intraperitonea1 administration 
of sodium arsenite (75 umol/kg body weight). The sacrificed at the 
times specified above. Controls received an injection of normal 
saline. Animals were allowed food in experiments longer that 16 hr. 
A l l  a bove r e s u l t s  are g i v e n  as X_+ S. D. of the n u m b e r  of 
observations in parentheses.
Differs from control values *p < 0.05; **p < 0.01.
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3.3.3 Effect on some mitochondrial markers.
Mitochondrial s£zymeSj_
Table 3.3.16 shows that arsenic produced no effect on 
cytochrome c oxidase and monoamine oxidase activities.
Serum assays_^
Table 3.3.16 shows that the activity of serum alanine amine 
t r a n s f e r a s e  had d e c r e a s e d  by 44% 16 hr a f t e r  As III
administration.
Serum bilirubin concentration was found not affected 16 hr 
after As III administration.
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TABLE 3.3.16 Effect of treatment with sodium arsenite on the 
activity of some hepatic enzymes, and on the serum alanine amino 
transferase and serum bilirubin content, in fasted and unfasted 
rats.
C O N T R O L  T R E A T E D
Mitochondrial assays® (5).
Cytochrome c oxidase^ 14.94 + 2.3 (5) 13.84 + 1.86 (5)
Monoamine oxidase^ 62.7 + 11.2 (5) 6 2 . 3 ^ 9 . 5 ( 5 )
Seric assays^ (2).
Alanine amine
transferase^ 64.5^ (2) 36.4^ (2)
Bilirubin^ 1.5^ (2) 2.0^ (2)
1 nmol Cytochrome c oxidized/mg liver homogenate protein/min.
2 nmol 4-Hydroxiquinoline/mg mitochondrial protein/min.
3 ALT units/ml.
4 mg bilirubin/dl.
® Rats were dosed intraperItoneally with sodium arsenite (75 
umol/kg body weight) 16 hr before death.
 ^ Rats were starved 8 hr before an intraperitoneal administration 
of sodium a r s e n i t e  (75 u m o l / k g  body weight). A n i m a l s  were 
sacrificed 16 hr later.Contre Is received an injection of normal 
saline.
All above results are given as X + S. D. or X of the number of 
observations in parentheses.
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3.4. BIOCHEMICAL EFFECTS OF THE ADMINISTRATION OF SODIUM ARSENITE 
ON THE LIVER OF RATS TREATED WITH INDUCERS OF CYTOCHROME P-4 50.
3.4.1 Effec_t on haem me_taboli.sm_^
Haem oxygenase.
Table 3.4.1 shows the effect of cytochrome P-450 inducers 
and/or sodium arsenite administration on the activity of hepatic 
haem oxygenase.
The following inducers of cytochrome P-450 were used: PB, 3- 
MC, and ISO. These inducers p r oduced a no s t a t i s t i c a l l y  
significant effect on the activity of haem oxygenase.
The coadministration-administration of 3-MC and arsenic 
produced the highest HO activity induction (27 times compared 
with the 3-MC treated rats), followed by PB (21 times), and ISO 
to a l e s s e r  e x t e n t  (6.6 times). In a l l  c a s e s ,  the 
coadministration of As III, with an inducer produced highly 
statistically significant increases in HO activity.
Zi^e^response curv^i The administration of PB alone produced no 
effect on HO activity, as shown in table 3.4.2.
Rats pretreated with phenobarbitone and dosed with As III 
showed a statistically significant induction (3.5 times) 2 hr 
after treatment. The induction peaked (16.2 times) 16 hr after 
administration, but decreased by 24 hr.
Bffcc^ of £cpe_tj.tiVe. phçnobarbi._tone admj.ni.s_tra^_ion^ Table 3.4.3 
shows the effect of repetitive administration of PB alone and
coadministered with one dose of As III.
The treatment with As III produced increases of 5.4, 8 and
21.4 fold in the haem o x y g e n a s e  a c t i v i t y ,  16 hr after
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administration to rats pretreated with 1, 2, or 3 PB doses (0.3 
mmol/kg body weight daily). All these increases were highly 
significant.
aci^ dehydratase^
Table 3.4.1 shows the effect of cytochrome P-450 inducers 
alone or coadministered with As III on the activity of cytosolic 
5-ALAD.
PB and-As III coadministration produced a 2 5% decrease in 
the activity of this enzyme. 3-MC and isosafrole showed no effect 
on the activity of this enzyme.
Repetitive administration of PB showed no effect on the 5- 
ALAD activity, neither did its coadministration with As III 
(table 3.4.3).
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TABLE 3.4.1 Effect of treatment with sodium arsenite on the 
activities of the hepatic microsomal^and the cytosolic 5- 
a m i n o l a e v u l i n i c  acid d e h y d r a t a s e  in rats pretreated with 
phenobarbitone (PB), 3-methylcholanthrene (3-MC), and isosafrole 
(ISO).
INDUCER HAEM OXYGENASE^ 5-ALAD^
Phenobarbitone 1.07 + 0.42 8.21 + 0.79
Phenobarbitone + As III 2 2 . 8 9 + 1 . 6  6 . 1 1 + 0 . 7 9
3-MethyIcholanthrene 0.44 + 0 . 2 2  8.20 + 0.38
3-MethyIcholanthrene + As III 12.26 + 5.15*** 7.75 + 0.38
Isosafrole 1 . 5 4 + 0 . 5 8  7 . 6 1 + 2 . 0
* *
Isosafrole + As III 10.19 + 2.6 9 . 9 0 + 2 . 1 2
 ^ nmol bilirubin/mg microsomal protein/min.
 ^ nmol porphobilinogen/rag cytosolic protein/hr.
All above results given as X + S. D. of 5 observations.
Differs from control at: p < 0.05, p < 0.01, and p < 0.005.
The rats received 0.3, or 0.75, or 5 mmol/kg body weight daily 
for 3 days of PB, 3-MC, or. ISO, respectively. Rats were starved 8 
hr before an administration of sodium arsenite (75 umol/kg body 
weight) and killed 16 hr afterwards. Controls received an 
injection of normal saline.
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TABLE 3.4.2. Time course-response to sodium arsenite of hepatic 
microsomal haem oxygenase activity (nmol bilirubin/mg microsomal 
protein/min), in rats pretreated with phenobarbitone.
Time ( hr ) PB PB + A s m
0.5 0 . 7 9 + 0.09 (3) 1.02 + 0.28 (4)
1 1.87 + 0 . 4 9 (3) 1.11 + 0.10 (4)
2 0 . 8 6 + 0 . 20 (3) 3.06 + 0 . 9 0 * ( 4 )
4 1 .20 + 0.56 (3) 9.55 + 1.46*(4)
16 1.13 + 0.33 (4) 18 . 34  + 2 . 4 4  ( '
24 1.17 (2) 7.07 (2)
36 0.73 + 0.21 (5) 1.85 + 0.45*(5)
4 8 1 .82 + 0.74 (5) 5.76 + 2.56*(5)
All above results are given as X t  S. D . of the number
observations! in parentheses.
Differs from PB treated rats at : *P < 0.05;
* *
p < 0.005.
Rats were treated intraperitoneally with PB (0.3 mmol/body weight 
daily for 3 days). They were they fasted for 8 hr before a dose 
of sodium arsenite (75 umol/kg body weight). Controls received an 
injection of normal saline. Rats were allowed food when the 
experiment lasted longer than 16 hr after arsenic administration.
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TABLE 3.4.3 Effect of treatment with sodium arsenite on the 
activity of hepatic microsomal haem oxygenase and cytosolic 5- 
aminolaevu 1inic acid in rats pretreated with phenobarbitone (PB) 
for 1, 2, or 3 days.
ASSAY/NUMBER OF PB 
DOSES. PB PB + As III
HAEM OXYGENASE ^ .
One®.
Two®. 
Three^. 
5-ALAD^. 
One®. 
Two®. 
Three^.
2.08 +1.13 
1.12 +'0.24 
1.0 7 + 0 . 4 2
7.83 + 0.88 
7.43 + 0.9 
8.21 + 0.79
11.2 5+ 2.7*** 
***
8.92 + 2 . 
22.9 + 1 .56
7.19 + 0.75 
7.76 + 0.76 
6.11 + 0.79
* * *
1
nmol Bilirubin/mg microsomal protein/min.
p
nmol Porphobilinogen/mg cytosolic protein/hr.
All above results given as X + S. D. of 5 observations. Differs
 ^  ^^   ^^  ^
from controls at: p < 0.0 5, p < 0.01, and p < 0.005.
Rats were pre treated with PB (0.3 mmol/kg body weight daily for 
one, two, or three days). Arsenic was dosed at the time of the 
last PB administration.
Rats were fasted hr before an administration of 75 umol
sodium arsenite/kg body weight and killed 16 hr after.
 ^ Rats were dosed with 75 umol sodium arsenite/kg body weight 16 
hr before killing. Controls received an injection of normal 
saline.
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M® tal^chela t ase_M
Treatment with As III to rats pretreated with PB produced a 
si g n i f i c a n t  d e c r e a s e  (27%) in the Co^'^incorporation into 
mesoporphyrin IX catalyzed by the metal-chelatase (table 3.4.4).
TABLE 3.4.4 Effect of the treatment with sodium arsenite on 
hepatic mitochondrial metal-chelatase activity, in phenobarbitone 
pretreated rats.
PB PB + As III
Metal-chelatase1 4.98 + 0.36 3.65 + 0.56*
^nmol Co^‘*'-Mesoporphyrin IX/mg mitochondrial protein/min.
All above given as X + S. D. of 5 observations.
Differs from controls at *p < 0.05.
Rats were dosed intraperitoneally with 0.3 mmol phenobarbit one/kg 
body weight/day for 3 days. They were then were subcutaneous ly 
dosed with 75 umol/kg body weight 16 hr before death.
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3.4.2 Effec^t on m i c r o s o m a l  cy_tochrome P-450 content and 
MOHOoxyEÊEÊÊÊ activity.
Phenobarbitone^
The effect of PB a l o n e  or c o a d m i n i s t e r e d  with sodium 
arsenite on rat hepatic microsomal monooxygenase system is shown 
in table 3.4.5.
The PB administration to rats resulted in an increase (2.18 
times) of the cytochrome P-450 content and in the activity of 
monooxygenase enzymes.
The activity of PROD was induced 253 fold, which confirms it 
as very susceptible enzyme to be induced by PB. EROD was also 
induced but to a lesser extent (4.8 times), ECOD and BPND were 
also induced 2.8 and 2.6 fold respectively.
The s u b c u t a n e o u s  a d m i n i s t r a t i o n  of As III p r o d u c e d  a 
decrease in the cytochrome P-450 content (25%) when compared with 
that of rats treated with PB alone. The activity of PROD (54%), 
and ECOD (52%) were the most affected, followed by BPND (45%). 
The effect of arsenic on. the activity of thasa- enzymes was 
statistically significant., but the effect on ECOD (9% decrease) 
was not.
Phenobarbitone pnetreatment^
The hepatic microsomal cytochrome P-450 content gradually 
increased, in a d o s e - r e s p o n s e  fashion, with r e p e t i t i v e  
administration of PB, as it is shown in table 3.4.6, and figure 
3.4.1.
The content of cytochrome P-45 0 increased 1.48, 1.96, and
2.18 fold after 1,2, or3 PB administrations (of 0.3 mrao/kg body
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weight per day). Control values are shown in, the table 3.4.5.
The 26.6, 9 8.5, and 253 fold increases in PROD activity
after 1, 2, and 3 PB administrations respectively, show it to be 
the most PB inducible monooxygenase out of the 4 enzymes assayed; 
followed by EROD, for which the activity increased 1.39, 2.42 
and 4.76 with the same treatment. BPND and ECOD increased 2 to 3 
fold during the first day then it remained at that l e v e l  
regardless of the number of PB administrations.
N A D P H - c y t o c h r o m e  c r e d u c t a s e  was not a f f e c t e d  by 
1, 2, or 3 daily doses of PB..
When PB and arsenic were coadministered, the increase in 
the content of the cytochrome P-450 seen with PB alone was 
modified. A greater difference in the cytochrome P-4 5 0 content 
was found after treatment with P.B + As III for 1 day (40% 
decrease of the PB treated) than after 2 days (2 5%), or 3 days 
(28%). This fact was not entirely reflected in the activities of 
the enzymes studied. While PROD was found to be the most affected 
after 3 days of PB treatment (54% decrease), EROD and BPND were 
also greatly affected after 3 days of PB treatment and one 
administration of As III. After one day of PB administration 
plus As III, BPND showed a significant decrease (52%). On the 
other hand, there was a progressive decrease in EROD activity, 
37%, 4 2%, and 52% after 1, 2, or 3 PB a d m i n i s t r a t i o n s
respectively.
As III significantly decreased ECOD activity (by 30%), after 
only 1 PB a d m i n i s t r a t i o n  (30%), but not after 2 or three 
administrations. NADP-cytochrome c reductase was not affected by 
the coadministration.
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TABLE 3.4.5 Effects of treatment with sodium arsenite on hepatic
m icrosomal cytochrome P-450 and monooxygenase enzymes activities,
in rats pretreated with phenobarbitone (PB).
Control PB PB + AsIII
Cytochrome P- 450 ^ 0.64 + 0.03 (1 5) 1 .4 + 0.0 5 1.0 1 + 0.08***
Ethoxycoumarin-0-
deethylase^ 0.6 1 + 0.08 (1 5) 1 .69 + 0.20 1 .55 + 0.30
Ethoxyresorufin-
0-deethylase^ 9.00 + 1 .56 (15) 42.9 + 7.88 20.6 + 3.50***
Benzphetamine-N-
demethylase^ 6.75 + 2.5 (6) 1 7.63 + 3.8 9.68 + 2.40***
Pentoxyresorufin
-0-deethylase^ 2.72 + 0.90 (8) 688 + 102 315 + 53.3***
 ^ nmol/mg Microsomal protein.
2 nmol 7-Hydroxycoumarln/mg microsomal protein/min.
"3
pmol Resorufin/mg microsmal protein/ min.
 ^ nmol NADP/ mg microsomal protein/min.
All above results are given as X + S. D. of 5 observations.
% % % % ^ %
Differs from PB treated rats at p < 0.01; p<0.01; p<0.005.
Rats were administered intraperitoneal ly with PB (0.3 mmol/kg 
body weight daily for 3 days). Then, rats were dosed with sodium 
arsenite (75 umol/kg body) weight a-nol ciq.oL \t> kr 3
Controls received an injection of normal saline.
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liEfzÇourse Response of the As I_IJ[ on _t h o a 0^21^112 of
Pcntoxyr^soruf^n^O^d^othyla^ie PB P£Otrea_ted rats.
The activity of rat hepatic microsomal pentoxyresorufin-0- 
deethylase decreased after the administration of As III (75 
umol/kg body weight. The decrease, 29%, was evident 2 hr after, 
and was statistically significant 4 hr after As III treatment. 
The greatest d e c r e a s e  was found 16 hr after the arsenic 
administration, at this time point the cytochrome P-450 content 
was also significantly diminished (-èa b (-<2
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op
TABLE 3.4.7. Time course-response to treatment with sodium 
arsenite of the hepatic microsomal content of cytochrome P-450 
and of pentoxyresorufin-O-dealkylase activity, in rats pretreated 
with phenobarbitone (PB).
Time 
(hr )
0.5
1 . 0
2.0
Cytochrome P-450
PB PB + A s m
1.11 + 0.07 1.0 1 + 0.21 
1 .22 + 0.22 1.1 + 0. 20 
1.24 + 0.14 1.15 + 0.09
4.0 1.2 9 +0.23 1 .0 1 + 0.10
16.Cr 1.40 + 0.05 1.01 + 0.08
Pentoxyresorufin-0- 
de-alkylase^
PB PB + A s m
628.6 130 661 . 2 j+. 164
N. A. 619 + 164
771.4 + 38 554 + 174
7 10.0 + 1 3 4 . 6  523.8+ 38
*
6 8 8 . 0  + 102 315 + 53.3
* *
nmol/mg Microsomal protein.
p
praol Resorufin/mg microsomal protein/min.
^ Unfasted rats.
All above results given as X + S. D. of 4 observations; except 
at 16 hr where the number of observations was 5.
Differs from PB treated rats at: *p < 0.05; **p < 0.01.
Rats were administered intraperitoneal ly with PB (0.3 mmol/kg 
body weight daily for three days). Then, animals were fasted for 
8 hr before an adminitration of sodium arsenite (75 umol/kg body 
weight) and s a c r i f i c e d  16 hr after. C o n t r o l s  r e c e i v e d  an 
injection of normal saline.
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Electrophoreses of microsomal p_  _____ _____
Plate 3.4.1 shows the effects of treatment with As III (75 
umol/kg body weight) on the microsomal proteins obtained from the 
livers of non-induced rats (A), and PB treated (0.3 mmol/kg body 
weight daily for 3 days) rats (B) and electrophoretically 
separated.
Plate A shows an slight increase in the bands around 30000 m 
w in the As III treated rats (wells 4, and 5).
In the wells 6, and 7 of plate B the area corresponding to 
cytochrome P-450 is heavily stained. In the samples obtained from 
PB/As III treated rats, a small increase was found in the 30000 
mw band (wells 8, 9, and 10). In the same samples the band
corresponding to the cytochrome P-450 fraction was slightly less 
intense.
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P L A T E  3.4.1. T h e  e f f e c t  o f  t r e a t m e n t  w i t h  s o d i u m  a r s e n i t e  o n  t h e
el ectrophoretic s eparation o f  h e p a t i c  m i c r o s o m a l  p r o t e i n s  f r o m
n o n - i n d u c e d  a n d  phenobarbitone (PB) induced rats.
1 2 3 4 5 6 7 8 9 10 11 mw*
A
Solubilization and SDS-polyacrylamide gel disc electrophoresis 
were carried out as described in Materials and Methods chapter.
Samples (15 ug protein) were applied in the following order.
PLATE WELLS SAMPLES
A 1, 2 Control (0.9% sodium chloride).
3 , 11 Standards.
4, 5 From As III rats (75 umol/kg body weight)
B 6,7 From PB treated samples (0.3 umol/kg body
weight daily for 3 days)
8, 9, 10 PB/As III treated rats.
_^Molecu‘, weight markers: a) 76000 to 78000; b ) 66200; c) 45000;
d) 30000; e) 17200; and f) 1 2300.
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^zMfthylpholanphrene^
The administration of 3-MC (0.75 mmol/kg body weight daily 
for 3 days) produced an increase (13%) in the hepatic microsomal 
cytochrome P-450 content (table 3.4.8). The greater increase in 
enzymatic activity was shown by EROD (22 fold). ECOD and BPND 
also showed an increased in their activity but to a lesser extent 
(2.6 and 1.1 fold respectively).
3-MC and As III co-administration decreased cytochrome P-450 
content and the activities of EROD, ECOD, and BPND, but these 
decreases were not statistically significant.
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TABLE 3.4.8. Effect of treatment with sodium arsenite on hepatic
m i c r o s o m a l  c y t o c h r o m e  P - 4 5 0  c o n t e n t ,  a n d  m o n o o x y g e n a s e
activities, in rat treated with 3 - m e t h y I c h o l a n t h r e n e  (3-MC).
CONTROL 3-MC 3-MC + As III
Cytochrome P-450^ 0.69 + 0.10 (7) 0.78 + 0.04 0.68 + 0.10
Ethoxycoumarin-0-
deethylase^ 0.53 + 0.10 (7) 1.39 + 0.04 1.25 + 0.27
Ethoxyresorufin-0-
deethylase^ 9.20 + 1 . 9 2  (7) 203.2 + 19.8** 186.1 + 23.5
Benzphetamine-N-
demethylase^ 4.60 + 1.39 (5) 5.15 + 0.57 4.46 + 0.72
 ^ nmol/mg Microsomal protein.
 ^ nmol/ 7-Hydroxycoumarin/mg microsomal protein/min.
pmol Resorufin/mg microsomal protein/min.
 ^ nmol NADP/mg microsomal protein/min.
All above results are given as X + S. D. of the number of control 
observations in parentheses and 4 test observations.
Differs from controls at * p < 0.05, * * p < 0.01, and ***p < 0.005. 
Rats were administered intraperitonea 1 ly with 3-MC (0.75 mmol/kg 
body weight daily for 3 days), while controls received corn oil 
injections. Then food was withdrawn 8 hr before an administration 
of sodium arsenite (75 umol/kg body weight) and killed 16 hr 
after. Controls received an injection of normal saline.
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Isosafrole.
The effect of As III on the c y t o c h r o m e  P-450 and 
monooxygenase activities of ISO pretreated rats is shown in table 
3.4.9.
The content of hepatic microsomal cytochrome P-4 5 0 of ISO 
pretreated rats increased 2.2 fold in comparison to those treated 
with corn oil alone.
EROD was found to be induced the most (15.5 fold the control 
value) in ISO treated rats, followed by ECOD, and BPND, which 
were induced 2.9 and 2,5 fold. The NADP-cytochrome c reductase 
activity was induced 2 fold.
When arsenic was administered to ISO pretreated rats, 
decreases in cytochrome P-450 content and in the activity of 
monooxygenases were observed.
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TABLE 3.4.9. Effect of treatment with sodium arsenite on hepatic 
microsomal cytochrome P-450 content and on the activity of 
monooxygenases in rats pretreated with isosafrole (ISO).
CONTROL ISO ISO + As III
Cytochrome P-450^ 0.69 + 0.10 (7) 1.52 + 0.23 1.18 + 0.34
Ethoxycoumarin-0-
O * *
deethylase 0.53 + 0.10 (7) 1.56 + 0.28 1.26 + 0.27
Ethoxyresorufin-0-
deethylase^ 9.20 + 1.92 (7) 142 + 41 114 + 23
Benzphetamine-N-
demethylase^ 4.60 + 1.39 (5) 11.36 + 4.38 6.23 + 2.37
NADP-cytochrome c
Reductase 27.78 + 4.7 (5) 54.8 + 12.8 40.65 + 6.5
^nmol/mg Microsomal protein.
^nmol 7-Hydroxycoumarin/mg microsomal protein/min.
pmol Resorufin/mg microsomal protein/min.
^nmol NADP/mg microsomal protein/min.
^umol reduced NADP-cytochrome c reduced/mg microsomal protein/min 
All.above results are given as X + S. D. of the number of 
control observations in parentheses and 5 test observations. 
Differs from control p < 0.05, p < 0.01, and p < 0.005.
Rats were administered intraperitonea11 y with ISO (5 mmol/kg body 
weight daily for 3 days). Controls received corn oil injections. 
Then, food was withdrawn 8 hr before subcutaneous administration 
of sodium arsenite (75 umol /kg body weight) and killed 16 hr 
after.
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3.4.3 Effect on mitochondrial enzyme markers.
Table 3.4.10 shows that neither cytochrome c oxidase nor 
m o n o a m i n e  oxidase a c t i v i t i e s  were a f f e c t e d  by the c o ­
administration of phenobarbitone and sodium arsenite.
It is also shown that the activity of the serum alanine 
amine transferase decreased, but the serum bilirubin content was 
not affected.
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T A B L E  3.4.10. E f f e c t  of the t r e a t m e n t  of s o d i u m  a r s e n i t e  on the
a c t i v i t y  of some h e p a t i c  m i t o c h o n d r i a l  e n z y m e s ,  the s e r u m
alanine a m ine transferase and serum bilirubin content.
PB PB + As III
Mitochondrial enzymes^ (5)
Cytochrome c oxidase^ 10.89 + 1.5 9.56 + 2.94
Monoamine oxidase^ 60.30 + 6.3 63.0 + 11.7
Serum assays^ {2)
o
Alanine amine transferase 54.8 44.3
Bilirubin^ 0.1 0.1
 ^ nmol Cytochrome c oxidized/mg microsomal protein/min.
 ^ nmol 4-Hydroxyquinoline/mg microsomal protein/min.
o
Alanine amine transferase units/dl serum.
4 mg bilirubin/dl serum.
The above results are given as X + S. D. or X of the number of 
observations in parentheses.
 ^ Rats were treated with PB (0.3 mmol/kg body weight daily for 3 
days), and killed 16 hr after an subcutaneous administration 
of sodium arsenite (75 umol/kg body weight).
 ^ Rats, after treatment with PB, were starved 8 hr before an 
subcutaneous administration of sodium arsenite (75 umol sodium 
arsenite/kg body weight) and killed 16 hr after. Controls 
received an injection of normal saline.
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3.5 IN VITRO EFFECT OF ARSENITE, ARSENATE, AND SELENITE ON THE 
RAT LIVER MICROSOMAL MONOOXYGENASE SYSTEM.
3 .5 . 1 • Effect of sodi.um arsenite^
SodiuM 1*^® in vppro effect of As III on cytochrome P-
450 is shown in figure 3.5.1. The cytochrome P-450 content 
decreased by 39% when microsomes were incubated in a shaking 
water bath at 30°C for 1 hr, at an As III concentration of 100 
mM. At lower concentration As III produced no effect.
The ECOD a c t i v i t y  of m i c r o s o m e s  exposed to v a r i a b l e  
c o n c e n t r a t i o n s  of As III was m e a s u r e d  (figure 3.5.2). 
Concentrations up to 100 mM produced a 12% decrease in the 
enzyme's activity.
The effect of As III on the activity of EROD and ECOD is 
shown in figure 3.5.3. As III p roduced no effect on ECOD 
activity, but the EROD a c t i v i t y  d e c r e a s e d  by 20.7% when 
microsomes were exposed to As III (50 mM), and 63% when the As 
III concentration was 100 mM. Arsenic concentrations of 12.5 and 
25 mM had no effect on enzymic activity.
As III produced no in vitro effect on BPND activity.
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FIGURE 3.5.1. In vitro effect of sodium arsenite on rat liver 
microsomal cytochrome P-450 content.
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F I G U R E  3.S.2. J[n vi^_tro e f f e c t  of s o d i u m  a r s e n i t e  on rat l i v e r
microsomal e t h o x y c oumarin-O-deethylase activity.
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F I G U R E  3.5.3. v i t r o e f f e c t  of s o d i u m  a r s e n i t e  on rat l i v e r
m i c r o s o m a l  e t h o x y c o u m a r i n - 0 - d e e t h y  1 a se (ECOD) a n d  e t h o x y -
r e s o r u f i n - O - d e e t h y l a s e  (EROD).
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Microsomes were preincubated for 5 min at 30°C in a shaking 
water bath at 120 cycles/min. The reaction was started by 
addition of NADPH, either 31 mM (E#OD) or 6.2 mM (ECOD). Sodium 
arsenite was added 30 sec later.
The results are given as X + S.E. of 5 observations. 
Differs from control * p < 0.05; **p < 0.005.
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Sodium a£seni.te plus NADPH^ The i. n v_itro effect of As 111 plus 
NADPH is shown in figure 3.5.4. The incubation of microsomes with
NADPH alone produced a decrease in cytochrome P-450 content.
After 1 hr incubation at 30°C the cytochrome content diminished
by 25%. When microsomes were incubated with As 111 and NADPH,
immediate decreases were found of 44%, 31%, and 22% using
concentrations of 50, 25, and 12.5 mM As 111 respectively. The 
effect was not significantly enhanced by longer incubation times.
The in effect of As 111 and NADPH on the activity of
microsomal ECOD is shown in figure 3.5.5. Exposure to NADPH alone 
produced a time-dependent decrease in enzyme activity, decreases 
of 16%, 25%, and 63% compared with the control, were found at 
10, 30, and 60 min respectively. These decreases were similar to
those produced by the combination of As 111 and NADPH.
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FIGURE 3.5.4. effect of NADPH and sodium arsenite on
rat liver microsomal cytochrome P-450 content.
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FIGURE 3.5.5. v itro effect of NADPH and sodium arsenite on rat
l i v e r  microsomal e t h o x y c oumarin-O-deethylase activity.
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3.5.2 Effect of sod_ium arsenate^
Sodium a£sena_te_^ The i. n v_i^ro effect of As V. on the content of 
the microsomal cytochrome P-450 is shown in the figure 3.5.6. 
Microsomes incubated in a shaking water bath at 30°C produced an 
immediate decrease (25%) which remained constant through the 1 hr 
incubation. Other As V concentrations produced no effect on 
cytochrome P-450 content.
The effect of As V on microsomal ECOD activity is shown in 
figure 3.5.7. An immediate increase in the enzyme activity was 
observed, this increase was directly proportional to the As V 
concentration. Thus 1.8, 2.0, 2.5, and 3.1 fold increases were
produced by 2 5, 50, 100, 200 mM As V respectively. The increase,
which was immediate, remai n e d  steady t h rough the 1 hour
incubation.
When the immediate effect of As V on ECOD and EROD was 
measured (figure 3.5.8), it was found that ECOD a c t i v i t y  
increased when As V concentrations increased. Therefore,the 1.4,
1.5 , 1.7 , and 2.0 fold increases were produced by 25, 50, 100,
and 2,00 mM As V concentrations respectively. Although EROD
a ctivity als o  increased, the extent of this i n c r e a s e  was 
inversely proportional to the concentrations of As V present i.e. 
2 5 , 50, 100, and 200 mM As V resulted in 2.35, 1.58, 1.3, and
1.32 fold increase in EROD respectively.
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FIGURE 3,5.6. _I n v r o effeect of sodium arsenate on rat liver 
microsomal cytochrome P-450 content.
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F I G U R E  3.5.7 v i t r o e f f e c t  of s o d i u m  a r s e n a t e  on rat l i v e r
ethoxycoumarin-O-deethylase activity.
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FIGURE 3,5.8. I^ n v_i_tro effect of sodium arsenate on rat liver 
microsomal e t h o x y c o u m a r i n - O - d e e t h y l a s e  (ECOD) and ethoxy- 
resorufin-O-deethylase (EROD).
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Sodium arsenate and NADPH_^ The effect of NADPH alone or in 
combination with As ,V on the content of microsomal cytochrome P- 
450 is shown in figure 3-. 5.9. NADPH decreased by 10% the content 
of cytochrome P-450 after being incubated at 30°C in a shaking 
water bath for Ihr. In the tubes in which a combination of NADPH 
and As V was present, a decrease between 16 and 33% was observed, 
which was not related to As V concentration.
The effect of NADPH alone or in combination with As V on the 
activity of the microsomal ECOD is shown in figure 3.5.10. NADPH 
produced an immediate decrease of 30% in the activity of the 
enzyme, this effect was greater after 1 hr of incubation at which 
a 69% decrease was observed. When NADPH and As V were assayed 
together, only 200 mM sodium arsenate produced an immediate 3 
fold increase through the 1 hr. incubation, in comparison with 
NADPH alone. Smaller As V concentrations caused an immediate 
increase in the enzyme's activity, but the effect was reduced 
after 10 min, and the activity was similar to that seen in the 
presence of NADPH after 30 and 60 minutes incubation.
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FIGURE 3.5.9. vitro effect of NADPH and sodium arsenate on rat 
liver microsomal cytochrome P-450 content.
0.7 m,
“ 0,6
O
S-
CL
0 . 5 -
0.4-
o
LO
î  '
a-0,3
QJ
E
O
L
JC
O 0.2
%  ' 
o
o .
io.l
0 J
O
e
m,
A
▲
□
10
r
30 60
I n c u b a t i o n  t i m e  ( m i n )
Microsomes were incubated at 30°C in a shaking water bath at 
120 cycles/min. Samples were withdrawn at the indicated times. 
NADPH was added to keep the concentration 250 uM.
Sodium arsenate concentrations (m M ): 200 ( a )» 100 ( a  ),
50 ( □ ) , 25 ( ■ ) . Control { • ) and NADPH ( O )•
-  236 -
F I G U R E  3 1 0 .  _In v^_tro e f f e c t  of N A D P H  a nd s o d i u m  a r s e n a t e  on
rat liver microsomal ethoxycouma^'in-Ô-deethylase activity.
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3.5.3 Effect of sodijum se 1 e t e
j. G effect of Se IV on the hepatic microsomal 
content of cytochrome P-450 is shown in figure 3.5.11. All the Se 
IV concentrations tested produced a decrease in the microsomal 
content of cytochrome P-450. Se IV produced an immediate decrease 
in cytochrome P-450 content, which remained steady throughout the 
1 hr incubation in a shaking water bath at 3 7°C. 5 3, 25, and 16% 
d e c r eases were p roduced by 50, 2 5, and 12.5 mM Se IV
concentrations respectively. Only the lowest concentration 
tested, 6.25 mM. produced no change in cytochrome P-450 content.
The effect of Se IV on the activity of microsomal ECOD is 
shown in figure 3.5.12. Se IV produced a decrease directly 
proportional to the Se IV concentration. This decrease became 
greater with time. A 50 mM Se IV concentration produced a 42% 
decrease after 10 min of incubation, and a 73% decrease after 30 
min incubation. ECOD activity showed 25, 30, and 48% decreases 
after 10, 30, and 60 min incubation with 25 mM Se IV. A 12%
decrease in the enzyme’s activity was produced by 12.5 mM Se IV, 
6.25 mM produce no change in the enzyme's activity.
The immediate i. n v^tro effects of Se IV on ECOD, EROD, and 
BPND activities are shown in figure 3.4.13. BPND was found to be 
the most sensitive of the enzymes assayed, a statistically 
significant decrease (42%) being observed at all the Se IV 
concentrations tested. The EROD activity was also affected, a 
slight decrease, around 17%, was produced by 6.25 and 12.5 mM. 
Decreases of 26.7 and 43.3% in EROD activity were produced by 25 
and 50 mM Se IV respectively; this effect was statistically
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signifleant. As far as the ECOD activity was concerned, Se IV 
concentrations up to 25 mM Se IV produced an Increase of around 
1.23 fold In the enzyme's activity, but this effect was not 
statistically significant. Finally, 50 mM Se IV produced no 
effect on the ECOD activity.
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FIGURE 3.S.11 v_i_tro effect of sodium selenite on rat liver 
microsomal cytochrome P-450.
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F I G U R E  3.6'12. v r o e f f e c t  o f s o d i u m  s e l e n i t e  on rat l i v e r
microsomal e t h o x y c o u m a r i n - O - d e e t h y l a s e .
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F I G U R E  3.6.13. J n  e f f e c t  of s o d i u m  s e l e n i t e  on rat l i v e r
microsomal ethoxycoumarin-O-deethylase (ECOD), ethoxyresorufin-0- 
deethylase (EROD), and benzphetamine-N-demethylase (BPND).
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Sodium se le ni. te and NADPHj^ The effects of NADPH alone and in 
combination with Se IV on the content of hepatic microsomal
c y t o c h r o m e  P-450 are shown in figure 3.5.14. Se IV at
concentrations up t o 6^. 2 5 and 12,5 mM decreased the cytochrome 
content between 24-32% and 38-52% r e s p e c t i v e l y ,  when the 
microsomes were incubated in a shaking water bath at 30°C for 
periods up to 1 hr. 12.5 mM or lower concentrations of Se IV
produced no effect on the enzyme's activity.
The effect of NADPH alone and in combination with Se IV on 
the activity of microsomal ECOD is shown in figure 3.4.15. NADPH 
alone produced a time-dependent decrease, which was 33 %, after 
30 min of incubation, and 52% after 1 hr. When NADPH and variable 
concentrations of Se IV were tested, an initial fall of 30% in 
ECOD activity was found, and the enzyme's activity decreased
further with time. The greatest decrease was produced by 12.5 mM
Se IV, which after 10 min of incubation had reduced ECOD activity 
by 71% in comparison with the system containing NADPH alone, at 
this Se IV concentration the enzyme's activity was almost
undetectable after . Ihr. Lower Se IV concentrations (6.25, 1.6 mM)
produced a smaller decrease than 12.5 mM. Decreases in the 
enzyme's activity up to 44, and 46.7% were produced by 6.25 and
1.6 mM respectively after 10 and 30 min of incubation. After 1 
hr, the activity was similar to that produced by NADPH added 
alone.
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FIGURE 3.5.14. v^_tro effect of NADPH and sodium selenite on 
rat liver microsomal cytochrome P-450.
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FIGURE 3.5.15. effect of NADPH and sodium selenite on
rat liver microsomal ethoxycoumarin-O-deethylase activity.
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3.6 EFFECT OF SODIUM ARSENITE ON ISOLATED RAT HEPATOCYTE.
The effect of As III on LDH leakage from isolated rat 
hepatocytes is shown in figure 3.6.1. Thus, 1.72, and 1.48 fold 
increases in the LDH leakage were produced by 10 and 1 mM As III 
respectively after 1 hr incubation in a shaking water bath at 
37°C. A 1.27 fold increase in the LDH leakage was produced by 
both 100 and 10 uM, however, there was no effect when the 
hepatocytes were exposed to 1 uM As III.
Figure 3.6.2 shows the time-course of LDH leakage and the 
percentage of viability of isolated rat hepatocytes exposed to 
100 uM As III. The viability, as measured by the trypan blue 
exclusion method, dropped from 88% at the beginning of the 
experiment to 68% in the control and 60% in the As III exposed 
hepatocytes after 1 hr of incubation. T h e  ui3-bllc-k| of coyi-fs-ol he 
remained unchanged for a further hour, and the test cells 
viability decreased to 55%. After 3 hr, 45% of control cells were 
viable compared with only 20% of the test cells.
The LDH leakage of the control cells was 34, 38, 42, and 57% 
at 0, 1, 2, and 3 hr of incubation respectively, while LDH
leakage of test hepatocytes was 34, 48, 55, and 70% at 0, 1, 2,
and 3 hr of incubation respectively.
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FIGURE 3.6.1 Dose and time course-responses of the effect of 
sodium arsenite on the LDH leakage in isolated rat hepatocytes.
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CHAPTER FOUR
DISCUSSION.
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4. DISCUSSION.
4. 1 Th_e r ajb a_s an £ ° £  jb of _b h e
hepatetoxicity produced by arsenic.
The extrapolation of animal toxicity data to man is not an 
easy task. Many factors may influence the responses obtained in 
different species. Therefore, the selection of an appropriate 
animal model for testing a specific toxic agent is an issue of 
great importance (Paget, 1970).
4.1.1 Species differences in haem metabolism.
Although haem is a crucial cofactor in many haemoproteins and 
is widely spread among living beings, its rates of synthesis and 
degradation, or at least the characteristics of the enzymes 
involved in these pathways, vary among different species(Tephly, 
1978). In the present study a comparison between rat and rabbit 
of the activity of some haem metabolizing enzymes was carried 
out.
Species and organ differences in relation to 5-ALAS activity 
were found. For example, 5-ALAS activities in rat liver, kidney 
and testes were significantly higher in rat than activities in 
corresponding rabbit organs (Table 3.1.1). This findings are 
comparable with the observations of Woods and Dixon (1972), 
where 5-ALAS activity in rat liver was 5 to 10 fold that in 
rabbit liver. Other workers have found rat hepatic 5-ALAS 
activity to be similar to that in other species like humans and 
chick embryo (Korineck and Moses, 1973), but mouse liver has an 
apparently even higher activity (De Matteis, et al., 1973).
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In both rat and rabbit the organ distribution of 5-ALAS 
activity was liver > kidney > testes, a similar distribution in 
the rat was observed by Sardesai _e^  a_l. (1972). In addition to 
species differences, variations among different organs were 
o b s e r v e d .  Thus, one m a y  p o s t u l a t e  tha t  i n d i v i d u a l  
characteristics of metabolism in c e l l u l a r  types found in 
different organs, such as kidney and testis could be responsible 
for the observed differences in the activities of haem metabolism 
enzymes.
5-ALAD activities exhibited neither species nor organ 
differences in the present study (Table 3.1.1).
F e r r o c h e l a t a s e  a c t i v i t i e s  als o  showed s i m i l a r  organ 
distribution between both rat and rabbit (Table 3.1.1).
The hepatic 5-ALAS:5-ALAD;FC activity ratios were 1:60:7 in 
rats and 1:800:15 in rabbits, confirming the role of 5-ALAS as a 
regulatory enzyme (Tephly 1978), and suggesting that FC might 
also play a regulatory role in haem synthesis. Furthermore, 
Wagner and Tephly (1973) have shown that FC is induced by PB and 
Dieldrin in a manner similar to 5-ALAS induction.
The HO activity, the rate limiting enzyme in the haem 
degradative pathway (Tenhunen _e^ a^j_, 1 969), was higher in rats 
than in rabbits. The activity of this enzyme was different in 
each of the organs studied. The hepatic enzyme activity ratios in 
rats showed that HO activity was 12 fold greater than 5-ALAS, 4.6 
fold smaller than 5-ALAD, and twice the ferrochelatase activity.
Biliverdin reductase activity was detectable in rats but not 
in rabbits. Because of this, the HO determinations in rabbits
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were performed using the cytosolic fraction of control rat liver 
as biliverdin reductase source. In rats, liver and kidney had the 
greatest activity. Hepatic biliverdin reductase was 12 fold more 
active than HO, which means that this enzyme excess with respect 
to H O .
The lack of detection of bilirubin dehydrogenase in rabbits, 
as it is shown in table 3.3.1, in spite of being a bilirubin 
excretor (Colleran and O'Carra, 1 978) might be due to the fact 
that in rabbits, the enzyme is located in the spleen rather than 
in the liver, as it is the case in ruminants such as ox and 
sheep. Another possibility could be that the enzyme may have a 
different structure, thereby presenting different p h y s i c o ­
chemical properties. However, Noguchi £_t a (1 97 9) found that 
biliverdin reductases present in pig spleen and rat liver have 
similar properties, and it is interesting to note that the diets 
of species are comparable. kuTTy and Maines ( 1983) have also 
characterized the enzyme and found differences from the results 
of Noguchi a ( 1 9 7 9), but considered that these differences 
might be due to the purification processes used.
4.1.2 Species differences in the mixed function oxidase system.
The a c t i v i t i e s  of the m o n o o x y g e n a s e  s y s t e m  and the 
cytochrome P-450 content vary not only among species (Axelrod, 
1956, Souha i 1 i -El Amri e^ 1986), but also among organs of
individuals. Therefore, in a single species twenty or more 
cytochrome P-450 isoproteins can be found character i s t i c a l l y  
distributed in every tissue (Guengerich, 1987).
In this work, the liver, kidney, and testicular cytochrome
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P- 450 content ratios in rats and rabbits were 18:3:1, and 
17:10:1, respectively, taking as a unity the testicular content, 
which was the lowest. Also, the hepatic and testicular cytochrome 
P-450 contents were slightly greater (20%) in rats than in 
rabbits, but this difference was not statistically significant. 
These results are comparable with those found in rat and rabbit 
liver by Souhaili-El Amri _e_t a 3^ (1986), and in rat liver by 
Davies e t  a (1969), but lower than those found by Chhabra _e^  
a_1 (197"f) and Ueng _e^ a ].j_ ( 1 9 8 7).
Species differences between rat and rabbit were observed in 
the activity of hepatic ECOD and EROD, being ECOD activity twice 
in rabbits than those in rats; these values were comparable to 
those of Souhaili- El Amri e_t a_l. (1986) However, Ueng aJ.. 
(1987) found a greater activity in rats using a different method, 
while hepatic EROD activity was significantly higher than that in 
rabbits.
The hepatic activity of the cytochrome b^ was 2 fold greater 
in rabbits than in rats. Similar results were found by Souhaili- 
El Amri je^  a (1 98 6).
The differences in cytochromes content and monooxygenase 
activity observed among results of this work and those of other 
authors might be due to differences in the developmental stage of 
the animal species, (Leakey and Fouts, 1979), differences in the 
experimental diet (Connelly, 1983. Cebrian, 1986), or differences 
in the strains.
Interestingly, the rat and rabbit hepatic cytochromes P-450 
and b5 content and ECOD activity observed in this work appeared
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to be lower compared with those found in human livers by Souhaili 
-El Amri e^ a_l. (1986), suggesting that the extrapolation of 
results found in at least the two species studied to humans might 
be difficult, and also that efforts have to be done to find 
better animal models to study drug metabolism, or monooxygenases 
whOSa behaviour resembles human characteristics. Besides, humans, 
like rats, are omnivores while rabbits are herbivores, and 
even more, the human diet, c o n t r a r y  to what h a p p e n s  with 
laboratory animals, is far from being a standard one.
4.1.3 The acute effect of arsenic alone or, in combination with 
cytochrome P-450 inducers on the morphology of the rat liver.
As shown in s e ction 3.2.1, the acute s u b c u t a n e o u s  
administration of As III produced an increase in the number of 
periportal lipid-containing vacuoles (confirmed by the ORO stain) 
and depletion of the hepatic glycogen.
However, the previous results were milder compared to those 
reported by Ishinishi e_t a_l* (1980) in rats exposed long term to 
As V in drinking water.
A novel finding in the present work was the demonstration 
that when As III is administered to PB pretreated rats, the 
morphological changes in liver are augmented; thus, hydropic 
degeneration and spotty necrotic hepatocytes in the centrilobu lar 
zone were found jointly with an extensive lipidic vacuolation of 
the periportal zone, and a depletion of glycogen, the latter has 
been considered as an early sign of toxicity (McLean _e_t a 1.
1965). The changes in the hepatic morphology d e v e l o p e d  by rats 
treated with As III-PB appear to be similar to those found in
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rats exposed long term to As V in drinking water (Ishinishi et 
a l . 1980), and also to those found in rats chronically exposed to 
As III or As V (Byron e t  a 1967). Mizuta _e^  a (1956) found 
similar effects in humans chronically exposed to arsenic 
contaminated food.
The cytological changes produced in liver of rats treated 
with As III, or PB, or PB + As III have been described in section 
3.2.2. From which the bile canaliculus dilation was consistently 
feature observed in As III treated animals. This observation has 
been described in rats long-term exposed to arsenic by Rouiller 
(1964).
Other changes produced by As III administration to PB 
pretreated rats were a dilation of in the Golgi complex; the RER 
was found to be more induced and more disorganized, and some of 
the RER also appeared degranulated. The SER was e x t e n s i v e l y  
vacuolated, with some of those vacuoles being greatly enlarged. 
Abundant myelinic figures were also present, presumably derived 
from SER segments or from degraded mitochondrial membranes. No 
glycogen was found in the livers of these rats, even when they 
were allowed food. An increase in coreless peroxisomes was also 
seen and, in some cases, autolysosomes containing o r g a n e l l e  
remnants.
The changes produced by As III + PB treatment to rats were 
largely consistent with those found by Frejaville _e_t a l . (1 972)
in human liver preparations taken from suicidais. This group also 
described a dilation of the Disse space in human livers, which is 
consistent with the dilation of the canal of Bering presented
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here (plate 1.1.3), and also with the observations of Ishinishi 
_e_t a_l_2_ (1 980) who found that long-term exposure to arsenic in 
drinking water produced a generalized vacuolation of the 
endoplasmic reticulum, an increase in lysosomes and collagen, 
proliferation of the bile duct, and spotty necrotic areas. 
Although in this work no nuclear alterations were observed in the 
livers of PB + As III rats, chromatin condensation appear to be 
observed in the liver of acute arsenic intoxicated humans 
(Frejaville e^ a_l« 1 972). However, those changes might be due to 
the amount of arsenic taken by the patients or by post-mortem 
deterioration of the tissues. M ohe 1 s ka _e^ a_l. (1 979) found that 
long-term arsenic exposed rats showed enlarged nuclear membrane 
s u r f a c e s  and i r r e g u l a r i t i e s  of n u c l e a r  and mitochondrial 
membranes too. Feussner _ejt a_l. (1979) found nuclear aberrations 
in bone m a r r o w  c e l l s ,  and r e l a t e d  this effect to As III 
interactions with DNA.
PB treatment and starvation produced an apparent increase in 
the number of mitochondria, with a faster turn over, since many 
of them seem to un d e r g o  d e g r a d a t i o n .  P h e n o b a r b i t o n e
administration itself has been reported to produce mitochondrial 
induction (Staubli _e^ a_l. 1969). The mitochondria of As III + 
PB treated rats developed degeneration and myelination, some were 
seen as phantoms in autolysosomes (Plate 3.2.36). In addition, a 
differential condensation (as if they were stopped in the stage 4 
resting on the mitochondrial cycle) was observed, possibly 
related to the location of the hepatocyte in the liver. This 
mitochondrial changes observed in the As III + PB group might be 
considered as an advanced stage of the toxicity process (McLean
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e t a l ,  ' ] 9 6 S ) ,  Similar changes in hepatic mitochondria were 
described in livers of humans acutely intoxicated with As III 
(Frejaville, 1972) and in rats exposed long-term to As III 
(Fowler _et al^ . 1977, Mohelska _e^  a_l. 1980). Furthermore, rats 
exposed long-term to As III appear to increase the volume 
occupied by mitochondria, which was considered to be related to 
a swelling process. (Fowler _et a_l. 1 977).
A profuse vacuolation mainly around the periportal area was 
also present. Some vacuoles contained lipid, giving the liver a 
fatty aspect (steatosis); this change was similar to that found 
by Frejaville e_t a_l. (1972). The administration of As III to PB 
treated rats also developed an increase in auto 1ysosomes. These 
structures are generated as a way to dispose of damaged cellular 
constituents, and are considered as prenecrotic changes (McLean 
Ê.ÏL 52' 1965). Anoxia also causes a post-mortem increase in
vacuoles containing eosinophilic material (Sykes e_t a_l. 1976), 
while those in this present work contained lipid, as confirmed by 
the ORO staining. B e c a u s e  of the f i n d i n g s  of S y k e s  and 
colleagues (1976), tissues were quickly fixed as a precaution to 
avoid damage.
The histological and cytological effects observed on the 
liver of rats treated acutely with As III were synergized by PB 
pretreatment. These effects were comparable to those observed in 
rats exposed long-term to As III or As V in drinking water 
(Ishinishi je_t a_l . 1980, Byron _e_t a_l. 1967, Fowler _e_t a_l. 1 9 77 , 
and Mohelska ejt a_l . 1980) and in the liver of humans dead by
acute arsenic intoxication (Frejaville et al, 1 972). All the
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changes already described point dut to the liver as primary 
target organ for arsenic toxicity , possibly due to the As III 
c a p a c i t y  to i n t e r a c t  with t h i o l - p r o t e i n s  or t h r o u g h  its 
conversion to As V which inhibits the respiratory chain and the 
energy supply (Squibb and Fowler, 1981), therefore affecting the 
whole homeostasis of .the liver.
4.1.4 Species differences and why rats were chosen as a model for 
arsenic hepatotoxicity.
To compare the toxic effects of arsenic administration among 
different species is difficult because many factors are involved 
in the toxic process in each one of the species studied. Examples 
of these differences are pharmacokinetics, biomethy 1 a t i o n , and 
s p e c i f i c  i n t e r a c t i o n s  be t w e e n  the toxic m o l e c u l e  and 
i n tracellular biomolecules (Vahter, 1983). Because of those 
differences, the rat has been considered as an inadequate model 
for the study of arsenic's effects, due to highly specific 
interactions of this element with intracellular receptors in rat 
tissues (Marafante _e_t a ]^, 1 982). This fact is reflected by a
very long half-life, a low cumulative excretion, and a high 
content of arsenic in the blood (Ducoff 52_i 1 948). However, a 
great part of arsenic which remains bound to red blood cells 
appears to be DMA (which is far less toxic than inorganic 
arsenic) rather than inorganic arsenic (Odanka _e_t a 1 980, 
Vahter _e_t a 3^, 1981, Herman and Clarkson, 1983), and bound to
haemoglobin (Fuentes e_t al., 1981). Furthermore, _in v itro assays 
have shown that inorganic arsenic does not bind to rat red blood 
cells (Vahter et al, 1981). No demethylating mechanisms have been
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discussed in the literature.
As far as liver is concerned, Vahter and Norin (1980) have 
shown that arsenic concentration in the mouse liver rises sharply 
30 min after administration, and decreases 6 hr afterwards. 
Furthermore, autoradiographic studies have shown that in mice and 
hamsters an increased amount of this element is found in the 
liver after its administration, with only gallbladder and kidney 
containing more arsenic. The content in the liver of mice dosed 
orally with As III (0.4 mg/kg body weight) decreased to 10% of 
the initial value after 6 hr. Besides, Lakso and Peoples (1975) 
shown that isolated liver maintains an active méthylation 
process, and Rowland and Davies (1982) observed that arsenic was 
completely methylated 3 hr after dosing.
Besides, differences in the metabolism, pharmacokinetics,
and distribution of arsenic in exposed animals have been reported
(Vahter, 1983), these differences affect the intensity of arsenic
]yiuers<2.
toxicity (Vahter e^ a 3^, 1982). There is A correlation between 
the ability to biomethylate As III and its toxic capacity (Vahter 
and Marafante, 1987), dimethylarsine being the metabolite found 
in g r e a t e s t  amount in the urine, with s m a l l  a m o u n t s  of 
monomethylarsine acid (Vahter, 1981). In man a combination of 
both is present in the urine (Crecelius, 1977). Marmosets are an 
example of species with a very low, or non-existent a r s e n i c - 
methylating capacity, and arsenic is extremely toxic in this 
species (Vahter e^_t al^, 1982, and 1985). In spite of this, LD^Q 
in rats, is not very different from other species.
It is possible that pharmacokinetics (Ducoff et al. 1948),
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may be of relatively small importance in the effects of inorganic 
arsenic on the histology and metabolism of the liver of rats. On 
the contrary, specific hepatic effects of arsenic have been 
shown, as the profound changes in the liver architecture which 
have been discussed above, the induction of the HO (Sardana _e^  
a 1., 1981), and the effects on the activity of mitochondrial 
enzymes (Squibb and Fowler, 1981) in this species, are examples 
of this.
Furthermore, one of the most controversial issues in the 
toxicology of arsenic is its capacity to produce cancer. Despite 
a lack of animal results, the I ARC, 1 980 has considered that 
"there is sufficient evidence that inorganic arsenic compounds 
are skin and lung carcinogens in humans". Recently Pershagen _e^  
a 1 ., 1 984, has reported the production of lung cancer in rats
which were given 15 intratracheal instillations with a suspension 
of sodium arsenite dissolved in water and sulphuric acid, and 
were observed during all their life span. However, interpretation 
is complicated by the fact that any animal model selected may 
have a different pharmacokinetic excretion pattern of this 
element from that presented by man (Ducoff a_lj_, 1 948). In
addition, ratio of the urinary metabolites excreted by other 
species are not similar to that present in human urine, which is: 
DMA, 50%; MMA, 14%, and Inorganic arsenic 7% (Creselius, 1977).
Vahter, 1 983; Bertolero e t  a I^, 1981 have suggested that
rabbits and mice are better animal models for the study of the 
toxicology of arsenic than rats; However, as it has been discussed 
previously, haem metabolism in rabbits presents peculiarities, 
while individual observations in mice are difficult to_ be
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p e r f o r m e d ,  p a r t i c u l a r l y  when s u r g e r y  is required. Hence, 
observations are made from homogenates of organs pooled from 
s e v e r a l  a n i m a l s ,  and v a r i a t i o n s  w hich may exist b e t w e e n  
individuals are obscured.
For the re a s o n s  giv e n ,  it was c o n s i d e r e d  that rat 
constitutes an animal model which will accurately reflect the 
main physiological and toxicological effects of arsenic in the 
liver. H o w e v e r ,  this s p ecies may not be a d e q u a t e  for 
pharmacokinetic studies.
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4.2 The effect of treatment with sodium arsenite on the activ ity 
of the haem metabol ism pathway enzymes.
4.2.1 Effect on the activity of the 5 - ami no 1 a e v u 1 inic acid 
dehydratase.
The activity of the rat liver 5-ALAD (table 3.3.2) was 
similar to that found by Woods and Fowler (1977), and was smaller 
than the activity found in control human liver biopsies by Kodama
5.2 52_L (1 983 ) (22 nmol p o r p h o b i l i n o g e n / m g  protei n / h r ) .
Subcutaneous As III administration produced no change in the 
activity of this enzyme, even under different nutritional 
regimens or pretreatments with cytochrome P-450 inducers (table
3.4.1). Similar results were obtained by Woods and Fowler (1977), 
in rats exposed long term to As V in drinking water, and in rats 
acutely dosed with Se IV (Maines and Kappas, 1976).
Interestingly, lead is a strong 5-ALAD inhibitor whereas As 
III is not (Sassa, 1978). The inhibition caused by lead is 
thought to be due to an interaction between lead and the SH 
groups of the enzyme. Why is 5-ALAD inhibited by lead and not by 
arsenic, as has been found in the current study, since both of 
them are powerful SH-affecting reagents?. The reasons are not 
certain, but some ideas can be offered to elucidate this fact. 
One explanation could be that the thiol groups located in the 
enzyme are not affected by arsenic because they might not be 
vicinal, making the interaction enzyme-arsenic very weak (Webb,
1966). Another possibility could be that the 5-ALAD's ions 
requirements may be only for m etallic divalent cations, since 
zinc is essential for the activity of the enzyme and cadmium
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could restore this activity (Shemin, 1976). Furthermore, cobalt 
is able to restore 20% of the total enzyme activity (Cheh and 
Nielands, 1973). Consequently, ionic groups as As III may not be 
able to interact directly the thiol groups of the enzyme, 
possibly because of a steric impairment imposed by the size of 
the ionic group.
4.2.2 Effects on the activity of haem oxygenase.
The activity of the hepatic microsomal HO was induced in all 
those rats dosed with As III, as reported for other metals 
(Maines and Kappas, 1 9 7 7 ; Eaton _e^  1 980; Drummond and
Kappas, 1980, and 1981; Cebrian, 1986). When As III was 
subcutaneously administered to PB pretreated rats, HO was induced 
3 fold 2 hr after administration, 10 fold 4 hr after, and 16 fold 
16 hr after, this increase coincides with the depletion found in 
the percentage of saturation of tryptophan pyrrolase (table 
3.3.3). The arsenic effect on the activity of HO was first 
described by Sardana e t  a_1 (1981), who found that 8 hr after As 
III administration the maximum induction was reached. Therefore 
the onset of the induction was very quick. results are
similar to those described in rats treated with arsenic alone by 
Sardana e^_t a I^ (1981). The peak of the induction produced by As 
III was reached earlier than that produced by tin, zinc, and 
antimonyum (Drummond and Kappas, 1980 and 1981). Cobalt appeared 
to f o l l o w  a similar pattern to that of As III, with the maximum 
activity being obtained 8 hr after an injection of cobalt 
chloride. The activity fell again 16 hr after dosing, and
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despite subsequent doses each 24 hr no further induction was 
observed (Maines and Kappas, 1975, .and 1977).
The HO activity in isosafrole pretreated rats was found 50% 
greater than that of the PB pretreated rats, but 3-MC rats showed 
only 50% of the activity of the PB group (table 3.4.1). These 
were also consistent with those found by Schacter and Mason 
(1974).
PB treatment produces an induction in the cytochrome P-450 
content and 5 -ALAS activity (Moore _e_t a ]^, 1970), but neither
single, nor repeated PB administrations induced HO a ctivity in 
spite of the g r a d u a l  i n c r e a s e  o b s e r v e d  in the c o n t e n t  of 
cytochrome P-450 (Tables 3.3.1, 3.4.1, 3.4.2, and 3.4.6). This
results are comparable to those reported by Ibrahim _ejt a 1. 
(1978). However, under specific circumstances PB induces HO. For 
example, in Se deficient rats (Correia and Burk, 1 97 6). Which 
might be due to an under-utilization of haem as a result of a 
delay in the production of apo-cytochrome P-450, leading to an 
excess of haem and to HO induction (Correia and Burk, 1 978). In 
addition, when PB is administered to chronically iron over l o a d  
rats, a significant induction of HO and a decrease in the 
cytochrome P-450 content is observed (Ibrahim _et a 1., 1981).
As III produced a differential HO induction (5, 8, and 21 
fold), when dosed to rats p r e t r e a t e d  with 1, 2, or 3 PB
administrations respectively. A reason for this, is that the 
requirement for haem to synthesize cytochrome P-450 might be 
greater during the first stages of the PB-induction.
The induction of the activity of the hepatic HO is not f u l l y  
understood. However, it is very likely that such induction is in
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response to an increase in the "free" haem pool. The source of 
the haem responsible for the induction could be external or 
internal. Tenhunen _ejt a (1 970) induced the enzyme activity 
after an injection of haem. On the other hand, the internal 
source of haem is more difficult to explain, particularly so in 
the case of As III. Therefore, possible mechanisms by which the 
"free" haem pool increases will be discussed.
As III induced the HO activity 2 hr after administration. 
When 5 - a mi no- [ 4 - ^^C] - 1 a e V u 1 i ni 0 acid was administered to bile 
duot-cannulated rats, 1 hr before dosing with As III, an increase 
in the bilirubin content in the bile was observed 6 hr after As 
III administration, and the bilirubin excretion in bile reached a 
peak 12 hr later (Fig 3.3.1), this increase is very likely to be 
related to the decrease in the percentage of saturation of 
tryptophan pyrrolase observed after 16 hr of administration of As 
III (table 3.3.3). After 24 hr the v a l u e s  for b i l i r u b i n  
excretion returned to normal levels. This "bel 1-shape" curve 
contrasts with that found by Maines, 1977, since after a cobalt 
administration the excretion of bilirubin increased continuously. 
Radioactivity was also monitored, and a sharp increase in the 
excretion was observed 4 hr after As III administration, reaching 
a peak 6 hr after treatment. Maines (1 977), found a peak in the 
r a d i o a c t i v i t y  e x c r e t e d  b e t w e e n  3 and 5 hr a fter c o b a l t  
administration. When bilirubin and excretion in the bile of
As III treated rats were compared, j^Ui-e-y- indicated that C 
excretion preceded the excretion of the bulk of the bilirubin 
(fig 3.3.3) and r e m a i n e d  e l e v a t e d  in c o m p a r i s o n  with the
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excretion of bilirubin of control rats.
These facts suggested that the hepatic haem is the first to 
be c a t a b o l i z e d ,  since 5 -ami no - [ 4 -  ^C ] - 1 a e vu 1 inic aoid is
specifically incorporated into the h e p a t o c e l l u l a r  haem (Tait, 
1 978), rather than into the haem of haemoglobin. Therefore, the 
bul k  of b i l i r u b i n  comes from two sources, one w h i c h  is 
intracellular, presumably from the "free" haem pool, and the 
other from haemolyzed erythrocytes. Bile immunoelectropherograms 
indicated that an increase in haptoglobin was one of the many 
changes observed in the composition of bile of As treated rats. 
The excretion of this protein was comparable to that of rats 
injected with haemoglobin labelled with Nal^^S (Hinton e t  a l., 
1980).
The mechanism by which haem is i n t r a c e l l u l a r l y  raised 
remains to be explained. However, some alternatives could be 
explored ;
a). Synthesis of a haem like derivative. The induction of hepatic 
HO by cobalt chloride may be due to the synthesis of an anomalous 
haem (Co-protoporphyrin IX). Which, in turn, exerts a continuous 
stimulus on the induction of the enzyme (De Matteis and Unseld, 
1976). This explanation is unlikely to be adequate for As III or 
non-metals in general, since contrary to the ionic nature of 
oobalt, a monoatomic divalent ion, is able to produce C o ­
protoporphyrin IX (Falk, 1964), the As III ion consists at least 
of 3 atoms [ASC2 "], which could make its inclusion into the 
porphyrinic ring very difficult.
b). Some compounds, like allyl isopropyl acetamide, are known as 
"suicide" P-450 substrates, they directly alkylate the haem
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moiety, depleting the "free" haem pool (Ortiz de Montellano, 
1983). However, three considerations make this possibility very 
unlikely to be applied to As III. 1). As III will have to compete 
against the ferrous ion in the core of the ring to c o v a l e n t l y  
bind the protoporphyrin IX, 2) As III does not seem to be 
metabollicaly "activated" in the way allyl isopropyl acetamide 
is. However, As III may be activated in a different manner, since 
_in _vÂ^Z^ e x p e r i m e n t s  in this study have shown that the 
cytochrome P-450 content deoreases immediately after addition of 
As III and NADPH. 3). More important than that, a l l y l  isopropyl 
acetamide reduces the "free" haem pool, producing a consequent 
decrease in the HO activity (De Matteis, 1982), which is opposite 
to what happens with As III.
0 ). As III might increase the peroxidation of endogenous lipids 
and the breakdown of cytochrome P-450, which would account for 
the increase in he "free" haem pool, in a way similar to that of 
lead (Penning and Scoppa, 1977). This possibility remains to be 
explored.
d). A wide variety of reagents convert cytochrome P-450 into
cytochrome P-420 (Yamano and Ishikawa, 1 982.) . Cytochrome P-420
releases the haem moiety easily since its affinity for haem is
lower than that of cytochrome P-450 (Maines, 1 97 7). When As III
was assayed directly with microsomes I n  v it ro (section 3.5) no
modification was found in the spectrum. However, EROD but not
ECOD activity decreased at As III concentrations up to 50 mM,
possibly because the isocytochrome P-450 which catalyses EROD
4(0
dealkylation could be more labile^As III than those catalyzing
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the dealkylation of ECOD.
e). Free haem could also rise as a consequence of a fault or 
decrease in haem apo-proteins, seen in the case of Se deficient 
rats, in which PB induces HO activity because of a delay in the 
synthesis of apo-cytochrome P-450 (Correia and Burk, 1976 and
1978). However, no effect of As III on protein synthesis has been 
reported, though its effects on DNA synthesis and repair are well 
known (Leonard and Lauwerys, 1980; Sirover, 1981; Chang 1987).
In addition. As III may prevent the access of the haem 
moiety to the newly made apocytochrome P-450, by binding the 
cysteine-thiol group which is vitally i n v o l v e d  in the haem 
cytochrome P-450 interaction (Castro, 1982; Gotoh e^a]^, 1983; 
and Bast, 1986). Hence, As III may produce a transient increase 
in the "free" haem pool, and as a consequence, an induction of 
the HO activity.
4.2.3 Effect of sodium arsenite on metal chelatase.
A subcutaneous dose of As III produced no effect on the 
activity of metal chelatase (Table 3.3.5). However, FC _in v i tr o 
is inhibited by many metals (Labbe and Hubbard, 1961; Taketani 
and Tokunaga, 1981) including As III (Dailey, 1986), by organo- 
metallic compounds as p-chloromercuribenzoate (Schwartz e_t a l ., 
1 959), and by elements as oxygen (Porra a_lj_, 1967). GSH
protects FC activity from inhibition, possibly because it keeps 
iron reduced (Labbe and Hubbard, 1961).
The measurement of FC activity is difficult, mainly because 
the incorporation of Fe^+ into the protoporphyrin ring is 
inhibited by oxygen (Porra et al., 1967), possibly beoause the
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ion is oxidized into Fe^+ and FC is highly specific for ferrous 
ions. To avoid suoh oxidation great amounts of GSH are used 
(Labbe and Hubbard 1961). In addition, a non- enzymic dependent 
incorporation of ferrous ions into the porphyrin ring whioh might 
increase the concentrations of haem, and consequently produce 
variable results (Isah, 1986). Because of this, a method using 
Co^+, (in this case the enzyme is called metal chelatase), which 
in v_i^ro behaves in a similar way to that of Fe^ + , without the 
problem of oxidation (Labbe and Hubbard, 1961), and mesoporphyrin 
IX was used instead of protoporphyrin IX (Jones and Jones, 1969).
Metal chelatase is an enzyme which is tightly bound to the 
inner mitochondrial membrane (Jones and Jones, 1968? McKay e t  
a 1., 1 969), and is inhibited _in vi^vo by cobalt (Wagner and
Tephly, 1 973), 3 ,5-diethoxycarbony 1 - 2,4,6-1r i m e t h y 1 pyridine
(Tephly _e^  a 1., 1971), griseofulvin and EDTA (Woods, 1976).
In this work, PB alone, on the other hand, was found to 
produce a 25% induction of metal chelatase activity in rat liver 
rat (tables 3.3.5 and 3.4.4). Similar results were found in FC 
induction by Tephly e_t a_lj_ ( 19 7 1), and Wagner and Tephly (1973). 
However, n u t r i t i o n a l  or g e n e t i c  fa c t o r s  a f f e c t  i n d u c t i v e  
responses. The former is illustrated by the lack of metal 
chelatase induction in Se deficient rats after administration of 
PB (Burk and Correia, 1977), or as in the case of isolated 
hepatocytes taken from diabetic rats in which PB produced an even 
higher induction than that observed in isolated hepatocytes 
obtained from oontrol rats (Canepa _et al., 1 985).
When As III was subcutaneously injected in PB pretreated
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rats, metal chelatase activity was significant 1 y inhibited (27%), 
c o m p a r e d  with PB p r e t r e a t e d  rats as shown in t a b l e  3.4.4. 
Apparently, PB pretreatment synergises the toxic effect of As 
III. This effect was comparable to that found in rats exposed 
long-term to As V in drinking water (Woods and Fowler, 1 978 and
1979).
Although metal chelatase has no important regulatory role in 
haem biosynthesis (Jones and Jones, 1969), it has been suggested 
that when 5-ALA is available to the cell in enough quantity, and 
5-ALAS is not functioning in a regulatory capacity, then metal 
chelatase may play that role. Furthermore, it has been considered 
that metal-chelatase is subjected to the feed-back of both, 
protoporphyrin IX and haem Wagner _et a 1. ( 1976).
As far as mitochondrial enzyme markers are concerned, the 
subcutaneous administration of As III produced a no significant 
d e c r e a s e  in c y t o c h r o m e  c oxidase, a m a r k e r  of the inner 
mitochondrial membrane. But when As III was administered to PB 
pre-treated rats, the cytoohrome c oxidase activity decreased 36% 
when compared with controls, and 13% when compared with rats 
treated with PB alone. Apparently PB decreases cytochrome c 
activity but induces metal-chelatase. However, As III decreases 
cytochrome c oxidase in PB pretreated rats (tables 3.3.16 and 
3.4.10).
Monoamine oxidase, a marker of the mitochondrial matrix, was 
not affected by As III administered under any conditions employed 
in the present study.
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4.3 E f f _e_c^  of 6 ajt m_e w_ijb h _s o^i^_um e n_i_t _e on _t h_e
function oxidase activity.
Nutritional conditions. Fasting or corn oil pretreatment produced 
no effect on the hepatic cytochrome P-450 content, when these 
values were compared with those of fed rats. However, Bock e_t a 1. 
(1973) observed that fasting produced a decrease in the content 
of hepatic cytochrome P-450 in rats. However, fasting produced a 
decrease in EROD, but not in ECOD or BPND, these results were 
comparable with those of Kato and Guillette (1965).
The s u b c u t a n e o u s  a d m i n i s t r a t i o n  of As III p r o d u c e d  a 
decrease in the hepatic cytochrome P-450 content 16 hr after 
dosing, in fasted rats (28%), and in fasted rats pretreated with 
corn oil (34%), this decreases were higher than those found in 
fed rats. Sardana _^t ( 19 8 1), found that cytochrome P-450
content decrease by 40% in rats treated with As III (lOOumol/kg 
body weight), after a similar period of treatment, but rats were 
fasted 12 hr before dosing, and f a s t i n g  c o n t i n u e d  u n t i l  
termination of the experiment. Cebrian (1986), found a similar 
decrease (41%) in rats fasted 24 hr before dosing and fasting 
also continued until the rats were killed 16 hr later. Starvation 
may increase the lability of the cytochrome P-450 making it more 
prone to damage.
When the activity of some mixed function oxidases were 
measured, the two groups of fasted, and fasted plus corn oil- 
pretreated rats were generally more severely affected by As III 
than fed rats. It is well known that starvation magnifies the 
hepatic effects of toxicants. Chloroform is an example of this.
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and it is also known that carbohydrate rich diets confer a 
certain degree of protection against such he patot oxi c effects 
(McLean _e_t a_lj_, 19 65). As III t o x i c i t y  a l s o  a p p e a r s  to be 
e x a c e r b a t e d  by s t a r v a t i o n .  F u r t h e r m o r e ,  many m e t a l s  and 
metalloids, such as As III in the case of the present study, 
decrease hepatic cytochrome P-450 content to around 30% of the 
control value, 16 hr after administration (Maines and Kappas, 
1975, and 1977; Eaton e_t a 1., 1980; and Drummond and Kappas 1980,
and 19 8 1).
As III decreased the hepatic cytochrome P-450 content in a 
time-responsive fashion. The lowest concentration occurs 24 hr 
after dosing, whereas from 36 hr onwards the cytochrome P-450 
content increased again towards control values. The EROD activity 
followed the cytochrome P-450 pattern; the lowest value (57% 
decrease), was found 24 hr after dosing. ECOD also deoreased down 
to 37% of control values 16 hr after treat me n t.
A continuous drop in hepatic cytochrome P-450 content 
produced by As III administration was observed by Sardana e^ a 1. 
(1981), however, the cytochrome P-450 content remained low 48
hr after dosing. Starvation for such a long period of time could 
impair the ability of hepatic cytochrome P-450 to recover. The 
cytochrome P-450 content has been reported to fall steadily 
during the first 24 hr after the administration of cobalt (Maines 
and Kappas, 1 975), zinc and antimony (Drummond and Kappas 1 9 80, 
and 1981), in a way comparable to that of arsenic. The activity 
of mixed function oxidases were not measured in any of these 
experiment s .
Despite the great variation in BPND activity in control
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values, a decrease in the activity of this enzyme was observed 
as a result of As III administration. However, NADPH-cytochrome c 
(P-450) reductase decreased only after 48 hr of treatment.
The effect of As III on both cytoohrome P-450 and some 
monooxygenases was studied after PB induction. The As III 
a d m i n i s t r a t i o n  p r o d u c e d  a g r e a t e r  effect on the h e p a t i c  
cytochrome P- 45 0 content of PB pretreated rats than that of the 
unpretreated rats (Table 3.4.6).
The PB pre treated rats showed a dose-related induction of 
both cytochrome P-450 and monooxygenase activity, BPND and PROD 
being the most induced. The activity of all of them were found 
very sensitive to As III treatment, demonstrating inhibition of 
up to 45 or 55% when compared to rats pretreated with PB alone.
Carbon disulphide produce liver enlargement and depression 
of drug metabolism, (Bond a2j_, 1 968). When carbon disulphide 
was dosed to PB pretreated and starved rats the hepatic injury 
was magnified (Magos and Buttler, 1972), hepatic cytochrome P-450 
decreased by 40% when male rats were pre treated with PB and 
starved before carbon disulphide administration (De Matteis and 
Seawright, 1 9 7 3). Although As III is an ion rather than a n o n ­
polar compound. As III resembles carbon disulphide insofar as its 
hepatotoxicity was synergized by pretreatment with PB. However, 
like a llyl isopropyl acetamide, carbon disulphide can be 
metabolized to an active metabolite that can react with haem, 
producing alkylated derivatives. Despite As III biomethy1 at ion in 
the liver (Lerman and Clarkson, 1983), there is no evidence that 
this metabolism is carried out in. the microsomal compartment, so.
-  273 -
it is very likely that the toxic mechanism of these compounds is 
different.
The half life of rat liver cytochrome P- 450 has been 
estimated between 8 and 24 hr (Tephly, 1 978), and this families 
of cytochromes account for the 32% of the c e l l u l a r  haem in the 
hepatocyte (Meyer and Marver, 1971), pointing for a need for 
rapid turnover and continuous synthesis. If arsenic delays the 
synthesis of the apocy tochrome P-450 as in the case of PB given 
to is Se deficient rats (Correia and Burk, 1976), or it interacts 
with the apo-cytochrome P-450 impairing the assembly of the 
cytochrome P-450, then a transient increase in the "free" haem 
pool could trigger the induction of HO.
When the effect of As III was measured, in a time response 
fashion, on the cytochrome P-450 content and PROD activity in 
rats pretreated with PB, it was observed that total cytochrome P- 
450 content had dropped by 8% 2 hr after treatment, while PROD 
activity dropped 28% during the same period of time. Four hours 
after dosing the cytochrome P-450 level had fall e n  by 21.7%, 
while the drop in PROD activity was 27%. Sixteen hours later the 
cytochrome P-450 concentration had fallen by 40% while the PROD 
activity was 55% of those values observed in livers of rats 
pretreated with PB (table 3.4.7). Besides, discussed earlier, the 
induction of mitochondria by PB, and many other proteins, may 
lead the hepatocyte to a severe energy distress which originates 
the pathologic changes which have been observed.
A fact favouring the possibility of impairment of the 
assembly between haem and apo-cytochrome P-450 by As III, is the 
fact that neither the e 1ectropherogram of microsomal suspensions
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taken from rats pretreated with saline or PB and then injected 
with As III showed a decrease in cytochrome P-450 content when 
compared with controls. This may be due to the presence of the 
apo-cytochrome P-450 instead of the hoio-cytochrome.
4.3.2 Effect of the administration of sodium arsenite to rats 
pretreated with different cytochrome P450 inducers.
Cytochrome P-450 content was induced 2.2 fold when rats were 
pretreated with PB or ISO, and 1.13 fold when pretreated with 3- 
MC, as shown in tables 3.45, 3.48, and 3.49. Mannering _ejt a 1. 
(1969) observed that PB produced a greater inductive effect than 
3-MC. With regard to the effects of ISO and 3-MC, hepatic 
c y t o c h r o m e  P-450 was found to be induced 3.8 and 1.7 fold 
respectively, in fed rats (Connelly 1983), but differences in 
the capacity for cytochrome P-450 induction have been found 
between animal species. Fennell (1980), for example, reported 
that ISO produced a 1.5 fold increase in mice while it was 1.8 
fold in rats.
When the a c t i v i t y  of the mixed f u n c t i o n  o x i d a s e  was 
measured, ECOD was induced 2.9, 2.8, and 2.6 fold by ISO, PB, and 
3-MC respectively. Connelly (1 983) found 8.9 and 5 fold induotions 
produced by ISO and 3-MC respectively.
EROD was induced 2.2, 15.4, and 4.8 fold by 3-MC, ISO, and 
PB. Connelly (1983), found 8.3 and 23 fold induction by 3-MC and 
ISO respectively.
The magnitude of the cytochrome P-450 and monooxygenase 
activity depends on the induoer used, the nutritional status of
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the animal species, and the experimental protocol.
Enzymes as BPND and PROD which are preferentially induced by 
PB, were the most affooted by As III, while ECOD which is less 
specifically induced by PB was also less affected by As III.
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4.4 " I n  v i t r o "  e f f e c t s  o f  a r s e n i t e ,  a r s e n a t e ,  a n d  s e l e n i t e  o n  t h e
££££.£££ ££JË f u n c t ion
oxidase.
Exposure of liver microsomes to high concent-rations of 
neutral salts resulted in the conversion of cytochrome P-450 into 
cytochrome P-420 (Imai and Sato, 1967). The hydroxylation and 
déméthylation activities were affected by the conversion into P- 
420. However, they were partially regenerated when cytochrome P- 
420 was totally reconverted into cytochrome P-450 by addition of 
polyols, by dilution, or by washing (Ishikawa e_t al., 1 969).
The interaction between cytoohrome P-450 and As III, As V, 
and Se IV produced different responses, which will be discussed 
as follows:
Only high concentrations of As III were able to deorease the 
cytochrome P-450 content, without forming cytochrome P-420, 
suggesting that the protein was partially degraded or possibly 
precipitated (Imai and Sato, 1978). Se IV decreased cytochrome P- 
450 at lower concentrations than As III, and As V produced no 
effect.
When the effect of As III, As V and Se IV was assayed _in 
vitro on the activity of ECOD, varying results were obtained. As 
V produce a concentration-related response in the activity of 
ECOD after 1 hr incubation at 30 °C (figure 3.5.2 and 3.5.3). This 
effect could be due to the steric and electronio similarities 
between As V and phosphate. In the case of As III no effect on 
the activity of this enzyme was found, but Se IV produced a 
significant decrease, this results agree with the assays on
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cytochrome P-450.
However EROD activity was found to be more sensitive to all 
the ions a s s a y e d , and concentrations up to 30 mM of As III 
significantly decreased the activity of this enzyme.
NADPH slightly decreased the cytochrome P-450 content with 
time, confirming the results of Levin a (1973). When NADPH 
plus As III, As V, or Se IV were added to microsomes, each 
treatment produced an immediate decrease in the amount of
cytochrome P-45 0 decreasing its spectrum at 450 nm, even at low 
c o n c e n t r a t i o n s .  One e x p l a n a t i o n  might be that As and Se
accelerate the peroxi dat i ve effect that NADPH n o r m a l l y  has 
(Hochstein and Ernster, 1963), a possible break down of the haem 
moiety could be the reason for the loss of spectra has been 
suggested by (Yamano and Ishikawa, 1982), to explain the laok of
production of a peak at 420 nm when NADPH is added in vitro.
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4.5 Effect of sodium a r s enite  on isolated rat h e p a t o c y t e s .
As III (100 uM) produced an increase in LDH leakage in 
isolated rat hepatocytes similar to that of control cells (figure
3.6.1). When LDH and viability (as estimated by a trypan blue 
exclusion assay) were estimated, it was found to remain constant 
for 2 hr; after this period the v i a b i l i t y  d e c r e a s e d  
significantly. Lerman and C 1 a r k s o n (1 983), found a significant 
uptake when 2.4 nmol of As III was added to liver slices. The As 
III was methylated in those slices which were incubated at 37°C 
for 4 hr and its uptake was found to be greater than that of As 
V. They also found that cultured rat hepatocytes had a greater 
affinity for As III, which was biomethylated, than for As V.
Attempts to increase the viability incubation time of 
isolated hepatocytes failed; the longer they were kept alive was 
2 hr, this period of time was not enough to induce HO in this 
system. However, Maines and Kappas (1977), and Srivastava e_t a 1.
(1980) have reported that embryonic chick cells may be kept 
viable for 16 hr, and that during that time, treatment with 
cobalt induced HO.
Efforts have to be done to design a proper i^ n _v££££ model 
which will a l l o w  to study the induction of both 5-ALAS and HO, in 
an isolated environment. In this way, a better evaluation of the 
role of As III, both as enzyme inductor and haem depleting agent, 
could be done.
CHAPTER F IV E
CONCLUSIONS AND FUTURE WORK
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5. CONCLUSIONS AND FUTURE WORK.
5 .1  CONCLUSIONS.
Many factors modify the toxic response of a living being to 
arsenic and the mechanism through which it causes liver damage is 
still not totally understood. One of those factors is the 
interaction of the toxicant with other drugs, such as PB in this 
case, which affect the speed and magnitude of the response.
Haem is one of the biomolecules which is greatly affected by 
As III, since both its rate of synthesis and degradation are 
modified. It has been found that As III treatment is able to 
produce a two fold induction in the rat hepatic 5-ALAS activity 
( A 1 bo res , 1984) and an even higher induction in the hepatic HO. 
This observations are comparable to those of Sardana_ejt a 1.
(1981), and Cebrian (1986). The paradoxical manner in which this 
twin induction occurs is matter of a great deal of investigation, 
and also has been one of the objectives of the present work.
As regulator enzymes, the activities of 5-ALAS and HO are 
controlled by a feed-back mechanism performed by the "free" haem 
pool, which comprises the haem not bound and reversibly bound 
to proteins. In this way the "free" haem can interact with the 
proper effectors in order to maintain an equilibrium in the 
enzymes which in turn carefully controlled the amount of "free" 
haem in the cytosol.
The subcutaneous administration of As III produces an 
enormous increase in HO activity, regardless of whether As III is 
dosed alone or to rats pretreated with cytochrome P-450 inducers. 
This As III dependent induction coincides with the elevation in
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the amount of bilirubin excreted in the bile. Results of this 
study suggest that, as a r e s uIt of As III treatment to rats 
injected with 5-amino-[4-^ ]-1aevu 1 inic acid, the hepatic haem 
is the first to be degraded, followed by the bulk of bilirubin 
which possibly comes from the degradation of extrahepatic haem, 
which possibly from erythrocytary haemoglobin. Since bile 
immunoelectropherograms of rats treated with As III showed an 
increased in haptoglobin excretion, indicating a certain degree 
of haemolysis.
But, how does As III cause an increase in the "free" haem 
pool?. First, arsenic is a strong thiol reagent, although it 
reacts more strongly with vicinal SH groups (Webb, 1966). 
Secondly, cytochrome P-450 accounts for 32% of the total haem in 
the hepatocyte (Meyer and Marver, 1971a); moreover, it is a 
haemoprotei n with one of the fastest turnover rates (Levin and 
Kuntzman, 1969; Meyer and Marver, 19 7 1b). It is possible then, 
that As III interferes with the linkage between haem and the a po - 
cytochrome P- 450, since _in v;_i^ro experiments showed that this 
compound alone has very little or no effect on the pre-existent 
cytochrome P-450 in the microsomes, and it is necessary to 
incorporate NADPH in the system in order to decrease the c y t o ­
chrome P-4 50 content. Therefore, As III might undergo a metabolic 
activation. On the other hand, electrophoretic separations of 
microsomal proteins showed no apparent decrease in the band 
corresponding to this protein, as if the protein is there, 
although it may not be enzymically active.
A direct inhibitory effect of As III on the biosynthesis of
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apo-cytochrome P-450 cannot be discarded. However, As III 
inhibitory effects on the biosynthesis of proteins has not been 
demonstrated yet, in spite of its effects on DNA repair on 
Escherichia coll irradiated with UV light (Rossman e_t a 1., 1977)*
The Vi.VO effects of As III on cytochrome P-450 appeared 
to be n o n - s p e c i f i c , t h i s  might imply that all isoforms of 
cytochrome P-450 could be a f f e c t e d e q u a l l y .  Results from this 
study have shown that As III + PB treatment produ c e s  a 
significant d ecrease in PROD a c t i v i t y  2 to 4 hr after 
administration. Therefore, it is possible that some cytochrome P- 
450 isoforms might be more vulnerable to the arsenic effects 
than others.
The fact that both enzymes, 5-ALAS and HO, are induced 
reflects alterations in the "free" haem pool equilibrium. The 
classic pattern followed by the 5-ALAS induction shows a decrease 
of the enzymatic activity followed by an increase some hr later 
(Sardana e t  aj^, 1981). This response might be; 1) a result of 
transient increase of the "free" haem pool inducing HO and 
degrading haem, and 2 ) once haem decreases, t r iggers the 
induction of 5-ALAS some hr later.
PB pretreatment increases the metabolic activity of the 
liver and the synthesis of some proteins and cofactors is also 
accelerated (Staubli e_t a 1., 1969). After PB treatment a decrease
in glycogen and an increase in mitochondrial number were 
evidence of the increase metabolic activity. When PB pretreated 
rats were starved for 24 hr, mitochondria suffered considerable 
damage, indicating that the liver of rats pretreated with PB and 
starved does not seem to cope with the energy requirements of the
- 283 -
induction.
As III effects were greater when a d m i n i s t e r e d  to PB 
pretreated rats. In such animals, glycogen was totally depleted, 
mitochondria showed different degrees of condensation, and many 
of them appeared degraded, myelinic figures filled dilated bile 
c a n a l i c u l i ,  and a u t o 1 y sosomes with remains of o r g a n e l l e  
structures were present. An increase in lipidic vacuolation 
around the periportal area was evident. All these are signs of a 
strong toxic response. The As III effects on cytochrome c 
reductase and FC, both enzymes tightly bound to the inner 
mitochondrial membrane, indicate the magnitude of the damage 
caused to these organelles. In addition. As III can be oxidized 
in £ £ £ £  (Ginsburg, 1 965), thus ATP production may be inhibited, 
decreasing the energy available to maintain the synthesis of 
proteins.
The first step in As V méthylation is its reduction to As 
III, then MM A is produced. Despite méthylation occurring in the 
cytosol, reactive metabolites could be formed and may attack 
membranes. The possibility of lipid peroxidation of hepatocyte 
membranes has yet to be investigated. Inhibition of methyl 
transferases by periodate oxidazed adenosine increase the As 
body burden, impairing detoxication mechanisms (Vahter and 
Maraf a n t e , 19 8 4). This detoxication mechanisms can also be
affected by diets deficient in methionine, choline, or proteins, 
increasing the arsenic r e t e ntion period in the body, and 
decreasing the excretion of As-methylated derivatives (Vahter and 
Maraf ante, 1 987).
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5 .2  FUTURE WORK.
In view of the role of protein binding in arsenic toxicity 
in{<irec) : , by these experiments and other studies, it should be of 
interest to assess the influence of nutritional deficiencies on 
As III effects on hepatic morphology, haem metabolism, cytochrome 
P-450 and monooxygenase activity. This could involve the use of 
low protein diets or feeds deficient in specific aminoacids such 
as cysteine or methionine. One could, in addition assess the 
effects of xenobiotics, whose metabolism requires large amounts 
of energy, on arsenic toxicity. These factors could be expected 
very likely to increase the toxicity of A s 1 1 1 . This toxicity may 
also be related to the hepatocellular content of glutathione, 
methyl-6 ^2 , 5-adenosylmethionine, and 5-adenosylhomocysteine, all 
of which are key factors in the méthylation and excretion of 
arsenic. Studies along these lines may help to understand the 
differences in the magnitude of toxic effects produced by 
arsenic observed among individuals of the same species.
The excretion of As-methyl derivatives should be extensively 
monitored in urine, faeces, and bile using bile duct-cannula ted 
rats. The separation, identification and quantification of 
the derivatives obtained from those biological samples will 
help to understand the contribution of each excretory route, 
and to evaluate the efficiency of the arsenic detoxifying 
mechanisms.
The interactions between As III and microsomal proteins 
should be studied in more depth using electrophoretic techniques. 
Through this methodology, a better insight of the process of
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cytochrome degradation could be gained. In addition, based on the 
electron micrographie observations and enzymic determinations 
performed in this study, an investigation of the effects of PB + 
As III coadministration on the respiratory cycle of mitochondria 
obtained from livers of rats fed with control and special diets, 
and on the biochemical mechanisms increasing lipidic vacuolation 
will help to explain the potetiating effect of PB on As III 
toxicity.
To find the proximal inducers of hepatic 5-ALAS and HO, 
isolated cells have to be used. However, freshly isolated 
hepatocytes do not seem to be completely valid, since they are 
exposed to a great metabolic stress, there are equal problems 
with cultured hepatocytes for their rapid lose of cytochrome P- 
450. A great effort has to be put in the development of vitro 
techniques to evaluate the actual inductive effect of As III.
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